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The advancements in Whole Genome Sequencing (WGS) have increased the amount of 
genomic information available for epidemiological analyses. WGS opens many avenues for 
investigation into the tracking of pathogens, but the rapid advancements in WGS could soon 
lead to a situation where traditional analytical techniques might become computationally 
impractical. For example, the traditional method to determine the origin of an isolate is to use 
phylogenetic analyses. However, phylogenetic analyses become computationally prohibitive 
with larger datasets and are best for retrospective epidemiology. Therefore, I investigated if 
there might be less computationally demanding methods of analysing the same data to obtain 
similar conclusions. This thesis describes a proof-of-principle method for evaluating if such 
alternative analysis techniques might be viable. In this thesis Methicillin resistant 
Staphylococcus aureus (MRSA) was used, and single nucleotide polymorphism (SNP) and 
insertion/deletion (indel) genomic variation. I move away from whole genome analysis 
techniques, such as phylogenetic analysis, and instead focus on individual SNPs.  
I showed that genetic signals (such as SNPs and indels) can be utilised in novel ways to 
rapidly produce a summary of the possible geographic origin of an isolate with a minimal 
demand on computational power. The methods described could be added to the suite of 
analytical epidemiological tools and are a promising indication of the viability of developing 
cheap, rapid diagnostic tools to be implemented in healthcare institutions. Furthermore, the 
principles behind the development of the methods described in this thesis could have much 
wider applications than just MRSA. This implies that further work based on the principles 
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Introduction                                                                                1 
1.1 Introduction to epidemiology 
 Epidemiology is the study of the aetiology, transmission and identification of 
outbreaks of a disease. This information may then be used to inform public health policy. A 
disease is defined as endemic if it is maintained in a particular population (for example the 
distribution of Plasmodium falciparum malaria; Snow et al., 2005) or epidemic if there is a 
rapid spread within a short period of time (for example, the 1918 flu epidemic; Patterson & 
Pyle, 1991). If an epidemic is seen globally this is called a pandemic (for example, the outbreak 
of severe acute respiratory syndrome (SARS) in November 2002; Chan-yeung & Xu, 2003). 
 For many centuries, diseases were thought to have been caused by bad airs, so called 
“miasma”. This led to such practices as blood-letting and trepanning (Plinio, 1995). Until the 
19th century there was a divide in the medical community between the miasmatists who 
believed that diseases were propagated via bad airs, and the contagionists who believed the 
diseases propagated through physical contact. One of the first examples of quarantine began 
in the early 19th century with the segregation of smallpox and fever patients (Woodward, 
1974). It was not until fairly recently that investigative epidemiology began. There were a few 
pivotal diseases and epidemiologists within the last couple of centuries which helped further 
the understanding of epidemiology and through the years the advent of microbiology, 
epidemiology and phylogenetics has provided insights into how infectious agents grow, 
transmit and evolve. However, there is still difficulty when attempting to identify the exact 
origin of a particular infection, which limits our ability to create treatments specific for 
particular outbreaks. The goal of this thesis is to provide alternative methods to the traditional 
techniques to attempt to determine the origin of a pathogen.  
1.1.1 A brief history of modern epidemiology 
John Snow is known as the father of modern epidemiology from his identification of 
the source of a cholera epidemic in 1854 in Broad Street, London (Johnson, 2004).  However, 
the bacterium responsible for cholera was first reported by Gabriel Pouchet, and the 
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significance of its pathogenicity first realised by Filippo Pacini in 1854 (Bentivoglio & Pacini, 
1995). Other important pioneers from the early days of modern epidemiology include Peter 
Anton Schleisner, who prevented a neonatal tetanus epidemic in 1849 (Garðarsdóttir & 
Guttormsson, 2009), and Ignaz Semmelweis, who used a disinfecting procedure to reduce 
rates of infant mortality in 1847 (Wyklicky & Skopec, 1983). However, it was not until Joseph 
Lister, basing his work on that of Louis Pasteur, that disinfecting became a routine practice 
(Bankston, 2004). The application of mathematical modelling to epidemiology was initiated by 
Bernoulli’s work on cowpox inoculation (Bacaër, 2011). In the early 20th century mathematical 
models were explicitly developed for epidemiology by Janet Lane-Claypon, Anderson Gray 
McKendrick, Ronald Ross, and others (Heyde et al., 2001). The integration of mathematical 
models into epidemiology is one of the cornerstones of this field of research. 
The latter half of the 20th century saw many instances of disease identification and 
acceptance. For example, the identification of the protozoan Giardia lamblia as the cause of 
giardiasis was only fully accepted in the 1970s (Ali & Hill, 2003), and the discovery in 1983 by 
Marshall and Warren of the bacterium Helicobacter pylori as the cause of certain stomach 
ulcers (Marshall & Warren, 1984). Even though there were reports of pathogenic 
enterotoxigenic Escherichia coli as early as 1947 (Ruchman & Dodd, 1947), there was 
reluctance in the scientific community to accept that E. coli could be pathogenic as it is a fairly 
common commensal of humans. It was not until the 1980s that official acceptance occurred 
(Riley et al., 1983). Another example of disease identification was the epidemiological tracking 
of the HIV/AIDS pandemic which started in the 1980s with the identification of a group of men 
who have sex with men presenting with rare opportunistic infections (Merson, 2006). 
Eventually, investigations led to the identification of a zoonotic origin of the virus in 
chimpanzees (Keele et al., 2006).  
 Modern epidemiology has seen the emergence of novel infectious agents, and the re-
emergence of pre-existing pathogens (Hethcote, 2000). For example, in the 20th century there 
has been the identification of the causative agent for Lyme disease in 1975 (Borchers et al., 
2014), Legionnaire’s disease in 1976 (Fraser et al., 1977), toxic-shock syndrome in 1978 (Todd 
et al., 1978), hepatitis C & E in 1989 and 1990 respectively (Choo et al., 1989; Khuroo, 2011), 
and hantavirus pulmonary syndrome in 1993 (Khan et al., 1996). Furthermore, antibiotic 
resistant strains of a number of diseases have arisen, such as pneumonia (Breiman et al., 1994) 
and tuberculosis (Cohn et al., 1997). The process of identifying new infectious agents 
continues, and requires continually updating novel epidemiological methods. The 
advancement of biomedical sciences has led to the identification of certain molecular traits 
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that can be used as predictors of risk for a certain disease. The epidemiological study of these 
disease biomarkers became broadly known as “molecular epidemiology” (Maslow et al., 2015). 
Recently, genome-wide association studies (GWAS) are becoming increasingly common and 
are used in conjunction with epidemiology to identify genetic risk factors for many diseases 
and health conditions (Hirschhorn & Daly, 2005). 
 The recent advancement of Next Generation Sequencing (NGS) and Whole Genome 
Sequencing (WGS) methodologies has had a major impact on molecular epidemiology. NGS, 
which is also known as high-throughput sequencing, allows DNA and RNA to be sequenced 
quickly and cheaply. This is done by the parallelisation of the sequencing process, which allows 
thousands of sequences to be processed concurrently (Hall, 2007; Tucker et al., 2009). WGS is 
a process which determines the entire genome of an organism at a single time. Earlier 
approaches used shotgun-sequencing, whereby DNA is randomly broken up into small 
sequences and the overlapping regions of these small sequences are identified, and computer 
programs are used to reassemble the short sequences into a longer sequence (Anderson, 
1981; Staden, 1979). In this way a map of the whole genome can be built, though for large 
genomes this could take a long time (Anderson, 1981; Staden, 1979). At present, there are a 
few methods being employed to accomplish cost-effective high-throughput sequencing, such 
as nanopore technology or pyrosequencing. The nanopore consists of a hole with an internal 
diameter of 1nm. When immersed in a conducting fluid, and a voltage applied, current can be 
observed through the conduction of ions via the pores. This current is highly sensitive to the 
size and shape of the nanopore. Therefore, if single nucleotides or strands of DNA pass 
through or near the nanopore there is a characteristic change in the magnitude of the current 
(Clarke et al., 2009). Pyrosequencing relies on the detection of pyrophosphate release on 
nucleotide incorporation. The intensity of the light emitted by this incorporation is directly 
related to the number of repeated nucleotide present in a row. This process is repeated for 
each of the four nucleotides, until the DNA sequence is determined (Ronaghi et al., 1996; 
Ronaghi et al., 1998). The dataset utilised for the development of the novel methods in this 
thesis was obtained through modern WGS techniques such as these. 
 There is a great drive to commercialise WGS, with a number of companies (e.g. 
Illumina, 454 Life Sciences, and Complete Genomics) competing to develop a commercially 
robust full genome sequencing platform. This competition, along with lucrative incentive, has 
driven the cost of WGS down at a rate faster than that predicted by Moore’s law (Figure 1.1). 
This decrease in cost has opened many avenues of investigation (e.g. personalised medicine; 




Figure 1.1. The cost to sequence a human genome has decreased drastically since 2001. This 
rapid decrease is faster than that predicted by Moore’s law. This decrease in cost has 
revolutionised genomics with large quantities of data now available for analysis and 
interpretation at a fraction of the cost of previous years. The figure was taken with 
permission from the National Human Genome Research Institute (NHGRI) and is accurate as 
of April 2015. 
 
 Advancements in WGS have been pivotal in obtaining large quantities of data, for 
example, in microbiology epidemiological studies a large number of isolates may be 
sequenced, each of which can vary in genome size from approximately 580 kb to roughly 7 Mb 
(Mira et al., 2001). This translates into a wealth of data that requires novel techniques and 
methodologies to interpret in order to produce answers to the specific epidemiological 
question being asked. It is important to note that WGS itself does not analyse or provide 
interpretation of the data. 
 One of the prime goals of epidemiology is identifying the origin of a pathogen. This 
would inform as to whether a pathogen is spreading, the rate at which it is spreading, and 
enables the targeting of the limited resources more effectively. Therefore, in this thesis I will 
describe the development of novel methods which attempt to determine the possible 
geographic origin of a pathogen. To answer this question, I will investigate the epidemiology of 
methicillin-resistant Staphylococcus aureus (MRSA) in the United Kingdom and Republic of 
Ireland. The main conclusion of this work is that by adopting methodologies that permit 
deeper analysis of the rich diversity of information provided by whole genome sequencing one 
could better understand the transmission and evolution of pathogenic microbes. 
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1.2 Staphylococcus aureus 
 Staphylococcus aureus is a common commensal Gram-positive, facultative anaerobic, 
coccal bacterium of mammals. It reproduces asexually, such that it is common to refer to each 
separate strain as a “clone”. Staphylococcus was first identified by Sir Alexander Ogston in 
1882 (Ogston, 1882) and later differentiated into S. aureus and S. albus, now S. epidermis, by 
Friedrich Julius Rosenbach in 1884 (Licitra, 2013). Macroscopically (Figure 1.2a), the bacterium 
presents a golden colour due to the expression of the carotenoid pigment staphyloxanthin 
(Pelz et al., 2005). This pigment acts as an antioxidant and helps the bacterium to resist 
hydrogen peroxide and hydroxyl radicals, which are important in neutrophil killing (Clauditz et 
al., 2006).  Microscopically (Figure 1.2b), S. aureus presents as clusters due to the cell division 
occurring in three alternative perpendicular planes. This results in irregular clumping of 
attached sister cells after division (Tsompanidou et al., 2011). 
  
Figure 1.2. The macroscopic structure of S. aureus ((a); taken from www.medchrome.com) 
showing the characteristic golden pigmentation. The “bunch of grapes” microscopic 
clustering structure which gives Staphylococcus its name is shown in (b) (taken from 
www.cdc.gov).  
 
Although primarily found in a host, S. aureus is robust with the ability to survive and 
reproduce outside a host in a variety of conditions. It can grow in harsh conditions; in 
temperatures between 7 to 48.5⁰C (Schmitt et al., 1990), in a pH range of 4.0 to 10.0, and in 
environments with a sodium chloride concentration of up to 3 M (Prescott et al., 2005). 
Although it does not have flagella, it has been shown to be able to spread across soft agar 
using teichoic acids and surfactant molecules (Kaito & Sekimizu, 2007; Tsompanidou et al., 
2011). This ability may help the bacterium colonise host tissue surfaces or fomites, such as 




In humans the dominant niche for S. aureus is the non-ciliated, keratinized epithelium 
of the anterior nares (vestibulum nasi) (Kluytmans & Verbrugh, 1997; Peacock et al., 2001), 
with occasional presence in the axillia and perineum (Williams, 1963). Presence of S. aureus in 
the pharynx may be transient due to the poor adherence to nasopharyngeal ciliated 
epithelium (Shuter et al., 1996).  However, the nares is likely the main reservoir for infection 
since colonisation of other sites may be prevented by the elimination of nasal carriage (Reagan 
et al., 1991). Due to this, the nasal carriage of S. aureus is a known risk factor in the 
development of S. aureus infection (Peacock et al., 2001; von Eiff et al., 2001). Nasal 
colonisation may be modulated by expression of secretions containing antimicrobial peptides 
(AMPs), such as lysozyme, lactoferrin, phospholipase A2 and defensins (Kaliner, 1991). Patients 
who are also carriers have a higher chance of symptomatic infection (Luzar et al., 1990; 
Weinstein, 1959)  with the majority of infecting strains identical to that of the carriage strain 
(Nguyen et al., 1999; Yu et al., 1986).  
Around 50% of individuals are nasal carriers of S. aureus, with 20% showing persistent 
carriage and the remaining 30% intermittent carriage (Kluytmans & Verbrugh, 1997; Wertheim 
et al., 2005; Williams, 1963). Current classification of nasal carriage is either “persistent” 
carriage or “other”, and is based on bacterial load and antibody profiles. A human colonisation 
model shows that S. aureus strains have a higher survival rate in persistent carriers compared 
to intermittent or non-carriers (van Belkum et al., 2009). However, prevalence and rate of re-
colonisation of S. aureus varies greatly and may be influenced by an individual’s demographics, 
such as ethnicity, sex, age, or presence of a chronic illness (Cole et al., 2001; Lipsky et al., 1987; 
Peacock et al., 2003; Yu et al., 1986).  
The exact reason why certain individuals show persistent carriage is not fully 
understood and is likely to be a combination of both host and bacterial factors, and the 
presence of other commensal organisms (Wertheim et al., 2005). For example, it was recently 
found that a serine protease, Esp, secreted by S. epidermidis led to the inhibition of S. aureus 
biofilm formation and nasal colonisation (Iwase et al., 2010). There is variation of S. aureus 
carriage by the host’s ethnicity, suggesting a genetic predisposition of the host to colonisation 
(Noble, 1974). This could be through the downregulation in nasal secretions of AMPs, which 
may lead to increased nasal carriage (Cole et al., 1999). In certain individuals, haemoglobin has 
been associated with increased colonisation (Pynnonen et al., 2011). It was found that the 
alpha and beta chains of haemoglobin inhibit exotoxin production in S. aureus by 
downregulating the global regulator agr (Schlievert et al., 2007). This decreased virulence may 
allow for easier colonisation. Finally, polymorphisms in the host’s immune genes, such as 
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glucocorticoids, C-reactive proteins, interleukin 4 and complement inhibitor proteins, may 
contribute to persistent nasal carriage state (Emonts et al., 2008; van den Akker et al., 2006). 
S. aureus infection arises from a break in the skin or mucosa which allows bacteria to 
invade the bloodstream and tissues (Gordon & Lowy, 2008; Lowy, 1998). S. aureus is the 
leading cause of nosocomial infections and the list of pathophysiological complications 
associated is long and varied (Klein et al., 2007). For example, S. aureus is the primary cause of 
lower respiratory tract and surgical site infections (Richards et al., 1999; Richards et al., 2000), 
and one of the most common causes of bacteraemia (Naber, 2009) and pneumonia (Klein et 
al., 2007). Together with the host immune system, the combination of genetic and virulence 
factors influences the severity of the disease progression. However, in some cases individual 
factors appear to be the primary cause; for example, staphylococcal scalded skin syndrome 
(Amagai et al., 2002; Ladhani, 2003), toxic shock syndrome (McCormick et al., 2001), and 
necrotic lesions of the skin or mucosa (Lina et al., 1999). Therefore, S. aureus infection is a 
dangerous disease and requires rapid diagnosis and treatment to prevent fatalities. 
Antibiotic resistance exacerbates the pathogenicity of the infection. Penicillin 
resistance was observed in S. aureus in the UK by the end of the 1940s (Grundmann et al., 
2006), and observed on the other side of world in Australia in the 1950s (Rountree & Freeman, 
1955). Methicillin-resistant S. aureus (MRSA) first appeared in an isolate in 1961 (Jevons, 
1961). Surgery, prolonged hospital stay, intensive care unit (ICU) admission, and antibiotic 
exposure were all known risks of hospital-acquired MRSA (Chambers, 2001). Furthermore, 
certain populations are at higher risk; healthcare workers, those with chronic illnesses, 
intravenous drug users, patients with in-dwelling devices (e.g. catheters) and diabetics (Lowy, 
1998).  
S. aureus and MRSA pathogenicity has a great impact on healthcare resources (de 
Angelis et al., 2010; Köser et al., 2012), with an estimated 11.74 MRSA related hospitalisations 
per 1000 in the USA in 2009 alone (Klein et al., 2013). In the latter half of the previous decade 
there were reports of approximately 19,000 MRSA-associated fatalities in the US annually, 
equal to the number due to AIDS, TB and viral hepatitis combined (Boucher & Corey, 2008; 
Klevens et al., 2007). In England and Wales in 2012 there were 292 MRSA-related fatalities 
(Olatunde, 2013). However, recent control measures such as hand-washing and provision of 
alcohol hand-gel have been correlated with a decrease in the number of MRSA cases in the UK 
(Allegranzi & Pittet, 2009; Rupp et al., 2008). Furthermore, rates of MRSA are increasingly 
being used as a metric for the quality of hospital hygiene (Donker et al., 2010; Ke et al., 2012). 
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Grundmann et al. (2010) found that MRSA clones display higher levels of phylogeographic 
clustering than their methicillin susceptible (MSSA) counterparts. One reason for this 
difference could be that MRSA clones have evolved more recently than MSSA clones and so 
have had less time to spread. Another reason could be the greater selective pressures placed 
on MRSA in the harsher environments of healthcare institutions, while MSSA is under much 
weaker selection pressure. There is variation in the MRSA policies used in different healthcare 
institutions (Hails et al., 2003), which might enable different MRSA strains to flourish under 
different conditions. However, the ability of the strain to survive is highly dependent on their 
specific genomic components. 
1.2.1 The genome of S. aureus 
 The S. aureus genome consists of a single circular chromosome which can range from 
2.7 to 3.1 million base pairs (Holden et al., 2010; Lindsay & Holden, 2006) and comprises three 
parts; the core genome, the accessory genome, and plasmids (if present). NGS and WGS 
technologies have been used to determine the genomes of many different S. aureus strains 
and elucidate conserved and variable genetic regions. The core genome, which comprises 
approximately 75% of the S. aureus genome, is the region of genes which are mostly conserved 
across all strains (Lindsay & Holden, 2006). Genes involved in essential functions, such as 
metabolism and survival, comprise the majority of the genes in the core genome. However, 
there are also some genes involved in virulence determination, such as those coding for 
surface proteins, adhesins, toxins and enzymes (Lindsay & Holden, 2004). 
 Although mostly conserved across all strains, the core genomes are not all identical. 
Subtle differences in genetic composition can leave genes functional, whilst possessing 
different functions and phenotypes (Lindsay & Holden, 2006). Therefore, S. aureus can be first 
divided into clonal complexes and subsequently into sequence types. The method used to 
determine sequence types is called multilocus sequence typing (MLST) and is described in 
Section 1.3. A sequence type (ST) is defined by the presence of particular alleles of specific 
housekeeping genes, while a clonal complex (CC) is defined as a group of S. aureus lineages 
where the isolates harbours identical alleles at five or more of the loci of the housekeeping 
genes (see Section 1.3). Isolates from differing CCs may show variability in many genes (Lindsay 
& Holden, 2004). Variation in genetic composition can occur in either coding or non-coding 
regions of the genome through single base pair changes (single nucleotide polymorphisms, 
SNPs; see Section 1.2.2), insertion or deletion of one or multiple base pairs (indels), or by 
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recombination of large blocks of genetic sequences (Castillo-Ramírez et al., 2012; Lindsay & 
Holden, 2006).  
 The accessory genome of S. aureus contains non-essential genes that are involved in 
virulence, resistance and other metabolic functions (Lindsay & Holden, 2006; Shittu et al., 
2007). The accessory genome can be highly variable between strains, due to the horizontal 
gene transfer (HGT) of mobile genetic elements (MGEs) from one isolate to another. This 
exchange is one of the mechanisms by which S. aureus evolves. The complete set of MGEs in a 
genome is called a mobilome, and can be comprised of plasmids, transposons, staphylococcal 
cassette chromosomes (SCCs) or lysogenic phages (Frost et al., 2005). 
 Plasmids are autonomously replicating circular segments of DNA. Previously classified 
according to their size and incompatibility (Novick, 1987), they are now classified by the 
sequence of replication (rep) genes (Jensen et al., 2010). Plasmids can encode a variety of 
useful characteristics, such as antibiotic resistance (e.g. pT181, tetracycline resistance in S. 
aureus strain COL; Khan & Novick, 1983), heavy metal resistance (e.g. pI258 cadmium 
resistance; Nucifora et al., 1989) and exfoliative toxin B (Amagai et al., 2002). There appears to 
be association between specific lineages of S. aureus and specific plasmid groups conferring 
virulence and antibiotic resistance (McCarthy & Lindsay, 2012). The lack of ubiquitous 
presence of any one plasmid group in all S. aureus lineages indicates that there may be some 
impediment to the evolution of a hyper-resistant and hyper-virulent S. aureus strain.  
SCCs are DNA fragments of 21-53kb in length. They may contain genes that affect 
antibiotic resistance or virulence factors. There are two main classifications of SCC; those with 
the mecA gene (SCCmec) which confers resistance to β-lactam antibiotics by coding for an 
alternative penicillin binding protein (PBP2a) which has extremely low reactivity with β-lactam 
antibiotics (Kim et al., 2012; Ubukata et al., 1989), and those without. The transcription and 
translation of the resistance protein PBP2a influences the minimum concentration of β-lactam 
antibiotics required to inhibit growth (Hartman & Tomasz, 1984). Additional SCCmec elements 
are mecI and mecR, which code for the repressor and signal membrane transducer respectively 
(Noto et al., 2008; Ubukata et al., 1989). Apart from the mec gene, all SCCmec element genes 
also contain cassette chromosome recombinases (ccrA, ccrB, ccrC; Noto et al., 2008). The 
combination of mec gene with ccr determines the classification of the SCCmec element, with 
eight identified thus far in S. aureus (Ito et al., 2013).  
Transposons are usually small and encode antibiotic resistance (e.g. Tn554 encodes for 
erythromycin resistance; Phillips & Novick, 1979). They contain a transposase gene (Rowland & 
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Dyke, 1989) which allows them to excise, replicate and integrate into a chromosome or other 
MGEs, such as SCCs or plasmids (Baba et al., 2002). 
 There are three processes by which HGT occurs to transfer MGEs; transformation, 
conjugation and transduction (Thomas & Nielsen, 2005). Transformation is the uptake of 
exogenous DNA directly from the surroundings. It was only recently that a successful 
transformation in S. aureus was observed (Morikawa et al., 2012). Conjugation is the transfer 
of genetic material during direct cell-to-cell contact via pili or pores. Due to the lack of pili in S. 
aureus it is believed that conjugation occurs through the pores (Lindsay, 2014). However this is 
not a common HGT process in S. aureus (Lindsay & Holden, 2006) since transfer (tra) genes are 
required to be present in the plasmid to be transferred (Guglielmini et al., 2013) and only a 
very few S. aureus isolates express these genes (McCarthy & Lindsay, 2012). Transduction is 
the main mechanism by which HGT occurs in S. aureus and requires a bacteriophage to act as a 
vector. A bacterium may be infected with a bacteriophage and either incorporate their genetic 
material into the bacterial chromosome or deliver foreign DNA (in the form of bacterial 
chromosomes or plasmids). This process is known as generalised transduction (Lindsay & 
Holden, 2006). Once incorporated the phage can either replicate and eventually lyse the 
bacterial cell releasing new phages (lytic phage), or remain integrated within the host genome 
(lysogenic phage). Many strains of S. aureus contain between one and four lysogenic phage 
types (Lindsay & Holden, 2006). Bacteriophages can carry virulence genes which code for 
factors such as Panton-Valentine Leukocidin (PVL; Kaneko et al., 1998), enterotoxin A (Betley & 
Mekalanos, 1985), and exfoliative toxin A (Yamaguchi et al., 2000). 
1.2.2 Genetic variation in S. aureus 
Apart from the assimilation of MGEs into the genome, genetic variation may arise 
through point mutations, indels, or recombination. Indels which are not multiples of three 
nucleotides cause a frameshift effect to occur in coding regions which could result in the 
production of a different protein chain, and would usually be subjected to purifying selection 
in coding regions (Chen et al., 2009). Indels have been used to infer phylogenetic relationships 
(Pereira et al., 2010) and as genetic markers (Väli et al., 2008). However, it may be difficult to 
infer the direction of evolution (i.e. has organism A lost a nucleotide, or has organism B gained 
one) through only using indels. In bacterial genomes, there is a significant deletion bias, with 
many more deletions than insertions identified (Mira et al., 2001). Homologous recombination 
also contributes substantially to genomic variation due to the exchange of up to several 
kilobases of genetic material (Castillo-Ramírez et al., 2012; Lindsay & Holden, 2006); for 
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example in the variable region of agrB and agrC in the accessory gene regulator operon 
(Dufour et al., 2002). Furthermore, there is some evidence to suggest that recombination, 
combined with selection, may favour the evolution of novel clonal complexes of S. aureus 
(Basic-Hammer et al., 2010). 
However, the most abundant type of variation is point mutation; SNPs. This is the 
variation of a single nucleotide (Adenine, Cytosine, Guanine or Thymine) in a genetic 
sequence. SNPs are either synonymous or non-synonymous (or neither in intergenic regions), 
and may result in subtle changes in the genome. With their accumulation they provide the 
majority of diversity between genomes (Gouy & Gautier, 1982). Due to the degeneracy in the 
amino acid code the majority of SNPs are synonymous (“silent”) mutations and do not result in 
a change in the functionality of the gene expression. However, non-synonymous mutations 
lead to a change in the amino acid and hence a potential altered gene or protein expression. 
The ratio of the number of non-synonymous nucleotide changes per non-synonymous site (dN) 
and the number of synonymous changes per synonymous site (dS) is often used to determine 
the rate of evolution in, or between, organisms (Hurst, 2002). However, work by Rocha et al. 
(2006) indicates that the dN/dS ratio might not be constant for an organism, and rather one 
should use the trajectories of dN/dS over time. S. aureus has a higher non-synonymous change 
bias within clones (dN/dS ~ 0.7) than between clones (dN/dS ~ 0.1) and this higher level of 
synonymous change between clones could be attributed to the acquisition of MGEs through 
HGT (Castillo-Ramírez et al., 2011). The four nucleotides are divided into pyrimidines (C and T) 
and purines (A and G). Therefore, SNPs may be either transversion (purine to pyrimidine, or 
vice-versa) or transition (purine to purine, or pyrimidine to pyrimidine) mutations. Although 
there are four ways for a transversion mutation to occur, compared to two ways for a 
transition, approximately 2/3rd of SNPs are transition mutations (Collins & Jukes, 1994). This is 
since transitions do not require alteration of the molecular ring structure (e.g. a single ring 
purine to a single ring purine), whereas transversions are changing the number of molecular 
rings (e.g. a single ring purine to a double ring pyrimidine, or vice-versa). 
The majority of SNPs are bi-allelic, only showing two possible nucleotides, and can be 
easily assayed (Sachidanandam et al., 2001). The frequency of the least common allele is 
defined as the minor allele frequency (MAF), and is usually specific to a particular population 
of the organism. The distribution of SNPs in a genome is often not homogenous; for example, 
in humans more SNPs occur in non-coding regions than those coding for specific genes (Varela 
& Amos, 2010). SNP density of a particular genetic region in humans can be predicted by the 
presence of microsatellites and the GC content (Varela & Amos, 2010). The fixing of specific 
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alleles in a population, mutation rate and recombination may all affect SNP density in the 
genome (Barreiro et al, 2008; Nachman, 2001). Linkage disequilibrium (i.e. the non-random 
association of alleles at different genetic loci) might be causing the co-occurrence of particular 
SNPs (Slatkin, 2008). A tag SNP may be used to represent a group of SNPs in a region of high 
linkage disequilibrium (Chen et al., 2014). 
In coding regions non-synonymous mutations can either create a missense mutation, 
where the amino acid code is changed (e.g. Asn→Asp at position 637 in the ileS gene in MRSA 
strains SA-7S and SA-7R; Fujimura et al., 2003), or a nonsense mutation, where a premature 
stop codon is expressed (e.g. the avirulence of strain 8325-4 is attributable to a nonsense 
mutation in the agrA  gene; Adhikari et al., 2007). Therefore, non-synonymous mutations may 
influence the expression of a gene and this altered expression may lead to antibiotic 
resistance; for example, the C→T mutation in strain ST239 at position 7255 in the DNA gyrase 
subunit A gene is involved in quinolone resistance (Harris et al., 2010).  
SNPs have a wide range of applications in epidemiology; for example, the identification 
of SNPs in certain diseases as next generation markers for pharmacogenomic targets of drug 
therapy (Lai, 2001). In microbiology, SNPs are important genetic markers which gained 
popularity at the turn of the millennium (Vignal et al, 2002). They can help identify 
relationships between strains of a pathogen, either through direct assay or the creation of a 
SNP-based phylogenetic tree. Unless specifically selected against or lost through genetic drift, 
SNPs accumulate in a genome over time and are often stably inherited (Thomas et al., 2011). 
Therefore, knowledge of the mutation rate will help infer relationships between isolates. For 
example, the mutation rate of S. aureus strain ST239 has been estimated as 3.3x10-6 per site 
per year (Harris et al., 2010). Furthermore, the probability of two independent base changes at 
a single position is very low (Vignal et al., 2002), decreasing the probability of a homoplasy 
occurring. Therefore, SNPs can be used as a stable signal for the propagation of a particular 
strain. This use is extended to population genetics for estimating genetic variation, 
identification of relatedness or parentage, measuring population structure and changes in 
population size over time (Morin et al., 2004). 
 Historically SNPs were found through laboratory methods (e.g. gel electrophoresis, or 
restriction fragment length polymorphism), but modern day techniques use sequencing and 
identification in silico (Morin et al., 2004). The advancements in WGS allow for rapid 
sequencing of entire genomes, which can be processed in silico to determine the harboured 
SNPs. Each isolate sequenced is compared against a relevant reference genome, and the 
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nucleotides which deviate from the reference genome are identified as SNPs. There are a 
number of growing online databases to which the SNP could be added. Many of them host 
information of multiple species, though there is often a focus on human genomes. For 
example, dbSNP is hosted by the National Centre for Biotechnology Information (NCBI) and 
contains information on 55 different organisms (Morin et al., 2004); Kaviar collates SNPs from 
multiple data sources of human genomes to inform on personalised medicine (Glusman et al., 
2011); SNPedia supports personal genome annotation and analysis of human genomes; OMIM 
database collates the known SNP-associated diseases in humans; and the Human Gene 
Mutation Database provides the gene mutations associated with inherited disease. The 
development of collated online databases is useful since SNP data, which in most cases is bi-
allelic and hence a simple Presence/Absence question, can be easily compared between 
different laboratories, unlike the inconsistency in determining allele size in microsatellite 
analysis (Delmotte et al., 2001; Vignal et al., 2002). Furthermore, SNPs can provide equivalent 
statistical power to microsatellites, yet cover a wider range of the genome (Morin et al., 2004). 
The information on the position and effects of SNPs has considerable potential to further our 
epidemiological understanding of certain diseases. However, the large quantities of 
information available in these databases and through WGS can be difficult to interpret and 





1.3 Methicillin-resistant Staphylococcus aureus 
Methicillin-resistant S. aureus (MRSA) was first reported in 1961, and likely began with 
the introduction of a SCCmec I element into a methicillin susceptible S. aureus (MSSA) isolate 
belonging to ST250 (Enright et al., 2002). The exact origin of this MGE is unknown but the 
evolutionary precursor of the mecA gene found in MRSA strains could be from S. sciuri (Wu et 
al., 1996; Wu et al., 2001). There appears to be at least 20 separate acquisitions of SCCmec 
into S. aureus (Robinson & Enright, 2003), indicated by strains from the same ST containing 
different SCCmec types.  
Protocols have been established to deal with the presence of MRSA; such as provision 
of alcoholic hand-gel (Rupp et al., 2008), increased hand washing (Allegranzi & Pittet, 2009), 
increased sanitation (Dancer, 2009), and the use of the final front-line drug, vancomycin 
(Bassetti et al., 2009). These methodologies are correlated with a decline in the rates of 
invasive MRSA infection in the UK (Office for National Statistics, 2011). However, a main 
drawback is that these approaches are generalist, treating every case of MRSA in the same 
way. Difficulties arise when the various strains of MRSA encountered respond differently. 
Within MRSA isolates there is some diversity, with more than 100 strains identified by 
Monecke et al. (2011). Knowledge of the genetic characteristics and relatedness of the MRSA 
isolates in a particular sub-population is required for targeted, effective action. There are a 
number of methods developed to identify the particular genotype of an isolate.  
Multilocus sequence typing (MLST) is used to determine the sequence type (ST) and 
clonal complex (CC) for a given isolate. MLST works by identifying which alleles are present in 
the S. aureus genome of seven different housekeeping genes (Maiden et al., 1998). The 
combination of specific alleles encodes for a specific sequence type (ST; Enright et al., 2000), 
with five or more identical alleles indicating the isolate belongs to a specific CC. Since there is 
low mutation rate in these housekeeping genes, MLST can be used for long evolutionary time 
which encompasses many generations. This is especially important in MRSA, since generational 
times can be measured in minutes (Laurent et al., 2001). Pulse-field gel electrophoresis (PFGE) 
separates chromosomal DNA fragments, digested by the enzyme SmaI, using agarose gel 
electrophoresis with an alternative voltage gradient. The resulting band patterns are 
processed using specialised software and related strains are grouped together (McDougal et 
al., 2003). One other sequence based analysis determines the variation in the polymorphic X-
region of the protein A gene (spa; Frénay et al., 1996). This spa-typing allows for discrimination 
between strains based on the number of tandem repeats in the sequence. With only one locus 
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sequenced, this method is cheaper and faster than MLST, however there is a corresponding 
reduction in discriminatory power if the same spa gene occurs in multiple clonal lineages 
through recombination (Deurenberg & Stobberingh, 2008). 
There are approximately 11 major S. aureus clonal complexes (CC1, CC5, CC8, CC12, 
CC15, CC22, CC25, CC30, CC45, and CC51) with many more smaller ones, and most MRSA 
isolates in healthcare locations belonging to CC5, CC8, CC22, CC30 and CC45 (Lindsay & 
Holden, 2006). In these five CCs, containing both MRSA and MSSA, there are at least 11 major 
STs (Enright et al., 2002); for example, ST247 is globally widespread but is commonly known as 
the Iberian clone (Sanches et al., 1995), and the highly transmissible and multi-drug resistant 
clone ST239 is known as the Brazilian clone (Johnson et al., 2001). These clones can be 
distinguished from each other through PFGE. There are a number of other major epidemic (E) 
MRSA sequence types that are found across the world; ST5, ST22, ST30 and ST45. 
Furthermore, although containing MSSA clones ST8 also contains EMRSA clones that have 
acquired SCCmec types II and IV (Enright et al., 2002). However, although some strains appear 
to dominate certain geographic locations, there is still great diversity seen at any one location. 
For example, Feil et al. (2003) found 75 unique sequence types from 334 isolates recovered 





Figure 1.3. This unrooted Bayesian phylogenetic tree is taken from Feil et al. (2003) and 
shows the diversity of the 75 different STs and CCs found in Oxfordshire, UK. All the major 
clonal complexes are denoted by the dashed rings, while the boxes represent singletons or 
minor groups that comprise of more than five isolates. The individual STs within each major 
clonal complex are not labelled, barring ST188. The isolates within a CC appear to cluster 
together very tightly, with comparatively large evolutionary distance between CCs.  
 
Successful HGT of MGEs is attributed to be the reason for the evolutionary success and 
dominance of certain MRSA clones (Lindsay et al., 2012). There is strong evidence that MGEs 
contribute to the emergence of highly virulent and multi-drug resistant clones; for example, a 
clone of the ST772 lineage shows resistance to six different antibiotics, mostly acquired 
through HGT of MGEs (Steinig et al., 2015). Furthermore, recombination plays an important 
role in the diversification of MGEs. Large chromosomal replacements via homologous 
recombination are likely to influence the long-term evolution of MRSA (Feil et al., 2003; 
Grundmann et al., 2006). For example, ST239 is a descendent of ST8 which acquired a large 
26 
 
(635kb) fragment from ST30 (Holden et al., 2010) and exhibits a mosaic genome profile. 
Furthermore, the ST239 clone also showed significant recombination variation, associated with 
phylogeography (Castillo-Ramírez et al., 2012). 
There is some evidence that MGEs are transferred with higher frequency in some 
lineages (Lindsay, 2014). There are preventative measures to impede the development of a 
hyper-resistant clone, with S. aureus expressing restriction and modification (RM) systems 
which destroy certain ‘foreign’ DNA based on the sequence and modification patterns 
(Lindsay, 2014). These RM systems usually prevent transfer of virulence or resistance genes 
between different CCs but in certain situations the lack of a particular target site allows a 
genetic transfer between lineages, which may be instrumental in driving the evolution of 
MRSA clones (Roberts et al., 2013). 
Unfortunately, the methods mentioned in this section only allow the categorisation of 
isolates to a particular lineage. Isolates within a CC would appear to be very similar and 
therefore cluster on a phylogenetic tree, while isolates from different CCs would show a 
distinct evolutionary distance. Furthermore, MSSA often shows very high genetic diversity and 
would also show significant evolutionary distance (Vandendriessche et al., 2013). It is difficult 
to use these methods to identify exact relatedness between any two isolates. Therefore higher 
genetic resolution is required. The publication of the first MRSA genome in 2001 (Kuroda et al., 
2001), the development of Next Generation Sequencing (NGS) techniques, and advancements 
in Whole Genome Sequencing (WGS) has revolutionised sequencing throughput efficiency as 
many sequences can be processed in parallel. Furthermore, the cost for rapid WGS of one 
MRSA isolate is currently less than £50 (Priest et al., 2012). WGS and NGS techniques can be 
used to generate SNP and indel maps of a particular isolate when compared to a reference 
genome (Harris et al., 2010). Multiple strains can be sequenced efficiently and all deviations 
from the reference sequence identified. The uses of WGS and NGS with respect to MRSA are 
developed further in Section 1.4.2. 
1.3.1 Epidemiology of MRSA 
Since the first appearance of methicillin resistance in the 1960s, MRSA strains are now 
endemic, and epidemic, in healthcare facilities and communities across the globe (Ayliffe, 
1997; Boucher & Corey, 2008; Diekema et al., 2004; Enright, 2003) due to rapid spread and 
colonisation (Roman et al., 1997). The population structure of MRSA is mainly clonal and it 
appears that point mutations, and not recombination, were predominant in the initial stages 
of clonal diversification (Enright et al., 2002; Feil et al., 2003). The population structure in 
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MRSA provides a good balance between genetic variation due in the SNPs and genetic 
conservation due to limited recombination, unlike other nosocomial pathogens which exhibit 
different genetic and population structure; for example, the many chromosomal 
rearrangements in the yeast Candida albicans (Rustchenko-bulgac et al., 1990) which may be 
found in intravascular catheters and can cause bloodstream infections (Akbari & Kjellerup, 
2015).  
Prevalence of MRSA is not globally uniform. The US, south-east Asia, southern Europe, 
parts of South America and Australia all show higher incidence rates (Grundmann et al., 2006), 
while the Netherlands and Scandinavian countries have the lowest MRSA prevalence rates. 
This is likely due to their highly effective search-and-destroy policies, which involves screening, 
quarantine, and eradication (Simoens et al, 2009). Although originally thought to be restricted 
to hospitals and other healthcare institutions there are now three epidemiological 
classifications of MRSA; healthcare acquired (HA), community acquired (CA), and livestock 
acquired (LA) MRSA. There are a number of LA-MRSA lineages; for example the CC398 lineage 
found in pigs, cattle and poultry (Köck et al., 2013), and the CC97 lineage, primarily found in 
cattle (Spoor et al., 2013). 
One primarily HA clone currently disseminating in the UK and abroad is EMRSA-15, 
from the ST22 lineage (Johnson et al., 2001). This clone showed rapid and efficient 
transmission within the hospital environment and is one of the most common MRSA clones in 
Europe (Grundmann et al., 2010), with transmissions from the UK to many different countries, 
such as Portugal, Germany, Spain and many more (Holden et al., 2013). To understand the 
genetic changes that contributed to the success of this clone, Holden et al., (2013) sequenced 
193 ST22 genomes from 15 countries and identified two non-synonymous SNP mutations 
associated with fluoroquinolone resistance as the key factors for the success of this particular 
clone. This resistance conferred a competitive advantage in environments where this antibiotic 
was frequently used. This study also identified, using Bayesian reconstruction, the origin of this 
clone to be in the middle of the UK in the mid-1980s. Furthermore, the ST22 isolates used in 
the Holden et al (2013) study shows a comet shaped Maximum Likelihood phylogeny, 
indicating the high level of clonal similarity in the majority of the isolates. Phylogenetic analysis 
in this study also indicates the single acquisition of SCCmec IVh just prior to the emergence of 
ST22. The ST22 lineage, especially the EMRSA-15 clone, is one of the main strains 
disseminating in UK healthcare institutions. This is one of the reasons why this clone is the one 
chosen to comprise the dataset used for analysis in this thesis. 
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CC30, the lineage to which phage type 80/81 belonged, also harbours one of the more 
successful HA epidemic clones, EMRSA-16 (Robinson et al., 2005). Isolates from both strains 
show that they diverged from a recent common ancestor (DeLeo et al., 2011). However, 
EMRSA-16 is less virulent than phage type 80/81 and is restricted to hospitals. This decrease in 
virulence could be due to the acquisition of SCCmec type II which, while still conferring β-
lactam antibiotic resistance, can interfere with agr signalling and a corresponding decrease in 
cytolytic toxin expression (Rudkin et al., 2012). Another example of specific genetic 
characteristics conferring advantages is the successful spread of ST239 in China following the 
recent acquisition of the sasX gene, a novel cell wall-anchored protein gene which may be 
related to the infection invasiveness (Li et al., 2012). Additionally, an increase in the presence 
of the ACME element in ST239 strains has been discovered in Singaporean hospitals between 
2006 and 2009 (Hon et al., 2013). 
Although this thesis primarily focuses on HA-MRSA isolates, there is currently growing 
concern over CA-MRSA, which appears to be acquired in individuals with no prior contact with 
healthcare institutions (Chambers & Deleo, 2009) or any other known risk factors. CA-MRSA 
emerged in the late 1990s and differs in both genotype and phenotype from HA-MRSA (Todd 
et al., 2005). CA-MRSA exhibits more clonal diversity than HA-MRSA (Feng et al., 2008; 
Francois et al., 2008). One of the possible origins of CA-MRSA is Panton-Valentine Leukocidin 
(PVL)-positive MSSA strains present in Japan which acquired SCCmec IV (Taneike et al., 2006). 
Within a few years CA-MRSA has spread globally, with different lineages of virulent CA-MRSA 
strains conforming to specific geographical predominance (Mediavilla et al., 2012). A ST1 clone 
is prevalent in Asia, Europe and the US, a ST30 clone is disseminating in Australia, Europe and 
South America, and a ST80 clone is in Asian Europe and the Middle East (Deurenberg & 
Stobberingh, 2008). The USA300 clone from ST8 is found mainly in North America (Patel et al., 
2013) with some dissemination in Europe (Witte et al., 2007) and South America (Reyes et al., 
2009), and is considered to be one of the most severe outbreaks globally (Otto, 2010). USA300 
appears to have emerged in the early 1990s (Uhlemann et al., 2014) and expresses the 
arginine catabolic mobile element (ACME), which is posited to be important in the overall 
fitness and transmissibility of the strain (Diep et al., 2008). There is some evidence that ACME 
might be responsible for attenuated virulence in certain isolates (Diep et al., 2008). Another 
reason for the dominance of USA300 in North America could be its resistance to polyamines, 
to which most S. aureus strains are hyper-sensitive (Joshi et al., 2011).  
Unlike HA-MRSA, CA-MRSA strains appear to cause disease, and a higher rate of 
mortality, in younger patients with no previously defined health risk factors (Fridkin et al., 
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2005; Hunt et al., 1999). CA-MRSA is highly associated with an increase in skin and soft tissue 
infections (SSTIs; Otto, 2010), and in rare cases can cause more severe, often fatal diseases 
such as necrotising pneumonia, Waterhouse-Friderichsen syndrome and necrotizing fasciitis 
(Klein et al, 2009; Miller et al., 2005). The increased virulence in CA-MRSA may be attributed to 
two possible MGEs, SCCmec type IV and prophage ΦSA2pvl (Baba et al., 2002). The SCCmec 
elements associated with HA-MRSA (SCCmec I, II and III) appear to have a greater fitness 
burden than the shorter SCCmec elements associated with CA-MRSA (SCCmec IV, V and VII; 
Lee et al., 2007). Due to the nature of their respective selective pressures, HA-MRSA is 
generally multi-drug resistant, while CA-MRSA isolates are usually non-beta-lactam antibiotic 
sensitive (Otto, 2013). Importantly, HA-MRSA requires much higher antibiotic concentrations 
for efficient eradication (Otto, 2010). Furthermore, non-genetic factors such as socioeconomic 
standards, rate of incarceration, and availability of adequate healthcare may all influence the 
transmission and success of CA-MRSA (Witte, 2009). 
HA-MRSA historically outcompeted CA-MRSA in healthcare institutions due to 
expression of higher antibiotic resistance. However, currently both HA- and CA-MRSA circulate 
in the community, with some CA-MRSA clones invading hospitals and healthcare facilities 
(Witte, 2009). This leads to a more complex epidemiology, though certain molecular traits can 
be used to distinguish between the two groups since some traits are associated mainly with 
CA-MRSA; for example SCCmec Type IV and V, or genes encoding PVL (Deurenberg et al., 
2007). This increase in the mixing of the MRSA clones and sub-populations warrants the 
development of methods which can determine the origin of an isolate, in order to facilitate 
treatment and inform preventative measures. The methods developed in this thesis would be 
applicable to CA-MRSA as well as HA-MRSA. 
It has been identified that humans are the vector by which different strains of MRSA 
move around the country and the world (Donker et al., 2014; Donker et al., 2010; Donker et 
al., 2012; Ke et al., 2012; Lutz et al., 2014; Mendiola et al., 2015). There are a number of 
methodologies to determine relatedness of MRSA isolates and hence the spread of particular 
strains from patient to patient, and institution to institution (David & Daum, 2014), as 
described in Section 1.3.2. However, the first step is obtaining the data. 
1.3.2 Epidemiological surveillance methodologies and MRSA 
There are currently many different ways in which samples and information of a 
particular MRSA strain and its pathogenic effects can be obtained. Both observational and 
experimental data are used to help identify, categorise and combat a pathogenic threat. 
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Epidemiologists may use qualitative studies of a single or group of patients, or select specific 
subjects based on their disease status. Cohort studies, such as GWAS, are very important and 
informative in understanding how particular conditions affect a group of individuals. Outbreak 
studies are the investigation of a sudden increase of a disease at a particular location or time 
and may be identified passively or actively. The number of cases which classifies an outbreak is 
relevant to the disease’s rarity and virulence. Outbreaks may be attributable to a common 
source, or propagated from individual to individual. Behavioural risks (e.g. working in a 
healthcare facility) or zoonotic transmissibility (e.g. LA-MRSA) may also influence the spread. 
Epidemiology studies are often used to inform governments and pan-governmental bodies of 
the risks posed by the particular MRSA strain. In essence, they aid health management in 
assessing the needs of a population and to efficiently implement the appropriate interventions 
required to limit transmission and impact. 
There are two levels with which the surveillance is conducted. Passive surveillance 
gathers data from all reporting healthcare workers as routine, but does not specifically require 
that the data be reported. Thus, passive surveillance is the cheapest and most common form 
of surveillance. However, passive surveillance usually increases the delay before proper 
identification of an outbreak can occur. Active surveillance requires more resources and 
trained practitioners, using multiple sources of data, to detect issues earlier on (Peterson & 
Brossette, 2002). More active surveillance is required to combat the modern epidemiological 
threat. However, this usually requires routine screening, targeted drug use and trained 
practitioners which all cost considerable resources. Although expensive, active surveillance 
could prevent, or at least slow down, the dissemination of a MRSA strain by identifying the 
outbreak faster and therefore minimising the number of individuals at risk (Peterson & 
Brossette, 2002). Furthermore, strong cooperation is required between healthcare institutions 
and clinical epidemiologists as the pathogens of concern affect both in- and out-patients, 
healthcare workers and the general community (Peterson & Brossette, 2002).  
The ideal surveillance system would contain analysis tools that automatically identify 
novel outbreaks, unusual patterns of spread, and determine the origin of the pathogen (Dean, 
1994). This may involve pattern identification and data mining to survey hospital and 
outpatient data (Peterson & Brossette, 2002). There is considerable drive to automate the 
surveillance, as this appears to provide the best way to rapidly assess and detect infectious 
diseases in our healthcare system (Peterson & Brossette, 2002). The Data Mining Surveillance 
System (DMSS; Brossette et al., 2000) represents the first generation of semi-automated 
surveillance systems for nosocomial infections. Although the DMSS appears to function well at 
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condensing and summarising the relevant information, this system still requires a manual 
interpretation by a trained investigator. However, the authors do note that this is just the first 
step and more work is required to develop these systems. Furthermore, an online central 
database could be used to monitor data from various institutions and allow rapid 
communication of emerging infectious diseases and be able to rapidly identify outbreaks 
(Bogich et al., 2013). Rapid identification is important, since the critical response time (i.e. the 
time period before the outbreak becomes an epidemic) for a given strain of MRSA may be very 
short (Rivas et al., 2003). Furthermore, reduction in identification time will reduce the time 
that colonised patients may have to disseminate the pathogen (Tacconelli, 2009). Ciccolini et 
al. (2014) showed that it would be possible to build an efficient early detection system for 
nosocomial pathogens using sentinel hospitals and the knowledge that patient referrals are 
the likely vector of transmission between locations. 
Although some surveillance methods have been developed (Mellmann et al., 2006; 
Peterson & Brossette, 2002), the current trend for ever cheaper WGS (Harris et al., 2013) 
opens up many avenues of approach to analyse an isolate’s genetic content. The increasing 
viability of WGS and NGS would permit their use in routine surveillance. There is a clear drive 
at the moment for developing greater global surveillance systems of MRSA in order to identify 
new introductions and outbreaks (Harris et al., 2010). Molecular epidemiology may generate 
large quantities of data, which need to be correctly analysed to identify patterns in the 
progression of a disease. If it was known where the isolate had originated from, what possible 
drug resistance genes it contains and the specific virulence factors, then the limited resources 
could be applied in the most effective manner. This thesis will attempt to utilise the increasing 
availability of WGS and routine sequencing in healthcare institutions to implement an analysis 
pipeline that might be able to elucidate the possible geographic origin of an MRSA isolate. 
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1.4 Using the data generated by WGS and NGS techniques 
The increasing viability of WGS has enabled investigation into detailed questions in the 
epidemiology of MRSA. A standard way of analysing epidemiological data, especially when 
attempting to identify transmission events and the origin of a pathogen, is to construct 
phylogenetic trees from the data. This methodology shows clustering of highly similar 
genomes which, when coupled with metadata of sampling location, could give an indication of 
the geographic origin of an isolate. If it appears that the isolate has originated from a location 
other than where it was sampled from, then this could be an indication of a transmission 
event. This process is further developed later in the thesis, particularly in Chapter 3. Many of 
the studies of MRSA that utilise WGS and NGS create phylogenetic trees of the sequenced data 
(see Section 1.4.2). However, there are many different methodologies available for the 
construction of phylogenetic trees, each with their own strengths and weaknesses. 
1.4.1 Phylogenetic analysis techniques 
Phylogenetics may use morphometric or molecular data to identify the evolution and 
divergence between species or, as in the case of MRSA, within a species. The goal is to create a 
phylogenetic tree (i.e. a phylogeny) of the evolution of a group of taxa, genes, or 
characteristics. A phylogenetic tree consists of a branching structure, where each bifurcation is 
indicative of an evolutionary split, and each taxon as a separate terminal node. Each dataset 
has a number of possible phylogenetic trees, defined as the “tree space”. These trees may be 
rooted or unrooted. Rooted trees compare the input sequences to a specified most recent 
common ancestor (MRCA), while unrooted trees determine the relationships between the 
input sequences. For sufficiently large datasets, attempting to reconstruct all the phylogenetic 
trees is computationally prohibitive. Therefore, search paths, using optimisation criteria, can 
be used to determine the “best” tree. However, the tree identified may only be optimum at 
the local level and not the global level. For example, in the hill-climbing method, which 
incrementally changes a single element in the tree in an attempt to find a better solution 
(Ganapathy et al., 2003), it is possible to arrive at a local optimal tree, whereas the Monte 
Carlo tree search methods fares better at finding the global optimal tree (Browne et al., 2012). 
Historically, phylogenetics developed using morphological characters, however 
molecular characters can be more informative in modern phylogenetics (Huson & Bryant, 
2006). Molecular characters could be nucleotides in DNA and RNA (i.e. genetic characters, 
SNPs), amino acids, or distinct gene alleles. These characters are used to generate a measure 
of genetic dissimilarity, or distance, between any two taxa, or nodes. Genetic distance 
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measures can create phylogenies with each individual input sequence assigned to a separate 
terminal node and the distances of the branches proportional to the genetic distances (Huson 
& Bryant, 2006). However, to determine which characters are homologous requires the 
alignment of all the sequences in the group, which may be troublesome if there are sufficient 
mutations, insertions, or deletions (Hogeweg & Hesper, 1984). There are a number of different 
methods of constructing a phylogeny; some of the most commonly used are Maximum 
Likelihood, Maximum Parsimony, Bayesian inference, and Neighbour Joining (Kuhner & 
Felsenstein, 1994). These methods may be parametric and require an underlying mathematical 
model, or non-parametric and use distance, or dissimilarity, measures (Huson & Bryant, 2006). 
The Neighbour Joining (NJ) method is an agglomerative clustering method first 
proposed by Saitou & Nei (1987). It uses a distance matrix Q, specifying the distance (i.e. 
dissimilarity) between each pair of nodes. The pair of unique nodes i and j for which Qij has the 
lowest value are identified. These two nodes are then combined into a newly created node. 
The distances between this new node and all other nodes are calculated, resulting in a new 
distance matrix. The method then repeats until all nodes are clustered. The NJ method is rapid 
and often used for large datasets where other analysis techniques might be computationally 
prohibitive (Day, 1987), such as large DNA or protein sequences (Didelot, 2010). However, it 
has been superseded by other methods which do not rely on distance metrics, such as 
Maximum Likelihood. 
Maximum Parsimony (MP), a non-parametric method, identifies the phylogenetic tree 
which requires the smallest number of evolutionary events to explain the observed data 
(Farris, 1970; Fitch, 1971). This idea of parsimony is prevalent in most phylogenetic methods ; 
i.e. a simpler chain of events required to obtain an output is favourable over a more complex 
one (Jaynes & Bretthorst, 2003). MP analysis works by giving each tree a parsimony score. The 
tree with the greatest parsimony is the favoured one. Since it would be impractical to 
exhaustively search for all possible trees for a large dataset, the favoured tree of the previous 
step is perturbed to see if a more parsimonious tree may be achieved. However, it was shown 
that MP may be inconsistent in a number of ways; for example long-branch attraction is a 
systematic error where distantly related taxa are incorrectly inferred to be closely related due 
to both taxa undergoing large amounts of change (Felsenstein, 1978).  
 Maximum Likelihood (ML) in phylogenetics was first attempted in 1964 (Edwards & 
Cavalli-Sforza, 1964), with the first nucleotide-based data attempt in 1974 (Neyman, 1974). It 
is one of the most popular alternative phylogenetic methods even though it is more 
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computationally demanding (Guindon & Gascuel, 2003). ML is a parametric statistical method 
which uses optimality criteria to determine the best topology of the phylogenetic trees. In ML, 
the tree with the highest maximum likelihood score is preferred (Swofford et al., 1996). 
Furthermore, ML requires an underlying model of the evolution of the characteristics which 
must be a reasonable approximation of the processes that produced the data. An incorrect 
model can produce a biased result. The stochastic model used in constructing a phylogeny with 
ML gives the probability of the change of a particular character. The model can have an 
exorbitant number of parameters, which could encompass probabilities of particular states, 
particular changes or differences in change among characters. The ML method usually 
produces trees which are very similar to the most parsimonious tree for the same dataset, and 
with fewer of the disadvantages associated with MP (Kolaczkowski & Thornton, 2004). 
 Bayesian inference phylogenetics is based on the probabilistic method developed by 
Thomas Bayes (Bayes & Price, 1763). Bayesian inference phylogenetics creates trees by 
constructing a posterior probability, using a model of evolution, from a likelihood function and 
prior probabilities, providing the most likely phylogenetic tree for the given data (Gelman et 
al., 2014a). It requires a large amount of computing power and so it has only relatively recently 
become popular. Furthermore, the large number of possibilities available when constructing 
the posterior probability results in a huge number of possible trees which require the 
implementation of Markov Chain Monte Carlo algorithms to sample and obtain the optimum 
tree (Z. Yang & Rannala, 1997). These algorithms also require substantial computing power. 
Therefore, Bayesian inference phylogenetics is not often used for large datasets, although it is 
often believed to be the most accurate of the phylogenetic models available, provided the 
correct parameters are implemented (Wiens & Moen, 2008). 
All parametric phylogenetic methods require a mathematical model that attempts to 
describe the evolution of the characters in the data. These models often make assumptions, 
either explicitly or implicitly about the input data. Thus, the output of any phylogenetic 
analysis is only a hypothesis for the evolution of the data, and may be inaccurate and biased. 
Furthermore, parametric molecular phylogenetic methods require the use of a defined 
substitution model referring to the rate of mutations at the various character sites examined 
(Sullivan & Joyce, 2005). The Jukes-Cantor model is the simplest and assigns an equal 
probability to all nucleotide bases (Jukes & Cantor, 1969). The models may become 
progressively more complicated to take into account various aspects of unequal mutation rate; 
for example, correcting for differences in transition and transversion rates, or correcting for 
context-dependent evolution of nucleotides (Siepel & Haussler, 2004). The selection of the 
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most appropriate model for the data is critical in obtaining a relevant phylogeny. Although 
there are methods to determine which model would best suit a given dataset (e.g. likelihood 
ratio test (Huelsenbeck & Bull, 1996), Akaike information criteria (Akaike, 1981), or Bayesian 
information criteria (Schwarz, 1978)) care must still be taken when choosing a model. 
Therefore, there is still some subjectivity on behalf of the investigator as to which model is 
chosen and presumed to best fit the data. 
Other than violating the assumptions mentioned there are a number of problems that 
may be encountered when attempting to construct the “true” phylogenetic tree. Firstly, 
certain characters, especially in molecular phylogenetics, may be the result of homoplasy. That 
is, two (or more) separate originations of the same character, leading to the erroneous 
assumption that the organisms in question are related through this character. This could be 
attributed to convergent evolution or due to random mutations at the same site. Secondly, 
organisms may inherit genetic material in two ways; vertical gene transfer is the passing of 
genetic material from parent to offspring, while horizontal gene transfer (HGT) is when genetic 
material may be passed between unrelated organisms. This process, if unaccounted for, may 
create artefacts in the phylogenetic reconstruction of a group of organisms. Missing data, lack 
of taxa and lack of appropriate characters all may play a part in providing a false phylogenetic 
output. Finally, recombination may, if unaccounted for, lead to an overestimation of the 
mutation rate heterogeneity or underestimate the timings of events, such as pathogenicity 
acquisition (Awadalla, 2003). 
 It is possible to determine how much support to assign to a particular phylogeny. 
Determining support can be done through a few different methods such as jack-knifing or 
bootstrapping (Phillips et al., 2004). Jack-knifing is a resampling technique which removes a 
single observation from the data and recalculates the output. This is repeated and the average 
value of each jack-knife is retained. In this way this resampling technique tests the bias, if any, 
of the tree. In bootstrapping all the data are resampled and the consistency with the original 
output is determined. This is repeated, usually between 100 and 500 replicates (Pattengale et 
al, 2010), and the number of consistent bootstraps lends support to the original output. 
Phylogenetic analysis in epidemiology is useful in answering questions related to 
transmission events or population structure. For example, the shape of the phylogeny is an 
important feature which may elucidate information of the population; star-like phylogenies 
are indicative of either a recent population expansion or recombination (Awadalla, 2003). 
However, a phylogenetic approach is only valid with the assumption that recombination does 
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not occur, or occurs at negligible levels (Awadalla, 2003). If recombination has occurred then 
methods which explicitly take this into account must be used, though all phylogenetic and 
comparative methods differ in their ability to detect recombination (Awadalla, 2003; Posada & 
Crandall, 2001). Since recombination allows genomic regions to have independent 
evolutionary histories, phylogenetics have been used to determine the extent to which 
recombination is occurring in a genome, which is essential for locating pathogenicity loci 
(Awadalla, 2003). Therefore, provided care is taken, phylogenetic analysis is an important tool 
in the study of epidemiology. 
1.4.2 Examples of WGS and NGS in the investigation of MRSA 
WGS investigation outperforms traditional methods (e.g. spa typing) in identifying 
transmission events in a number of studies. In one study by Price et al., (2014) the spa typing 
method falsely suggested transmissions between patients, and failed to identify other 
transmission events. This finding was obtained through WGS of the isolates and maximum-
likelihood phylogenetics. A further study by Török et al. (2014) of five MRSA bacteraemia 
isolates from a Cambridge University hospital showed that MLST indicated high relatedness 
between these isolates with four of them from ST22 and one from ST2046. However, WGS 
demonstrated that the cases were actually all unrelated. This indicates the frequent 
introduction of MRSA into this healthcare institution, rather than spread within the institution. 
Another study by Harris et al. (2013) in a special care baby unit in Cambridge identified 26 
related cases of MRSA ST2371 (belonging to the same CC as EMRSA-15) carriage and used WGS 
and phylogenetics to show that transmission events occurred both in the healthcare institution 
and in the community. Furthermore, WGS was able to confirm that a staff member of the 
healthcare institution carried the ST2371 strain between known infections and therefore 
allowed the outbreak to persist. These findings could not be resolved with conventional 
methods. This study shows that WGS allows for rapid identification of subtle differences in an 
isolate’s genome and SNP variation that can be used to trace isolates during outbreaks and 
determine their relatedness. Köser et al. (2012) constructed a phylogenetic tree using SNPs of 
an EMRSA-15 clone (ST22). They found a distinct clustering of outbreak isolates which were 
separated from non-outbreak isolates, with the identification of a previously missed 
transmission event. They also identified a hyper-mutator strain, indicating that a simple SNP 
cut-off threshold to indicate relevance to transmission events is an invalid approach. 
Furthermore, they showed that the use of WGS is clinically valid with regards to rapidity of 
analysis, at no (or negligible) extra cost. This study further highlights the value of WGS in real 
time control of MRSA in healthcare institutions. However, the authors do note that automated 
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interpretation of the WGS data is likely to be a necessity to make this a practical approach. 
Another study, by McAdam et al. (2012) on isolates from CC30 which includes the pandemic 
EMRSA-16 clone, showed molecular correlates of MGEs and non-synonymous mutations 
affecting virulence and antibiotic resistance with HA and CA pandemics. This study used 
Bayesian phylogenetic construction to show that EMRSA-16 in the UK spread to smaller 
healthcare institutions from hospitals in large population centres. This study also implicates 
patient transfers as the vector by which MRSA spreads, which supports the work by Donker et 
al. (2012; 2014). The McAdam et al. (2012) study showed the promise of using WGS and 
phylogenetic techniques to track the emergence and transmission of an epidemic MRSA clone. 
Using WGS Harris et al., (2010) revealed the temporal and global spread of multi-drug 
resistant MRSA strain ST239. They used core genome SNPs found through WGS to create a 
maximum likelihood phylogeny of the hospital and intercontinental spread of ST239. Little 
homoplasy was identified and the few homoplasic SNPs were in genes known to be involved in 
drug resistance. The phylogeny showed a consistent geographic clustering, with the European 
isolates clustered basally on the tree. This is consistent with an European origin for this clone, 
with the most recent common ancestor dated to the mid-1960s. However, several exceptions 
to this clustering indicate inter-continental spread; for example, two European clones 
clustered within the Thai clade. This study also enabled fine scale transmission events between 
or within hospitals to be identified; for example, five isolates from a Thai hospital differed only 
by 14 SNPs. This finding has important implications for targeted infection control, since it is 
possible that a single SNP can distinguish between highly related isolates. This study highlights 
the need for more global surveillance strategies.  
 The use of WGS could help reduce the burden of nosocomial infection in resource-
restricted healthcare settings. Tong et al. (2015) used WGS techniques to sequence 79 ST239 
isolates from a hospital in northeast Thailand and found, using a maximum likelihood 
phylogenetic analysis, that there was distinct variation in ST239 clades over time. This is 
indicative of cycles of introduction, transmission and extinction. Furthermore, this study 
identified variability in the particular resistance encoding genes and MGE complements. 
Therefore, the information of multiple transmission and introduction events obtained through 
the use of WGS would enable the targeting of the limited resources available.  
WGS has also been used to investigate the zoonotic transmission to and from animal 
reservoirs; for example,  Price et al. (2012), Harrison et al. (2013; 2014), and Spoor et al. 
(2012). Price et al. (2013) investigated the livestock associated clonal complex CC398. They 
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obtained 4238 SNPs through WGS of 89 core genomes and used this information to construct a 
maximum likelihood phylogenetic tree. The tree strongly suggests an MSSA human origin for 
CC398, with rapid radiation with the first human to animal transmission and the subsequent 
acquisition of tetracycline and methicillin resistance. Furthermore, the diversity of SCCmec 
subtypes in this CC is suggestive of antimicrobial selection pressures. In the Harrison et al. 
(2013) study isolates (both human and animal) were taken from two Danish farms associated 
with LA-MRSA infections. The isolates from the two farms were indistinguishable by 
conventional techniques (e.g. MLST, PFGE, spa-typing). However, phylogenetic analysis of the 
WGS data showed two distinct farm-specific clusters of isolates. The isolates sampled from the 
humans and livestock of the same farm only differed by a few SNPs, indicating a zoonotic 
origin. The study by Spoor et al. (2013) showed, using the mainly bovine complex CC97 and 
high-resolution phylogenetics, the limited number of evolutionary events required for a 
zoonotic jump to occur. The authors concluded that livestock represent a reservoir of MRSA 
with major public health implications. It is not just livestock which may be reservoirs for MRSA. 
Harrison et al. (2014) investigated the ST22 strain in companion animals, such as cats, horses 
and dogs. The authors found evidence for a human source of the isolates infecting companion 
animals. The studies mentioned here do raise some concerns as to the validity of the “one 
health” view of infectious diseases; that is that the pathogens which show zoonotic capabilities 
intrinsically link multiple species. This implies that antibiotic use in non-human species might 
lead to antibiotic resistance in a pathogen which might then make the jump into humans. This 
complex zoonotic epidemiology will be difficult to untangle, and the use of WGS and 
appropriate tracking techniques will be important in combating the spread. 
 Furthermore, the use of WGS and phylogenetics in a study by Paterson et al. (2015) 
illustrates the considerable within-host diversity and fluctuation in the diversity in both human 
and animal patients. Therefore, this study demonstrates the need for the sequencing of 
multiple isolates from individuals to elucidate the accurate transmission networks. Computer 
simulations conducted by Worby et al. (2014) show that sequencing a single isolate from each 
host is inadequate to obtain transmission networks and may lead to misleading 
interpretations. The authors further conclude that the use of sequence data alone is not 
sufficient, and other traditional methodologies (e.g. identification of overlapping admittance 
to a healthcare institution) are required. Finally, work by Colijn & Gardy (2014) showed that it 
is possible to characterise transmission events based on simple topological properties of the 
phylogenetic tree constructed from WGS genome data.  
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 These examples clearly show the advantages of WGS compared to traditional 
methodologies, especially in the study of transmission routes and timing events of MRSA.  
However, most of these examples provided have used relatively small datasets to generate the 
phylogenetic trees. If WGS becomes a routine procedure in healthcare institutions with a 
corresponding online database, then there will soon be too many isolates to realistically 
conduct phylogenetic analysis, since this approach may become cumbersome and impractical 
for large datasets. Furthermore, as was noted by Kӧser et al (2012), there is a need for 
automation to make this financially and practically viable. Therefore, there is an opportunity 
here to develop novel methods that could identify the origin of an MRSA isolate automatically, 
without resorting to phylogenetic construction. 
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1.5 Conclusion and summary of thesis 
The advancements in Whole Genome Sequencing have paved the way for the 
development of novel analysis techniques. WGS has allowed for the generation of large 
datasets, and has already provided crucial insights into the epidemiology of MRSA. However, 
phylogenetic analysis of large datasets is computationally prohibitive, especially if attempting 
to combat an ongoing outbreak by rapidly answering such epidemiological questions as the 
origin and transmission of a MRSA isolate. Therefore, this thesis presents the development of 
novel methods which will attempt to elucidate the possible geographic origin of a given MRSA 
isolate, within the confines of the sampling dataset. These novel methods will attempt to 
remove the necessity of the construction of a phylogenetic tree. However, these methods 
would be applicable to isolates within a clonal complex, since alternative methodologies (such 
as MLST or PFGE) are robust at defining isolates up to this resolution. Therefore, the 
application of these methods would fall within an analysis pipeline that would include 
conventional genotyping techniques. Each chapter is built on the findings of the previous one. 
The primary dataset used in this thesis is a collated ST22 MRSA dataset comprising 
1022 isolates sampled from 46 hospital locations across the UK and Ireland between 2001 and 
2010. However, there are some isolates in the collated dataset sampled in 2011 and 2012, 
which are used in Chapter 4. Furthermore, isolates obtained from Holden et al (2013) are also 
used in Chapter 4. Finally, I used an indel dataset in Chapter 6. These additional datasets are 
described in their respective chapters. The primary dataset is examined in detail in Chapter 2 
at two geographic resolutions; either with individual hospitals or with a group of hospitals 
(defined as a Referral Cluster) as the MRSA sub-populations. The SNPs found in the isolates are 
used to draw phylogenetic trees and it is found that there is phylogeographic clustering. 
Further examination shows that the SNPs are in fewer locations than expected for the number 
of isolates they are harboured in. The SNP similarity of the MRSA sub-populations is influenced 
by the geographic proximity of the locations, and the number of patient transfers between 
locations. Therefore, this shows that there is structure in the MRSA sub-populations, and the 
movement of strains from one location to another is important in maintaining the genetic 
heterogeneity of the sub-populations. 
Chapter 3 explores the identification of introduction events of MRSA from one location 
to another. Introduction events were determined using a phylogenetic approach. Each isolate 
defined as an introduction was examined to identify if any of the SNPs harboured in that 
isolate could be defined as a signature SNP for a particular location. A signature SNP is one that 
41 
 
is only ever seen in one location, and therefore could be a good indicator that the introduction 
may have originated from that location. It was found that a select few of the introduction 
events can be characterised by a signature SNP from the posited origin location. Therefore, it 
may be possible to identify introduction events by looking at the SNPs an isolate contains. 
In Chapter 4 this idea is developed further. A novel method is developed where the 
SNPs harboured in an isolate are examined for geographic signal, and converted into a 
diagnostic value of origination for each of the locations in the dataset. This method is termed 
the SNP-based Assignment of Pathogen Origin (SnAPO). The isolates identified as introduction 
events in Chapter 3 were first used to test SnAPO, since it might be expected that there would 
be some signal indicating that the isolate is a transmission event. SnAPO was then tested using 
all isolates sampled in 2010 as test cases, where there was not necessarily an expected 
introduction event signal. It was found that SnAPO is able to give a posited origin location of 
any isolate, although there is great variation in the signal clarity. The output of SnAPO was 
then compared to the results obtained by three independent researchers who used a 
phylogenetic approach to determine the possible origin of the isolate, with the majority of test 
cases conforming between the phylogenetic approach and SnAPO. However, the subjectivity of 
the phylogenetic approach was seen in the variation of the posited origin locations for the test 
isolates, while SnAPO is consistent and objective. Further testing of SnAPO was conducted on 
BSAC isolates sampled in 2011 and 2012 which had their location metadata removed. Finally, 
an alternative dataset, extracted from Holden et al (2013), was used to show that SnAPO could 
work on isolates from a different dataset. Therefore, a novel method has been developed 
which is objective, fast, simple and obviates the phylogenetic requirement. 
Chapter 5 explores the development of an alternative approach to determine the 
possible geographic origin of an isolate using a Bayesian inference approach. This would use 
established statistical approaches and move away from the heuristic SnAPO method. It was 
found that the Bayesian approach concurs with SnAPO for the origin location in the majority of 
test cases. 
Finally, Chapter 6 explores some of the possible limitations of SnAPO and the 
modification of SnAPO for an indel dataset. The robustness of the method was investigated by 
removing isolates from the dataset and it was found that SnAPO is robust to changes in the 
dataset since it predicts the same origin location in the majority of the test isolates. It was 
found that older isolates may be obscuring some information and so an optimum dataset size 
of 6 years prior to target isolate was identified. The SnAPO method was applied to an indel 
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dataset and it is found that the indel data can also be used to generate a posited origin 
location for an isolate that matches the one obtained from the SNP data. Therefore this 
method may be applicable to other systems. Finally, the effect of degrading the signal 
expressed in a focal isolate’s SNPs was explored, and it was found that an isolate could have 
approximately a third of its SNPs replaced before a different origin location is posited. 
 In this thesis I present the development of novel methods which obviate the need for a 
phylogenetic tree and determine the possible geographic origin of an MRSA isolate within 
CC22. These methods are rapid, objective and easily interpretable. These properties will be 
useful to quickly determine if an isolate is an introduction, and if so, potentially warn of the 
beginning of an epidemic spread while it happens. In this way the limited resources available 
may be better focussed to combat the spread. Furthermore, I show that the principles 
developed in this thesis may allow for deeper understanding of the rich diversity of 
information available through WGS, and enable detailed investigation into the transmission 




Characterisation of the dataset                                     2 
2.1 Background 
 Methicillin-resistance Staphylococcus aureus (MRSA) was first isolated in the UK in 
1961 (Jevons, 1961). The prevalence of MRSA in the UK gradually increased, with full UK 
coverage observed by the mid-1980s (Johnson et al., 2005). However, mandatory reporting of 
all cases of S. aureus bacteraemia and the number due to MRSA only began in 2001 (Pearson 
et al., 2009). Prior to 2001 voluntary reporting was the routine method of surveillance. 
Mandatory reporting, coupled with an increase in active surveillance, has allowed the 
development of larger MRSA genomic collections. 
There are a number of collections of MRSA genomes in the UK. One collection, 
numbering several thousand genomes, is the British Society of Antimicrobial Chemotherapy 
(BSAC), which coordinates an antimicrobial resistance surveillance project (www.bsacsurv.org; 
Reynolds et al., 2008). Each hospital or laboratory is required to submit the first 10-14 clinically 
significant S. aureus genomes each calendar year to the BSAC collection. The collection is 
further bolstered in size by voluntary MRSA isolate submissions. This MRSA collection is one of 
the largest of its kind in the world; the product of many different collaborating laboratories 
and scientists. This collection provides unique opportunities for investigation and is a powerful 
resource for the analysis of MRSA outbreaks.  
 One of the main aims of the BSAC collection was to understand the population 
structure and dynamics of MRSA spread across UK and Republic of Ireland over the last 
decade. Reuter et al., (2015) found that the majority of isolates belonged to Clonal Complex 
(CC) 22, which contains the dominant UK epidemic clone (EMRSA-15). The second most 
frequent CC in the UK was CC30, containing EMRSA-16. Isolates from a number of other CCs 
comprise the rest of the collection. Geographic structuring of EMRSA-15 was found to be 
consistent with widespread dissemination followed by local diversification prior to the 
sampling period. Local and regional differences in antibiotic resistance were also observed. 
Finally, research on an England-only subset of the BSAC collection by Donker et al. (2012, 
2014) showed that there is phylogeographic clustering of the isolates based on the healthcare 
44 
 
Referral Cluster (RC) they were sampled from. An RC is defined by the level of patient transfer, 
with higher numbers of patient referrals within than between an RC. 
The central contention of this thesis is that it might be possible to obtain a clearer 
picture of how pathogenic microbes, in this case MRSA, might evolve and transmit by 
designing analytic tools which focus on genetic variation SNP-by-SNP. The goal of this chapter 
is to assess the extent to which SNPs spatially and phylogenetically cluster. In this chapter I 
describe the collated single nucleotide polymorphism (SNP) dataset of 1000+ MRSA genomes 
taken over a decade from across England, Scotland, Wales, Northern Ireland and Republic of 
Ireland (UK&I). Isolates sampled in the same geographic location could be considered to be 
from the same MRSA sub-population. These 1000+ isolates are all CC22 isolates and are taken 
mainly from the BSAC collection, with some taken from the East of England (EoE) collection. 
The EoE collection mainly contains isolates sampled in Cambridge Addenbrooke’s Hospital and 
Papworth Hospital. I investigate the SNPs to identify similarity between isolates and MRSA sub-
populations. The traditional phylogenetic approach indicated phylogeographic clustering of 
genetically similar isolates. This was further supported by the finding that some SNPs are in 
fewer locations than expected for their relative abundance. Finally, I used the level of SNP 
similarity between isolates and MRSA sub-populations to show that there is differentiation in 
the MRSA genetic structure of the sub-populations, which may be attributable to the level of 






2.2 Methods for obtaining the data 
The genetic information of the 1022 isolates used in this thesis was determined as 
described in Reuter et al. (2015) which is summarised here. DNA extraction was conducted on 
a QIAxtractor (QIAGEN) and library preparation was performed as described in Köser et al. 
(2012). Index-tagged libraries were created, and sequenced using the Illumina HiSeq platform 
(Illumina Inc.) to generate pair ended reads of 100 base-pairs (bp) at the Wellcome Trust 
Sanger Institute. The pair-end reads were mapped against the chromosome of S. aureus HO 
50960412 (accession no. HE681097). Indels were identified using Dindel (Albers et al., 2011). 
SNPs were identified using ssaha_pileup, with filtering to remove those sites with a SNP quality 
score less than 30 and those SNPs at sites with heterogeneous mappings, if the SNP was 
present in less than 75% of reads at that site (supplementary material, Harris et al., 2010). 
SNPs from unmapped reads or sequences that were not present in all genomes were not 
considered part of the core genome and therefore excluded from the analysis. Furthermore, 
SNPs falling within MGEs regions, and those within high density regions, were also excluded. 
Additionally, the SCCmec element, which contains the mecA antimicrobial resistance gene, was 
removed prior to receiving the data from BSAC and EoE. The core genome was curated 
manually for increased quality assurance and is comprised of 2,643,131 bp. The SNPs in the 
core genome were extracted, reducing down to the 29651 SNPs used for analysis in this thesis, 
both phylogenetic and otherwise. Therefore, the data collated from the BSAC and EoE 
collection and used in this thesis contained 1022 isolates with 29651 SNPs (see Section 2.4 for 
description of the SNPs). This will be termed the Unmodified Dataset. 
2.3 Isolate sampling 
 All 1022 isolates in the Unmodified Dataset were sampled between 2001 and 2010 in 
46 hospitals across England, Scotland, Wales, Northern Ireland and the Republic of Ireland 
(UK&I). The number of hospitals sampled each year varied slightly over the decade (median = 
25, range = 23 – 32). Using a different collated dataset from the BSAC collection, which 
included a large number of hospitals located in England, Donker et al. (2012, 2014) created 
geographic regions within which there was a higher level of patient referral than between 
regions. Each region is termed a Referral Cluster (RC) and it is posited that the movement of 
MRSA-infected patients is one of the main processes by which MRSA is spread to various 
locations. If this is true then there may be variation in the genetic diversity of the MRSA sub-
populations between different RCs and hospitals. The non-English hospitals have been 
subsequently grouped into their respective countries as individual RCs (Figure 2.1). However, it 
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is possible that with increased sampling of hospitals in the other countries of the UK and 
Ireland, there may be further division into smaller RCs. The sampling was not uniform between 
all hospitals or years. Some hospitals, and therefore RCs, had much greater sampling than 
others (Figure 2.2). 
 Two resolutions of geographic sub-populations were considered in this thesis; the 
hospital resolution (where each MRSA sub-population contains the isolates sampled in that 
hospital), and the RC resolution (where each MRSA sub-population contains the isolates 
sampled in that RC). It must be noted that in most cities, except for Glasgow and London, there 
are only isolates from one hospital. Therefore, for convenience, the hospital is called by the 
name of the city. The full name of each hospital in this thesis is provided in Appendix A 
(Supplementary Table A1). 
 
Figure 2.1. A map showing the 46 hospitals present in this thesis, across the United Kingdom, 
Northern Ireland and the Republic of Ireland. The hospitals have been grouped into 16 
separate Referral Clusters (RCs) based on the regions identified in Donker et al. (2012, 2014). 
The hospitals are numbered according to geographic location and RC, with hospitals located 






Figure 2.2. The sampling 
effort in the Unmodified 
Dataset is broken down 
by year (a) and hospital 
(b). In (a) the RC origin 
of the samples is 
indicated by the 
coloured bands. In (b) 
the hospitals along the 
x-axis are ordered in the 
same manner as in 
Figure 2.1, with 
hospitals in the same RC 
grouped together. The 
key to RC colour is 
provided in the top right 
corner of (b). Although 
there is similar sampling 
effort across the 10 
years (ranging from 78 
to 130 isolates per year), 
there is considerable 
variation in the sampling 
across the hospitals 
(ranging from 1 to 135 





2.4 Single nucleotide polymorphisms 
Phylogenetic tree analysis is often integral in epidemiological studies when 
determining the possible geographic origin of the isolates (e.g. Harris et al., 2013; Köser et al., 
2012; Price et al., 2014), since phylogenetic analysis will group those isolates with high genetic 
similarity together regardless of sampling location. Phylogeographic structuring would be 
indicated by phylogenetic clustering of isolates from the same geographic location. 
Furthermore, transmission events may be identified by the phylogenetic clustering of isolates 
from disparate locations (e.g. an isolate from Location A is phylogenetically clustered with a 
group of isolates from Location B, indicating a transmission event from B to A). Therefore there 
are three terms that will be used throughout this thesis; the “sampling location” is where the 
isolate was sampled, the “origin location” is where the isolate is thought to have come from, 
and if the sampling location and the origin location are different then this could be a 
“transmission event”. 
In this section I take the traditional initial step of creating phylogenetic trees of the 
isolates using the SNP data of the 1022 isolates. These isolates are all within Clonal Complex 
22, and so depict the evolution within this CC. which may result in isolates which differ by only 
one SNP. In MRSA this phylogenetic approach is viable since there is a low recombination rate 
and SNPs are stably inherited (Thomas et al., 2011). Therefore, isolates which contain the 
same SNP could be considered to have shared ancestry. The non-singleton SNPs (i.e. the SNPs 
harboured in more than one isolate) are then examined to show that there is a limiting factor 
on the geographic range they occupy. Finally I explore the possible complications arising from 
the fact that some SNPs are linked. 
2.4.1 Constructing phylogenetic trees of the 1022 isolates 
Genetic phylogenetic trees may be constructed using full genome or SNP data and are 
a common way of determining similarity between genomes (Lee et al, 2014). There are a 
number of phylogenetic methods that can use SNP data (discussed in Section 1.4.1), but in this 
thesis I will use the Neighbour Joining (NJ; Saitou & Nei, 1987) and Maximum Likelihood 
methods (ML; Siepel & Haussler, 2004). NJ is a non-parametric method and uses a dissimilarity 
matrix to infer distances between taxa, whereas ML is a parametric method and requires an 
underlying model of the evolution and nucleotide substitution rates of the genomes. NJ and 
ML methods are two of the most common techniques used to generate phylogenetic trees, 
although they require greatly differing levels of computational power. The variation in 
computational power required is due to the differing trade-offs between speed and accuracy; 
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the NJ method is fast yet can be inaccurate, while the ML method is slow yet more likely to 
generate an accurate phylogeny (Kuhner & Felsenstein, 1994). These two methods were 
chosen since they could result in two different phylogenetic trees. 
Two unrooted phylogenetic trees were constructed of the 1022 isolates sampled 
between 2001 and 2010. One tree was constructed in MEGA5 (Tamura et al., 2011) using the 
NJ method (Figure 2.3). The other was constructed in RAxML (Stamatakis, 2014) using the ML 
method with a generalised time reduction CAT evolutionary model (Figure 2.4). Both trees 
were bootstrapped with 1000 replicates and were visualised using the online tool: Interactive 
Tree of Life (iToL; Letunic & Bork, 2006). The singleton SNPs (i.e. the SNPs harboured in only 
one isolate) were retained and those known to be associated with drug resistance were 
excluded in order to reduce the occurrence of homoplasy. As described in Holden et al (2013) 
the literature was mined for the identification of the SNPs associated with drug resistances. 
The original papers are supplied here for completeness: Aubry-Damon et al., 1998; Castanheira 
et al., 2010; Chen et al., 2010; Cui et al., 2010; Cui et al., 2009; Griggs, 2003; Gu et al., 2013; 
Howe et al., 2003; Hurdle et al., 2004; Lannergard et al., 2008; Livermore et al., 2009; 
Livermore et al., 2007; Locke et al., 2009; Meka et al., 2004; Neoh et al., 2008; North et al., 
2005; Prunier et al., 2003; Roberts, 2008; Swaney et al., 1998; Tsiodras et al., 2001; Vester & 
Douthwaite, 2001; Vickers et al., 2009; Yang et al., 2010. Sampling location information at both 
the RC and the hospital geographic resolution level was retained. This provided 29627 SNPs 
and 1022 isolates available with which to construct the phylogenetic trees. This will be termed 








Figure 2.3. The Neighbour Joining phylogenetic tree with 1000 bootstraps of the 1022 
isolates sampled between 2001 and 2010 across 46 UK and Ireland hospitals. The taxa labels 
have been aligned and branch lengths have been homogenised to facilitate visualisation. The 
colours correspond to the Referral Cluster (RC) each isolate was sampled in, as noted in 
Figure 2.1. There are some phylogenetic sub-clades with isolates all from one RC (e.g. red 
circle), indicating there is geographic clustering of genetically similar isolates. However, 
there are a number of isolates which are located close to isolates from a different RC (e.g. 





Figure 2.4. The Maximum Likelihood phylogenetic tree with 1000 bootstraps of the 1022 
isolates sampled between 2001 and 2010 across 46 UK and Ireland hospitals. The taxa labels 
have been aligned and branch lengths homogenised to facilitate visualisation. The colours 
correspond to the Referral Cluster (RC) each isolate was sampled in, as noted in Figure 2.1. 
As with the NJ tree, there are some phylogenetic sub-clades with isolates all from one RC 
(e.g. red circle), indicating there is geographic clustering of genetically similar isolates. 
Similarly to the NJ tree, there are a number of isolates which are located close to isolates 
from a different RC (e.g. red arrow), indicating a possible transmission event. However, there 
are a few differences between the two trees, which is developed in this section. 
 
The phylogenetic tree can be manually divided into sub-clades, and isolates within a 
sub-clade can be considered phylogenetic neighbours and share genetic similarity. In this 
thesis the sole considerations of sub-clade definition were to maximise the bootstrap and 
branch length values; the geographic or temporal sampling information was not considered. In 
certain cases some isolates could not be assigned to a sub-clade. This usually occurred where 
adding the isolate to the sub-clade would drastically decrease the bootstrap value of that sub-
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clade, or where the tree presented a polytomy (see Figure 2.5 for an example). However, these 
measures to try and standardise the sub-clade definition are not infallible, and so sub-clade 
definition remains a subjective and time-consuming process. 
 
Figure 2.5. Part of the Maximum Likelihood (ML) phylogenetic tree showing two sub-clades 
(denoted by the red dashed boxes) and an isolate which cannot be assigned to a sub-clade 
(indicated by a red circle). Branch length is proportional to difference in the number of SNPs 
in the isolates. The numbers above the branches leading to bifurcations are the bootstrap 
values. If these numbers are absent then this split has a bootstrap value less than 80. 
Therefore, in this example this part of the ML phylogenetic tree was split into two sub-clades 
which have bootstrap values of 100 and clear branch lengths. The branches are coloured by 
the Referral Cluster where the isolate was sampled, and this colour code is repeated in the 
right colour column. The left colour column indicates the hospital where the isolate was 
sampled. The isolate code are used as taxa labels. 
 
There is a range of phylogenetic clustering with regards to geographic location. The 
sub-clades may contain isolates all from one location, all isolates from a different location, and 
all variations in between (Figure 2.6). Finally, the consistency of sub-clade clustering between 
the two phylogenetic trees was determined by displaying them graphically in a Tanglegram 





Figure 2.6. Each sub-clade usually contains one geographic location which is more prevalent 
than the others. The x-axis denotes the proportion of isolates in a sub-clade which were 
sampled in the most common geographic location for that sub-clade. The majority of sub-
clades show geographic grouping at the hospital and RC geographic resolution, with many 
sub-clades being solely comprised of isolates from the same location. There is a large 
number of sub-clades which are divided equally between two locations; these sub-clades are 
likely to be ones with only two isolates. Some sub-clades have a very low proportion of the 
majority location, indicating that the sub-clade is very geographically mixed with no one 
location as the clear majority. For identification of transmission events, the most 
illuminating sub-clades are the ones which contain a high proportion of the majority location 







Figure 2.7. A Tanglegram created in Dendroscope showing the differences in clustering between the Maximum Likelihood tree (a) and the Neighbour 
Joining tree (b). Each isolate is matched up to itself in the opposite tree, creating a number of grey lines. Although all connecting lines are shown, due to 
the large number of isolates only a few (n = 68) of the 1022 possible leaf labels are displayed. If the two trees were dissimilar there would be a large 
number of intersecting lines. However, in this example there are a large number of horizontal and parallel lines, indicating that the sub-clade clustering 





The Tanglegram (Figure 2.7) displays a substantial number of horizontal and parallel 
lines between the two trees. This indicates a high sub-clade clustering similarity, and so the 
two trees cluster the isolates in a similar way. Although the two methods are creating similar 
sub-clades it is necessary to ensure that the subclades have similar support in each phylogeny. 
This can be done by examining the distribution of bootstrap values from each phylogeny 
(Figure 2.8). 
 
Figure 2.8. The bootstrap values’ distributions from the Neighbour Joining (a) and the 
Maximum Likelihood (b) phylogenies. Both trees used 1000 bootstrap replicates. Although 
both trees appear to have a large number of well-supported phylogenetic splits, there 
appears to be greater support in the ML tree, with more splits that are fully supported. This 
indicates that the ML tree might be a more accurate tree of the evolution of the 1022 
isolates within CC22.  
 
 The distribution of bootstrap values appear to show greater support of the 
phylogenetic splits in the ML phylogeny compared to the NJ phylogeny. Therefore, there is no 
clear distinction between the sub-clade clustering (as seen in Figure 2.7), yet there is a 
difference in the bootstrap values (as seen in Figure 2.8). Henceforth the ML tree will be used, 
since it might be a more accurate depiction of the evolution of the isolates within CC22. 
However, it should be noted that the bootstrap values from the NJ tree still show high support. 
2.4.2 Investigating the non-singleton SNPs 
Over 80% of the 29627 SNP positions are singletons; i.e. they are only ever found in 





by increasing branch lengths on phylogenetic trees), singletons are uninformative when 
comparing similarity between isolates. Therefore these singleton SNPs are removed from the 
Prime Dataset. Furthermore, those SNPs which are poly-allelic were removed, leaving only bi-
allelic SNPs. Some SNP positions have N-nucleotides; i.e. those nucleotides which are unknown 
due to either insertion, deletion or misreading when compared to the reference genome. 
Those SNP positions which have less than 1% of the 1022 isolates as N-nucleotides were 
retained while the rest were discarded. A threshold of 1% was chosen since those SNP 
positions with a higher N-incidence are likely to be more unreliable. The ones retained had the 
N-nucleotides converted to the majority nucleotide of the SNP position, as the more 
conservative solution. This resulted in 5469 bi-allelic non-singleton SNP positions spread over 
the entirety of the circular genome (Figure 2.9). This is termed the Bi-allelic Dataset. 
 
Figure 2.9. A linear diagrammatic representation of the circular genome of approximately 3 
million base-pairs of MRSA, with the position of all 5649 bi-allelic non-singleton SNPs. These 
SNPs are spread out across the whole genome. The SCCmec element, which contains the 
mecA gene coding for methicillin resistance and can be spread through horizontal transfer as 
a plasmid, has been removed from the genome in the Bi-allelic Dataset. The genome position 
numbering starts from the origin of replication. 
 
At any given bi-allelic SNP position one nucleotide is less common than the other 
across the 1022 isolates in the Bi-allelic Dataset. This is termed the Minor Allele Frequency 
(MAF). Therefore, each SNP position can be reduced to a majority and minority nucleotide 
(Figure 2.10). The majority nucleotide can be considered the genetic background for that 
particular SNP position, while the minority nucleotide is the mutation that causes that 
particular position on the genome to be a SNP. Henceforth, the minority nucleotide will be 
termed as the “SNP”, with “SNP position” referring to the position on the approximately 3 




It is important to mention that the majority and minority nucleotides might be 
different in a separate dataset and the particular MAF nucleotide may be different in separate 
populations. Furthermore, adding more isolates to the Bi-allelic Dataset may cause some of 
the minority nucleotides to become majority nucleotides. This will only be an issue for those 
SNP positions where there is close to a 50% incidence of minority nucleotides. In the Bi-allelic 
Dataset there are only 8 SNP positions which are above 40% minority nucleotide, therefore it is 
unlikely that the addition of more isolates would cause significant deviation from the identified 








Figure 2.10. There are 5469 bi-allelic 
non-singleton SNP positions across 
the 1022 isolates. Each bi-allelic SNP 
position has, across the 1022 
isolates, one nucleotide which is 
more common than the other. This 
can be represented as a majority 
nucleotide (grey) and a minority 
nucleotide (black). The majority 
nucleotide can be considered as the 
genetic background for that SNP 
position, while the minority 
nucleotide is the mutation that 
causes that position to be a SNP. 
This plot shows variation in the 
number of minority nucleotides per 
position. For example, there is a 
SNP position with a high number of 
minority nucleotides (black arrow). 
The isolates are ordered left-to-right 
by sampling date and the SNP 
positions are ordered top-to-
bottom by the position on the 
circular genome in ascending order 




There is some variation in the number of SNPs each isolate contains (Figure 2.11), with 
a slight trend for the later isolates to harbour more SNPs (Figure 2.12). This is as expected, 
since once a mutation occurs at a SNP position it is unlikely to be reversed and is often stably 
inherited. This stable inheritance means that the phylogenetic analysis, and the novel methods 
developed in future chapters, are likely to be valid approaches since a shared SNP would be 
indicative of shared ancestry. There is also considerable variation in the number of isolates 
which exhibit a particular SNP (Figure 2.13), with the majority of SNPs found in few isolates. 
Furthermore, there appears to be a slight trend for the more common SNPs to have been seen 
earlier in the Bi-allelic Dataset (Figure 2.14). This implies that there might be a steady 
evolutionary progression of SNPs from rare to common with eventually the minority SNP 
becoming the majority one. The finding that isolates sampled later have more SNPs and that 
the more common SNPs are seen earlier is indicative of a noticeable mutation rate. Therefore, 
it might be possible to track the evolution of an isolate, and determine its origin location. 
 
Figure 2.11. The distribution of the number of SNPs of the 1022 isolates in the Bi-allelic 
Dataset shows that although each isolate can vary in any of the 5469 SNP positions, the 
actual number of SNPs in each isolate is considerably less. Therefore an entire column of red 






Figure 2.12. There is a slight trend (R2 = 0.114) for isolates that are sampled later in the Bi-
allelic Dataset to harbour more SNPs. This is since once a mutation occurs at a SNP position, 
and is not selected against, it is unlikely to be reversed and is often stably inherited. The Bi-
allelic Dataset is ordered with the first isolate sampled in 2001 at Rank 1, and the last isolate 








Figure 2.13. There is considerable variation in the rarity of the 5469 non-singleton bi-allelic 
SNPs. Rarity is defined as the percentage of the 1022 isolates which harbour that SNP. Some 
SNPs appear in many isolates while the majority of SNPs appear in only a few isolates. With 
the removal of singletons in this study a SNP can be found in a minimum of two isolates. The 
majority of SNPs (n = 2655) are contained in only two isolates, while the most common SNP 






Figure 2.14. Using linear regression, there is a slight trend for the rarer SNPs to be first seen 
later in the Bi-allelic Dataset (Coefficient = -0.124, p-value = <0.001). Therefore, if this trend 
will continue there would be a progression of rare SNPs to more common ones, with 
eventually the minority SNP becoming the majority SNP. In this way there will be a steady 
turn-over of nucleotides at any given bi-allelic SNP position. Each point indicates when a SNP 
was first seen and in how many isolates over the 10 years in the Bi-allelic Dataset. 
 
 There is a trend for the earlier SNPs to be present in more isolates. Therefore these 
SNPs may have an increased geographic range. However, this posited increase in geographic 
range may be limited by the number of patient referrals between RCs. I hypothesised that if 
MRSA is spread by patient transfer then these RCs would limit the number of unique hospitals 
a SNP is present in, when compared to the expected number. Therefore, the number of 
isolates which harbour each SNP and the number of unique hospitals they were sampled from 
was recorded. These observed values were compared to expected values calculated by 
sampling at random, without replacement, successive numbers of isolates from the Bi-allelic 
Dataset. The number of unique hospitals that these randomly selected isolates were sampled 




5000 times. As shown in Figure 2.15, there are a large number of SNPs which are in fewer than 
expected hospitals. 
 
Figure 2.15. The red points indicate the number of isolates and the number of unique 
hospitals each individual SNP was found in. Since each SNP can only be found in one isolate a 
random sample of isolates from the Bi-allelic Dataset was taken (iteratively between 1 and 
500 isolates) to determine the number of unique hospitals that many isolates are expected 
to be found in. This was repeated 5000 times. The mean number of unique hospitals (black 
curve) is shown with the Standard Error of the Mean (SEM; blue error bars). Many of the 
individual SNPs fall short of the expected number of unique hospitals they should be present 
in for the given number of isolates they are found in. Therefore the SNPs appear to show 
geographic clustering to particular hospitals, indicating that there is some process limiting 
the spread of the SNPs. 
 
2.4.3 Sets of linked SNPs 
 Some of the 5469 SNPs are harboured in the same number of isolates and hospitals. 
Furthermore, some SNPs show the exact same pattern of incidence; i.e. they are always 
present in the exact same isolates in the Bi-allelic Dataset. Therefore, it is possible that these 
SNPs are linked together by some mechanism; for example, linkage disequilibrium. A group of 




repeated information. Therefore, one SNP may be used per SLS to represent the one unique 
piece of information obtained. This representation could be considered similar to Tag SNPs, 
which are used to represent a group of SNPs associated by linkage disequilibrium (Chen et al., 
2014). It was found that there are 1391 unique SLSs in the Bi-allelic Dataset. However, there is 
considerable variation in the number of SNPs which form an SLS (Figure 2.16). 
 
Figure 2.16. An SLS is a group of SNPs which are always harboured in the exact same isolates 
as another SNP in the Bi-allelic Dataset. The majority of SLSs only contain 1 SNP; i.e. there is 
no other SNP with the exact same incidence pattern. However, there is considerable 
variation in the number of SNPs in each SLS. Therefore it is possible that these SLSs contain 
duplicated information, which may affect the interpretation of the similarity between any 
two isolates. 
 
However, the membership of each SLS can change if additional isolates are added to 
the dataset (either to the Bi-allelic Dataset, or prior to that in the Prime Dataset). Furthermore, 
although the definition of an SLS is a group of SNPS that are contained in the exact same 
isolates, some SLSs only differ by the absence of one SNP in one isolate. These SLSs are 




SLS B), or partially nested (e.g. SLS A is mostly within SLS B, except for a few isolates). This is 
visualised in Figure 2.17.  
 
Figure 2.17. An extract from Figure 2.10 showing 23 of the 1022 isolates and 33 of the 5469 
bi-allelic non-singleton SNPs. The isolates are ordered on the x-axis by sampling date and the 
SNPs are ordered on the y-axis according to increasing rarity. A black colour denotes a 
mutation in that isolate of that SNP, while the grey colour denotes the background 
nucleotide. Every SNP in this diagram could be considered to be nested within the top SNP. 
However, there are some SNPs which are only partially nested within each other, a simple 
example is denoted by the dashed black box. 
 
Examining the incidence of each SLS it was found that almost every SLS is entirely or 
partially nested within another. This partial nestedness may be attributable to insufficient 
sampling, recombination of the genetic material, or separate evolution of the SNPs in different 
isolates since the first appearance. Therefore, using SLSs might not be a valid approach. 
Although some pseudo-replication may be created by using individual SNPs, each SNP is 
assigned equal importance. The same cannot be said for the SLSs due to their fluid definition 
and nestedness arising from the sampling of this collated Bi-allelic Dataset. Therefore, the 
conservative approach is taken and individual SNPs are used instead of SLSs in this thesis. It 
must be noted, that since the SLSs show nestedness, both full and partial, then the SNPs would 
also show nestedness. Therefore, one must remain aware of this nestedness when interpreting 




2.5 Factors influencing MRSA sub-population genetic similarity 
 The population of MRSA examined is from the UK and Ireland. This MRSA population 
can be divided into two levels of sub-populations: hospital and RC. In this section I will examine 
the connectivity of the sub-populations, both in terms of patient referral and genetic similarity 
by using the Bi-allelic Dataset of 1022 isolates with 5469 bi-allelic non-singleton SNPs. The 
inter-connectedness of the MRSA sub-populations can be considered a network, with the 
nodes as individual hospitals or RCs and the edges connecting them as the geographic 
distance, genetic similarity or patient referral. I show that there is genetic segregation of the 
MRSA sub-populations based on their geographic proximity to one another. I further show that 
this genetic similarity may be influenced by the level of patient referral between the sub-
populations and geographic proximity of the sub-populations.  
In this section two statistical analyses are used: the Mantel correlation test to 
determine the correlation between two matrices (Mantel, 1967), and Newman’s measure of 
assortativity (Newman, 2003) with jack-knifing (Efron & Gong, 1983). Assortativity is used to 
determine the preference of nodes to attach to other nodes which are similar. Similar nodes 
can be grouped into classes. However, in this thesis there are pre-defined classes, assigned by 
the geographic sampling locations (i.e. hospital or RC), where higher genetic similarity within 
the class than between might be expected. Therefore, the assortativity with jack-knifing will 
measure how well the genetic variation in the MRSA sub-populations conforms to these pre-
defined classes; i.e. a measure of the level to which the sub-populations are segregating.  
The direct distance and the road distance between each pair of hospitals (Appendix A 
Supplementary Tables A2 and A3, respectively) was found to be highly correlated (r = 0.914, p 
= 0.001) using a Mantel correlation test. The road distance was calculated using the shortest 
driving distance according to Google Maps. In this section the direct geographic distance is 
used as the measure of geographic proximity of MRSA sub-populations.  
2.5.1 Hospital sub-population genetic similarity 
The initial step was to determine if there is any effect of geographic distance on the 
genetic similarity of hospital sub-populations. In population genetics a conventional method to 
determine genetic similarity is to calculate the Fixation Index (FST; Equation 2.1; Holsinger & 
Weir, 2009; Meirmans & Hedrick, 2011) of each pairwise sub-population (Appendix A 
Supplementary Table A4). This was one of the measures used in the Ke et al. (2012) study 
which showed that patient transfers increase MRSA sub-population similarity. FST is a measure 






between two sub-populations (πBETWEEN) with the average number within the same sub-
population (πWITHIN):  
. 
Values close to 0 indicate that the two populations are highly genetically similar, while 
values close to 1 imply that the two sub-populations are genetically distinct (Hudson et al., 
1992). In certain rare cases it is possible to obtain negative FST values, which implies that the 
isolates from different sub-populations are genetically more similar than the isolates within a 
sub-population. 
An increase of geographic distance would be expected to cause a decrease in the level 
of similarity between the MRSA sub-populations. A Mantel correlation test between FST and 
the direct geographic distance was conducted. It was found that there was a significant 
relationship (r = 0.155, p = 0.047) between the FST values and the direct geographic distance 
between hospitals; i.e. a higher FST value is associated with a greater distance. This indicates 
that geographic proximity may affect the genetic similarity of the MRSA sub-populations.  
However, the use and interpretation of FST have limitations (see Meirmans & Hedrick 
(2011) for full review). The one most pertinent to the Bi-allelic Dataset is the issue of uneven 
sampling. With fewer than three samples per sub-population there is no meaningful πWITHIN. In 
the Bi-allelic Dataset there are some locations with fewer than three samples, therefore these 
FST values may be incorrect. Also, FST cannot be calculated on a sub-population containing only 
one isolate, such as the case of Ulster Hospital in this thesis. Therefore, a different measure is 
needed to determine the genetic similarity of the hospital MRSA sub-populations. As 
previously found (Figure 2.15), certain SNPs are in fewer hospitals than expected. The variation 
in the incidence of SNPs could be used as the unit of similarity between sub-populations. 
 A new method of comparing the genetic similarity between two isolates based on their 
SNPs was developed. This is termed the SNPSIMILARITY. The SNPs found in one isolate (Si) were 
compared with those contained in another isolate (Sj). These isolates may be from the same 
location, or from different locations. Each SNP which was found in both isolates indicates 
increased the similarity between the two isolates. The number of SNPs found in both isolates 
(SB) is standardised by the sum of the number of SNPs harboured in each isolate (Si + Sj; 





This provides a measure of SNPSIMILARITY for any two isolates. The values can range from 
0 which indicates the two isolates have completely dissimilar SNPs, to 0.5 which indicates the 
isolates have identical SNPs. One isolate was randomly selected from each hospital in a pair 
and calculated the SNPSIMILARITY measure. This was repeated 5000 times for each pair of 
hospitals. The mean of the 5000 repeats is the value of the SNP similarity between the two 
hospitals. This was repeated for all 46 hospitals in the Bi-allelic Dataset to populate a 
SNPSIMILARITY matrix (Appendix A Supplementary Table A5). A higher SNP similarity value would 
indicate a closer genetic association between the sub-populations. Therefore, it might be 
expected that with increasing geographic distance there will be a corresponding decrease in 
SNP similarity. It was found that there is a significant negative relationship between these two 
measures (Mantel correlation r = -0.1571, p = 0.003). This finding further supports the 
geographic segregation of the sub-populations.  
 Another alternative measure of genetic similarity between MRSA sub-populations was 
developed for this project. This is termed the SNPCONNECTIVITY. Each SNP was examined in turn 
and identified the sub-populations which contained the SNP. These sub-populations are 
therefore connected via the sharing of this SNP and so this increases their genetic similarity 
measure. For example, if a SNP is seen in two hospitals (A and B) then this is considered a 
connection between these two hospitals. Furthermore, if multiple isolates in the same sub-
population harbour the SNP this will count towards their self-similarity. For each pair of 
hospitals it was determined which of the 5469 SNPs appear in both. This number is now the 
SNPCONNECTIVITY of those two hospitals. This procedure was repeated for all 46 hospitals and 
populated a SNPCONNECTIVITY matrix (Appendix A Supplementary Table A6). A higher number of 
SNPs appearing in both hospitals indicates a greater level of connectivity between the sub-
populations. The SNPs found in multiple isolates in the same hospital are used to give a 
measure of the assortativity of the matrix.  
Using the SNPCONNECTIVITY matrix it was found that there is a hospital-level assortativity 
of r = 0.159 (p < 0.001). However, the majority of SNPs are only ever seen in two isolates 
(Figure 2.13). These SNPs can be termed “rare SNPs”. These rare SNPs might be more 
informative since the more common SNPs might be present in all sub-populations, and 
therefore contribute “noise” to the network. Therefore any SNP was removed which was 
found in more than two isolates, and created a Rare SNP Dataset which comprises 1022 
isolates and 2655 SNPs. Using the Rare SNP Dataset there is a much greater level of 
assortativity (Newman’s r = 0.609, p < 0.001; Appendix A Supplementary Table A7). This is 




relationship between the direct geographical distances of the hospitals and the level of SNP 
connectivity, using either the Bi-allelic Dataset (r = -0.2183, p = 0.001) or just the Rare SNP 
Dataset (r = -0.1499, p = 0.001). This implies that with increased geographic distance between 
two hospitals there is reduced genetic similarity in the sub-populations. 
All three genetic similarity measures (FST, SNPSIMILARITY, and SNPCONNECTIVITY) support the 
conclusion that the geographic proximity of the MRSA sub-populations influences the genetic 
similarity. However, this relationship is relatively weak with r-values around 0.15. Therefore, 
the geographic proximity of the sub-populations is not the only factor influencing genetic 
similarity. 
2.5.2 Patient referral influences hospital sub-population genetic similarity 
 It is possible that it is not solely the geographic distance between hospitals which is 
important, but rather some other measure of connectivity. A UK study by Donker et al. (2012, 
2014) posited that it is the level of patient referral between hospitals which influences the 
connectivity. This was also the finding by Ke et al (2012) in hospitals from California and by 
Donker et al. (2010) in Dutch hospitals. If this is the case then it is possible for a pair of 
hospitals which are geographically distant to become genetically closer with increased number 
of patient referrals. Although Donker et al. (2012, 2014) contained samples from more English 
hospitals than are present in this thesis, I investigated whether the SNP connectivity network 
created here would still support the RC definitions. For the comparison of patient referral data 
and the genetic similarity the SNPCONNECTIVITY measure described in the previous section was 
used.  
Since Donker et al. (2012, 2014) only used patient referral data from English hospitals 
all sampling locations were excluded where there was not also patient referral data. This 
leaves 27 hospitals from England where there is both patient referral data and genetic data. 
The relevant patient referral data was extracted for the hospitals in this study (Appendix A 
Supplementary Table A8) and it was found that there remains a high level of patient referral 
assortativity at both the hospital level (Newman’s r = 0.976, p < 0.001) and the RC level 
(Newman’s r = 0.993, p < 0.001) for this England-only set of locations. Therefore, even on this 
attenuated sub-set of the Donker et al. (2012, 2014) study, the patient referral data still 
conforms to the RC definitions.  
I next confirmed, on this England-only subset of the Bi-allelic Dataset, that there is still 




assortment of SNPs by RC (Newman’s r = 0.304, p = 0.003) than when only using those rare 
SNPs (Newman’s r = 0.686, p < 0.001). This implies that there is an effect of the RCs on the SNP 
similarity of RC sub-populations. Therefore, even with the much fewer English hospitals 
available in this thesis the RCs are still a valid delineation of geographic regions. 
Therefore, to determine the influence of patient referral on genetic similarity of MRSA 
sub-populations, a Mantel correlation analysis was conducted. A significant correlation was 
discovered between the patient referral data and the SNPCONNECTIVITY data at the hospital level, 
using either all the bi-allelic SNPs (r = 0.158, p = 0.01) or just the rare SNPs (r = 0.220, p = 
0.013). At the RC level there is an even stronger correlation between the patient referrals and 
the SNPCONNECTIVITY, using either all the bi-allelic SNPs (r = 0.558, p = 0.001) or just the rare SNPs 
(r = 0.310, p = 0.041). This indicates that a higher number of patient referrals is related to an 
increase of genetic similarity between the MRSA sub-populations at both the hospital level and 
the RC level. There are higher r-values in the Mantel correlation tests between the patient 
referral data and the genetic similarity than between the geographic distance and genetic 
similarity. Therefore, it appears that patient referrals are a more important factor in 
determining genetic similarity of MRSA sub-populations. It would be important for all hospitals 
within a referral cluster to adopt the same infection prevention strategies, and those which 
might be considered hubs (e.g. large city hospitals) to have targeted prevention measures 
(Ciccolini et al., 2013). Additionally, as was concluded by Donker et al. (2010), the rate of 
patient transfers should be included when using the rate of MRSA incidence to gauge the level 
of hospital hygiene. 
 These findings show that the MRSA sub-populations exhibit genetic diversity based on 
their geographic proximity. Further than that, there is population structure based around the 
amount of patient referrals between hospitals and between the RCs posited in Donker et al. 
(2012, 2014). Analysis of the genetic similarity of the MRSA sub-populations indicate that these 
RCs are a valid way to geographically segregate the hospitals in this thesis. Therefore, there are 
two geographic resolutions for attempting to determine the geographic origin of an isolate in 
future chapters; the hospital resolution, and the coarser RC resolution. Furthermore, the 






 Although there is variable sampling in the data used in this thesis, phylogenetic 
examination of the Prime Dataset indicates that there may be geographic clustering of 
genetically similar isolates. Using the Bi-allelic Dataset I show that there is variation in the 
rarity of the SNPs, with some SNPs found in fewer locations than expected for their relative 
abundance. Although geographic proximity plays a role in limiting SNPs to specific locations, I 
show that the level of patient referrals between locations is an important factor affecting the 
genetic similarity of the sub-populations. 
 Therefore I have shown that there is some evidence for the movement of genetic 
material from one MRSA sub-population to another. The next step would be to determine 
which of the isolates between any two pairwise sub-populations are causing the increased 
genetic similarity. This identification of isolates that have been introduced to a new sub-
population (i.e. transmission events) could provide information on the spread of particular 





Identification of MRSA introduction events               3 
3.1 Background 
Phylogenetic analysis is an integral part of the process to determine the geographic 
origin of a pathogen, which helps to understand the epidemiology, transmission rates, and the 
most effective control measures. Phylogenetic analysis is often used to determine the 
transmission route and origin of an MRSA isolate or lineage (for example, Deurenberg et al., 
2005; Harris et al., 2010; Harrison et al., 2013; Holden et al., 2013; McAdam et al., 2012). 
However, there are limitations to the practicality of using a phylogenetic approach. For 
example, increasing the number of isolates or amount of genetic information per isolate 
drastically increases the computational time required (Kuhner & Felsenstein, 1994).  
Therefore, I investigated whether there may be an alternative route to determine the 
geographic origin of a pathogen. 
In the previous chapter I demonstrated a genetic differentiation between the MRSA 
sub-populations based on the Single Nucleotide Polymorphisms (SNPs), both at the Referral 
Cluster (RC) or hospital geographic level of resolution. This structure in the genetic similarity 
may be attributable to geographic proximity and level of patient referrals between sub-
populations. Furthermore, the SNPs are not uniformly distributed across all isolates (Section 
2.4.2) and it is possible that certain SNPs may be contained within a particular geographical 
area. Therefore, I investigated if any of the SNPs provided a signature for a particular 
geographic location and if this information can be used to identify transmission events of 
MRSA from one sub-population to another. These will be termed Candidate Introduction (CI) 
events. Any SNP shared between isolates is assumed to be an indication of a shared ancestor 
of those isolates. This assumption can be made due to the clonal nature of MRSA that results 
in a very low rate of homoplasy and recombination in the core genome (Castillo-Ramírez et al., 
2011). Furthermore, the SNPs known to be associated with drug-resistance genes were 
removed to reduce the incidence of homoplasy (see Section 2.4.1). 
 A signature SNP for a geographic location would be one which is only ever found in 




from Cambridge, then this SNP is a signature for Cambridge. If any subsequently sampled 
isolates harbour this SNP it could be an indication of an association with Cambridge. Therefore, 
this signature SNP can be used as a diagnostic to indicate the potential origin of that isolate as 
Cambridge. Although I focus on the geographic origin characteristic in this chapter, it is 
important to note that signature SNPs might be present for other characteristics provided the 
appropriate metadata are known. For example, if a certain SNP is always harboured in isolates 
with a certain virulence factor then this SNP would be a signature SNP for that virulence factor. 
 In Section 2.4.2 it was found that many of the SNPs in the Prime Dataset are 
singletons; i.e. only ever found in one isolate. Singletons, although useful in phylogenetic 
analysis to determine branch length, will not be signature SNPs since they do not provide 
information on the similarity between isolates. However, singletons do provide a large source 
of potential signature SNPs if more isolates were to be added to the Prime Dataset. If a 
singleton SNP is subsequently seen in a newly added isolate which shares the same 
characteristic (e.g. geographic location), this SNP is now a signature SNP. In this manner there 
would be a continuous turn-over of SNPs; from singletons, to possible signature SNPs, to 
becoming more common (see Chapter 2, Figure 2.11). Therefore, although in this chapter the 
Bi-allelic Dataset is used, if more isolates were to become available then all SNPs would need 
to be included. The identification of the SNPs used in this thesis is described in Section 2.2. 
In summary, in this chapter I investigated introduction events based on a signature 
SNP. I used the Maximum Likelihood (ML) phylogenetic tree to identify possible CIs. I then 
determined which isolates exhibit signature SNPs. I used this information to identify CIs which 
may be characterised by a signature SNP. I discovered that it is possible to identify a number of 





3.2.1 Phylogenetic candidate introductions identification 
The ML tree was used to determine any potential CIs. The first step in determining CIs 
was to manually partition the phylogenetic tree into sub-clades, within which the isolates 
could be considered phylogenetic neighbours. This process is described in detail in Section 
2.4.1.  
As seen in Section 2.4.1 (Figure 2.5) there are many different variations in the 
geographic grouping of isolates within sub-clades; from isolates all sampled in one geographic 
location to all isolates from disparate geographic locations (Figure 3.1). A particular type of 
sub-clade clustering could be used to determine if an isolate is a possible introduction event 
from one geographic location to another. A single isolate phylogenetically clustered with 
isolates from a single different geographic sampling location is suggestive of an introduction 
event (Figure 3.1b). The geographic location of the majority of the isolates in the sub-clade is 
posited to be the origin location. Since the phylogenetic tree is being used to determine the 
origin of the isolate this is termed as a Tree-based Assignment of Pathogen Origin (TAPO). 
 
Figure 3.1. Example sub-clades of a 
phylogenetic tree which show 
phylogenetically close isolates (i.e. 
isolates with high genetic similarity to 
each other). In (a) all isolates were 
sampled in the blue geographic location. 
Therefore, it can be posited that all 
isolates have originated from this 
geographic location. In (b) all bar one of 
the isolates were sampled in the blue 
geographic location. Therefore, the 
isolate sampled in the red geographic 
location is a possible introduction from 
the blue geographic location. In (c) there 
are two possible isolates which could be 
introduction event. This could be 
indicative of either a single introduction 
which replicated or two separate 
introductions. In situations like this the 
conservative approach is to consider this 







There are differing degrees of confidence in a phylogenetic approach when 
determining the origin of an isolate and whether or not it could be an introduction event. For 
example, if there is a large sub-clade with all isolates bar one originating from the same 
geographic location then this isolate is more likely to be an introduction event than the same 
situation in a smaller sub-clade. Alternatively, there may be a sub-clade where it is unclear 
which is the origin location since there are many different geographic locations represented. 
Therefore, stringent thresholds were applied that need to be satisfied, as follows.  
Firstly, in some situations there are duplicated CIs in the same sub-clade (Figure 3.1c). 
In these situations it is difficult to determine if this is indicative of multiple separate 
introductions or one introduction that has since replicated within the new location. The 
conservative approach is to reduce these situations to the earliest sampled isolate and use this 
isolate as the possible CI. Secondly, those CIs where there is no clear geographic origin in the 
sub-clade due to many different locations being represented were removed. Finally, those CIs 
that come from sub-clades which are too small were eliminated. For this study, I only 
considered those CIs which are non-duplicates and come from sub-clades that have 80% or 
more of the isolates from one location, with a minimum of 5 isolates in a sub-clade. 
There is now a method by which it may be possible to identify CIs using a phylogenetic 
tree. The next step is to investigate if some of these CIs can also be identified using signature 
SNPs. To do this, it must be determined which isolates harbour signature SNPs for a specific 
location. 
3.2.2 Determining signature SNPs 
The SNPs in the Bi-allelic Dataset are not uniformly distributed across all isolates (see 
Section 2.4.2), and it is possible that some SNPs will be found only in isolates from a specific 
geographic sampling location. Geographic locations are examined at two resolutions; 
individual hospitals and Referral Clusters (RCs).  
The first step is to identify a focal isolate to be examined. Any isolate sampled after the 
focal isolate is excluded from the analysis. The focal isolate’s SNPs were then identified. Each 
SNP was examined and it was determined in which previous isolates it was found, up to but 
excluding the focal isolate. If the SNP is present in isolates which have only been sampled in 
one location then this SNP is a signature SNP for that location. These SNPs are termed as 
Location Specific SNPs (LSSs). For the focal isolate any LSSs were noted. It is possible for a 




repeated for all 1022 isolates in the Bi-allelic Dataset, at both the hospital and RC geographic 
resolution. 
3.2.3 Candidate introductions with location specific SNPs 
It is now known which isolates could be considered CIs and which isolates harbour 
LSSs. Therefore, those isolates which fall into both categories are extracted. However, it is 
possible that a CI may have LSSs for multiple geographic locations that contradict one another, 
or an LSS for a location that contradicts the TAPO posited origin. Since this is a proof-of-
principle investigation to determine if an isolate can be defined as a CI based on a single SNP, 
those CIs which have LSSs for multiple geographic locations and those with LSSs for geographic 
locations than contradict the origin posited by TAPO were removed. This left those CIs that 
only harbour one LSS, or multiple LSSs for the same location. Furthermore, this LSS location 
must be the one posited as the possible origin location of the isolate by TAPO. This idea is 





3.3.1 Phylogenetic candidate introductions determined by TAPO 
  The Candidate Introductions (CIs) were determined based on the ML phylogenetic 
tree. There were 127 possible CIs at the hospital geographic resolution, while there were 72 
CIs at the RC resolution. Subsequently, those CIs which do not conform to the stringent 
thresholds described in the method Section 3.2.2 were excluded. Those isolates which were 
non-independent introduction events (see Figure 3.1c) were eliminated. Further, those isolates 
which came from sub-clades that were too small (i.e. less than 5 isolates) or did not show a 
single majority origin location were eliminated. This process resulted in 57 hospital CIs (Figure 
3.2) and 39 RC CIs (Figure 3.3) which are independent and arise in sub-clades of sufficient size 
which have a single majority origin location. 
 
Figure 3.2. The ML phylogenetic tree was used to identify 127 possible CIs at the hospital 
resolution out of the 1022 isolates in the Bi-allelic Dataset. Those CIs which are not 
independent CIs and those without sufficient confidence were removed. This resulted in 57 






Figure 3.3. The ML phylogenetic tree was used to identify 72 possible CIs at the RC resolution 
out of the 1022 isolates in the Bi-allelic Dataset. Similarly to the hospital resolution CIs, those 
CIs which are not independent CIs and those without sufficient confidence were removed. 
This resulted in 39 potential RC CIs based on the ML phylogenetic tree. There are fewer CIs 
than at the hospital resolution due to the coarser geographic scale involved. 
 
3.3.2 Isolates with location specific SNPs  
The next step in this investigation was to identify any isolates which harbour Location 
Specific SNPs (LSSs). Of the 1022 isolates it was found that 881 isolates (86.2%) in the Bi-allelic 





Figure 3.4. There is considerable variation in the number of hospital LSSs harboured by a 
given isolate. The majority (n = 881, 86.2%) of isolates have at least 1 hospital LSS, with a 
large number (n = 764, 74.8%) of isolates containing multiple hospital LSSs. Some isolates 
harbour multiple LSSs for the same hospital location. There does not appear to be any 
correlation between the sampling date and number of LSSs an isolate contains. 
  
Of the 881 isolates which harbour hospital LSSs, the majority (n = 599, 68%) exhibit 
only one LSS location, while the rest (n = 282, 32%) exhibit multiple LSS locations. Although a 
slight majority of the 881 isolates harbour an LSS for the location they were sampled in (n = 
490, 55.6%), an even greater number of isolates harbour an LSS for the sampling location of 
one of their phylogenetic neighbours (n = 652, 74.0%). Finally, a small number (n = 102, 11.6%) 
of the isolates which exhibit hospital LSSs were not assigned to any sub-clade on the ML 





Figure 3.5. The breakdown of the hospital LSSs for the 1022 isolates. The majority of isolates 
contain LSSs (column B, n = 881, 86.2%), with most isolates exhibiting only one LSS (column B 
light grey, n = 599, 68.0%). Many of the isolates have an LSS for their sampling location 
(column C, n = 490, 55.6%), but a greater number have an LSS for the sampling location of at 
least one of their phylogenetic neighbours (column D, n = 652, 74.0%). Furthermore, a few 
isolates could not be assigned to any sub-clade on the ML phylogenetic tree yet still harbour 
LSSs (column E, n = 102, 11.6%). 
 
 A coarser resolution of geographic delineation was examined: the Referral Clusters 
(RCs). It was found that 924 of the 1022 isolates (90.4%) in the Bi-allelic Dataset harbour an LSS 





Figure 3.6. Similarly to what was found using the hospital geographic resolution, there is 
variation in the number of LSSs harboured by a given isolate at the RC geographic resolution. 
The considerable majority of isolates (n = 924, 90.4%) exhibit at least one RC LSS, with a large 
number of isolates (n = 836, 81.8%) harbouring multiple LSSs. Some isolates exhibit multiple 
LSSs for the same RC location. There does not appear to be any correlation between the 
sampling date and number of LSSs an isolate contains, even at this coarser level of 
geographic resolution. 
 
Of the 924 isolates which do harbour RC LSSs, the majority (n = 618, 66.9%) exhibit 
only one LSS location, while some exhibit multiple LSS locations (n = 306, 33.1%). The majority 
of the 924 isolates contain an LSS for the location they were sampled in (n = 651, 70.5%). An 
even greater number of the isolates have an LSS for the sampling location of one of their 
phylogenetic neighbours (n = 728, 78.8%). Finally, a small number (n = 109, 11.8%) of the 






Figure 3.7. The breakdown of the RC LSSs for the 1022 isolates. As was found at the hospital 
geographic resolution, the majority of isolates contain LSSs (column B, n = 924, 90.4%), with 
most isolates harbouring only one LSS (column B light grey, 66.9%). Many of the isolates 
have an LSS for their sampling location (column C, 70.4%), but a greater number exhibit an 
LSS for the sampling location of at least one of their phylogenetic neighbours (column D, 
78.8%). Furthermore, a few isolates could not be assigned to any sub-clade on the ML 
phylogenetic tree yet still exhibit LSSs (column E, 11.8%). The pattern of LSS incidence 
appears to be similar at both geographic resolutions. 
 
3.3.3 Candidate introductions with location specific SNPs 
 Thus far, 57 isolates at the hospital geographic resolution and 39 isolates at the RC 
resolution were identified which could be considered CIs. However, these isolates show a wide 
variety of different LSS incidences. Since the aim is to determine if an introduction event may 
be characterised by a single SNP all those CIs which do not have an LSS, and those which 
harbour an LSS for a location other than the one posited by TAPO were excluded. Finally, those 
CIs which exhibit multiple LSS locations were excluded. This leaves CIs which harbour LSSs for 
only one location, which is the same location as that posited to be the origin by TAPO. There 
are 18 hospital CIs (Figure 3.8) and 16 RC CIs (Figure 3.9) that also can be characterised by an 





Figure 3.8. 57 possible hospital CIs were previously identified using the TAPO process. This 
number was further reduced based on the LSSs expressed in each CI. Those few CIs which do 
not contain any LSSs (n = 8) were removed. Next, those CIs which do exhibit an LSS but do so 
for a different location than that posited as the origin location by TAPO (n = 21) were 
removed. Finally, those CIs which exhibit multiple LSS locations (n = 10) were removed. This 
process results in 18 hospital CIs. There are a greater number of hospital CIs between RCs 








Figure 3.9. 39 possible RC CIs were previously identified using the TAPO process. The 
possible CIs were further reduced based on their LSSs. 3 CIs were removed which do not 
have any LSSs. Then, those which harbour an LSS for a different location than that posited as 
the origin location by TAPO (n = 10) were removed. Finally, those CIs which exhibit multiple 
LSS locations (n = 10) were removed. This process results in 16 RC CIs. The slight discrepancy 
between the hospital CIs and the RC CIs is due to the sub-clade clustering and initial 
definition of a CI. 
 
The majority of the hospital CIs are between RCs (n = 12, 66.7%, Figure 3.10, Appendix 
B Supplementary Table B1). Examining the RC CIs, if those Cis which are between RCs that do 
not share a land border are ignored then the majority of RC CIs are to non-adjacent RCs (n = 





Figure 3.10. Out of 1022 isolates there are 18 hospital CIs that meet all the conservative 
thresholds. 127 isolates were initially identified using the TAPO process. These were then 
reduced to 18 CIs which have only one LSS for the same location that the TAPO method 
posits as the origin. There are a greater number of CIs between than within Referral Clusters 
(RCs), and a large number of those are to non-adjacent RCs. The hospitals have been 
grouped into 16 separate RCs based on the regions identified in Donker et al. (2012, 2014). 
The hospitals are numbered according to geographic location and RC, with hospitals located 





Figure 3.11. Out of 1022 isolates there are 16 Referral Cluster (RC) level Candidate 
Introductions (CIs) that meet all the conservative thresholds. 72 isolates were initially 
identified using the TAPO process. These were then reduced to 16 CIs which have only one 
LSS for the same location that the TAPO method posits as the origin. A large number of these 
CIs are to non-adjacent RCs. The RC CIs are slightly different to the hospital CIs due to the 
sub-clade determination on the ML tree. The hospitals have been grouped into 16 separate 
RCs based on the regions identified in Donker et al. (2012, 2014). The hospitals are 







There are a small number of LSS-containing isolates can be considered as CI events at 
either the hospital or the RC geographic resolution. This implies that it may be possible to 
identify introduction events based on a single SNP. Since the considerable majority of isolates 
have at least one LSS, at either the hospital or RC geographic resolution, this could be a quick 
way of identifying the origin of any isolate. However, it must be noted that of the 1022 isolates 
only a few could be considered possible transmission events (127 isolates at the hospital 
resolution and 72 isolates at the RC resolution), and of these few a tiny fraction survived the 
strict elimination process described in this chapter (18 isolates at the hospital resolution and 
16 isolates at the RC resolution). Therefore, although this method works, it does not have a 
sufficiently high success rate to be a viable strategy.  However, it serves as a proof-of-principle 
that SNPs can be used to identify transmission events. 
A majority of the CIs are between geographically non-adjacent RCs. This is in contrast 
to the historical finding that ST22 started in the East Midlands and spread across the UK over 
the next decade (Holden et al., 2013). However, a study by Donker et al. (2010) implied that 
the modern day spread of MRSA does not conform to a diffusion pattern, but rather shows a 
large number of long-range transmission events. Although long-range transmission may seem 
counter-intuitive, if patient referrals are a method of MRSA transmission (Donker et al., 2012; 
2014) these results appear reasonable. These long range transmission events could be due to 
patients being referred to specialist hospitals for specific treatments, or people moving or 
travelling. Furthermore, long range transmissions might be more likely to be observed since 
the focal isolate would be from a sub-population with a different complement of SNPs and 
thus stand out more from the genetic background. Unfortunately these longer range 
transmissions greatly complicate the possible mathematical modelling of the spread of MRSA 
strains. 
Although the majority of isolates contain LSSs it would be a mistake to assume that the 
LSS location must be the origin location of the isolate. The LSS definition is dependent on the 
dataset being used, and therefore insufficient uniform sampling may create incorrect LSSs 
which could lead to an erroneous assumption of the origin of an isolate. Furthermore, a 
number of the isolates exhibit multiple conflicting locations, which could be due to insufficient 
sampling or horizontal gene transfer. Therefore, a way to assess the viability of the LSS location 
as the origin location is required. Although not all SNPs are LSSs, it is clear that not all SNPs are 




geographic locations. This variable rarity could be informative to the validity of the LSS location 
as the origin location if the more common SNPs are also found in similar locations. Even if an 
isolate’s exact origin could not be specified, using increasingly rare SNPs would enable the 
narrowing of the possibilities. It is important to note that the possible origin of the isolate is 
always within the confines of the sampling, and therefore isolates which may have originated 
in un-sampled locations or other countries may not be able to be assigned an origin. 
The method presented here appears promising, but there are some limitations. Firstly, 
a phylogenetic tree is required. For small datasets this is not an issue. However, with large and 
expanding datasets the creation of a phylogenetic tree becomes a lengthy and computationally 
prohibitive process (Day, 1987). Related to that, the determination of the phylogenetic sub-
clades is subjective and requires specialised knowledge. Since the potential CIs are initially 
determined by their position within a sub-clade, this subjectivity may cause some CIs to be 
overlooked. Secondly, the criteria thresholds imposed upon the potential CIs are somewhat 
arbitrary. These thresholds could be modified to be more or less conservative. For example, in 
this chapter only those sub-clades with five or more isolates were considered. The potential 
pool of Cis could be increased by reducing this threshold and consider sub-clades with fewer 
isolates. Finally, those isolates sampled at the beginning of the collection are more likely to 
present LSSs, since not many isolates have been sampled prior to them. This could artificially 
inflate the number of LSSs found in the earlier isolates. However, in the Bi-allelic Dataset no 
trend was found between the number of LSSs an isolate exhibits and the sampling date.  
Currently, a manual interpretation of a phylogenetic tree is still required to cross-
reference the process of identifying CIs based on a single signature SNP. Therefore, the next 
step would be to incorporate all the SNPs that an isolate contains to determine the possible 
geographic origin without using a phylogenetic tree. This process would need to be a broader 
approach to be able to identify any isolate’s geographic origin, within the sampling confines. 
Furthermore, it might be possible to automate this process, removing the requirement for a 
manual interpretation of a phylogenetic tree. This could enable the rapid identification of 






 Using the Bi-allelic Dataset, which comprises of non-singleton bi-allelic SNPs, I have 
shown that it is possible to identify isolates which are introduction events based on a single 
signature SNP; a Location Specific SNP (LSS). This process currently requires interpretation of a 
phylogenetic tree and subjective sub-clade definition, and resulted in only a few, very specific, 
Candidate Introduction (CI) events. Therefore, a broader approach is required. The next step 
would be to devise a way to identify the possible geographic origin of any isolate within the Bi-









                   4 
4.1 Background 
In this thesis thus far it has been found that there is genetic similarity between MRSA 
sub-populations due to geographic proximity and level of patient transfer (Chapter 2). It was 
also found that is sometimes possible to identify introduction events from a phylogenetic tree 
and characterise them with a signature Single Nucleotide Polymorphism (SNP) for a particular 
location; a Location Specific SNP (LSS; Chapter 3). In this chapter I will take the identification of 
introduction events one step further and attempt to remove the necessity of a phylogenetic 
tree. Furthermore, I will attempt to automate the process of identifying the geographic origin 
of any given isolate within the confines of the sampling. 
Information on the geographic origin of an isolate would enable inform if a particular 
outbreak is developing into an epidemic, or as found in Köser et al (2012), if there is a 
previously undetected transmission event. As mentioned previously in this thesis, the 
traditional approach to determine an isolate’s origin is to build a phylogenetic tree of all the 
isolates in question and then look at the phylogenetic clustering (for example, Deurenberg et 
al., 2005; Harris et al., 2010; Harrison et al., 2013; Holden et al., 2013; McAdam et al., 2012). 
This process explained in greater detail in Section 3.2.1. 
However, this tree-based approach becomes cumbersome when dealing with large 
datasets since the computational time required will increase dramatically. Kuhner & 
Felsenstein (1994) showed that for an increase of 5 taxa the Neighbour Joining (NJ) method led 
to a 2.5 times longer computation calculation, while Maximum Likelihood (ML) method took 5 
times longer. Furthermore, larger trees would take longer to successfully manually identify all 
sub-clades. The large quantity of data can be difficult to interpret, and there is a drive towards 
simpler, potentially automated, data interpretation (Köser et al., 2012). 
The plummeting cost of Whole Genome Sequencing (WGS), currently less than £50 for 
one MRSA isolate (Priest et al., 2012), opens up opportunities for the use of WGS as a routine 
practice in healthcare institutions in the near future. If every case of MRSA bacteraemia 
identified in a healthcare institution was sequenced using WGS, a large repository of MRSA 
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genomes would soon be built up. If this sequencing practice is adopted across the UK and 
Ireland each institution could add their genomes to a collated online database. Therefore, a 
computationally cheap method could be integrated into the analysis pipeline of the MRSA 
isolates in each healthcare institution which would use the collated online database to 
determine the possible geographic origin of the MRSA isolate. 
The ML phylogenetic tree in Chapter 2 (Figure 2.4) was used to determine the possible 
geographic origin location of the isolates. However, if a different phylogenetic construction 
method was implemented (e.g. Neighbour Joining) then a slightly different set of Candidate 
Introduction (CI) events may have arisen. Finally, if a different person was to characterise the 
same phylogenetic tree there may be discrepancies between how each person defines the sub-
clades. Since it is this sub-clade definition which is used to define the geographic origin of an 
isolate this discrepancy would also result in a different set of CIs. Therefore, an automatic 
method is required that would consistently provide the same geographic origin for a given 
isolate. One potential approach would be to examine an isolate’s SNPs and use these SNPs to 
posit a potential geographic origin. This would obviate the need for constructing a 
phylogenetic tree and remove some of the subjectivity of the current standard process. Finally, 
by-passing the phylogenetic approach would reduce the time required in determining the 
geographic origin for an isolate. 
In this chapter I present a novel method which will examine the SNPs an MRSA isolate 
harbours to determine which geographic location the isolate has originated from by 
comparison to the SNPs present in the other MRSA genomes. The identification of the SNPs 
used in this is described in Section 2.2. I will attempt to elucidate the possible geographic 
origin of the isolate at both the hospital and the RC geographic resolution. RCs are regions 
within which hospitals refer patients to one another and are described in Donker et al. (2012, 
2014) and Section 2.3. This method will attempt to circumvent the traditional tree based 
approaches and may be integrated into the routine pipeline of MRSA diagnosis in hospitals to 
provide early warning of a new import. I start by explaining, with a hypothetical example, the 
process by which SNPs are used to determine an isolate’s origin. I will be using the Bi-allelic 
Dataset as in the previous chapter(s); 5469 non-singleton bi-allelic SNPs which are present in at 
least 2 of the 1022 isolates of EMRSA-15 in Clonal Complex 22 present across 46 hospitals in 
the UK and Ireland (UK&I) between 2001 and 2010. Therefore, any posited origin for an isolate 
will be constrained to the locations sampled. I will use two sub-sets of isolates from the Bi-
allelic Dataset to test this novel method, and an additional set of isolates sampled from 2011 




determined in Chapter 3, which might be expected to show a clear signal of transmission. This 
group of isolates is termed the CI Test Subset. The second group of test isolates will contain all 
the isolates sampled in 2010. The genetic profiles of these isolates are very varied and there 
are no prior preconceptions of the geographic origin of these isolates. This group of isolates is 
termed the 2010 Test Subset. Using these two subsets of isolates I show that it is possible to 
determine the potential geographic origin location, within the confines of the sampling, of an 
isolate based on the SNPs it contains. I also investigated how the computational time and 
efficiency of SnAPO will scale with an increasing database size. I show that SnAPO would likely 
be computationally faster than standard phylogenetic methods with ever increasing database 
sizes. 
Additionally, the BSAC isolates sampled in 2011 and 2012 were used to test how 
SnAPO performs if the sampling location metadata is obscured. These isolates were processed 
using SnAPO and investigated if the origin location could be determined without knowing the 
sampling location. Finally, in a test of SnAPO’s robustness and ability to cope with data from 
other studies, isolates obtained in an alternate study were examined and processed using 
SnAPO. The isolates were from Holden et al (2013), which examined the spread of EMRSA-15 
across the world and used phylogenetic analysis to show the origin of this strain to be in the 
English Midlands (see Section 1.4.2 for more details). This study contains a large number of 
isolates from all across the world and so would provide a diverse dataset which could be used 
to determine the various types of output that may be obtained through SnAPO for a wide 







4.2.1 A SNP-based assignment of pathogen origin 
There is high variability in the rarity of the SNPs in the Bi-allelic Dataset; some are 
found in many isolates, while others are harboured in a select few (Section 2.4). In Chapter 3 I 
demonstrated that certain SNPs can be used as a signature for a specific geographic location 
(Location Specific SNP; LSS), and this signature can be used to identify some Candidate 
Introduction (CI) events. However, it was found that only a few CIs can be identified in this 
way. Therefore an approach with broader application might be necessary. The method 
described in this section could be applicable to all isolates. 
It is assumed that any SNP shared between isolates is an indication of a shared 
ancestor of those isolates. This assumption can be made due to the clonal nature of MRSA that 
results in a very low rate of homoplasy and recombination in the core genome (Castillo-
Ramírez et al., 2011). Furthermore, unless specifically selected against or lost through genetic 
drift, it is known that SNPs accumulate in a genome over time and can be inherited vertically 
(Thomas et al., 2011). Since I am attempting to elucidate the potential geographic origin of an 
isolate I will examine the geographic incidence of the individual SNPs. It must be noted that 
this is a heuristic method, however in Chapter 5 a Bayesian analysis is applied to this problem 
with similar results. 
 A hypothetical example, with typical numbers and distributions of SNPs, will be first 
used to illustrate this method. In the results Section 4.3.1 three real examples are provided as 
case-studies to further illustrate this method. The first step in this heuristic method was to 
choose a focal isolate. Any isolates sampled after the focal isolate were excluded from the 
analysis. Once this was done the SNPs the focal isolate harbours were determined and, for 
each SNP (S), how many isolates (n) and locations (L) they have appeared in before. This 





Figure 4.1. Each SNP is assigned an index number (S). The number of isolates (n) each SNP is 
found in for each location (L) is obtained; n(L,S). In this hypothetical example I provide 
examples of typical SNP geographic incidence distributions. In (a) the majority of isolates 
with S = 1 are in L = 2; in (b) the SNP appears in many isolates; in (c) there is the same 
distribution as in (a); (d) is an LSS for L = 2; (e) is a SNP that is found in every location equally; 
(f) is a SNP which shows a similar distribution to (a) and (c), except in a few more isolates. 
These SNP geographic distributions are conflicting in their indication of the origin of the 
hypothetical isolate. Although there is an LSS for L = 2 in (d), there are many isolates from L = 
4 that share S = 2 in (b). S = 2 is likely an older SNP that has penetrated more isolates, while S 
= 4 is probably a younger one. 
 
 The incidence of each SNP in the hypothetical focal isolate has been identified (Figure 
4.1). In this hypothetical example there is an LSS for Location 2 (S = 4, Figure 4.1d) indicating 
that the isolate in question might have originated, within the confines of our sampling, from 
Location 2. However, there is some conflicting evidence that Location 4 might be the origin, 
since many isolates in that location share the SNP S = 2 (Figure 4.1b). Therefore, it should not 




isolate. If the location of the LSS is indeed the origin of the focal isolate then this location will 
be supported by other, more common, SNPs which the focal isolate harbours. A lack of support 
could be indicate that the LSS might have arisen through homoplasy, recombination or under-
sampling. 
 The more common SNPs (such as S = 2 and S = 6 in Figure 4.1), which are usually older 
(Section 2.4.2, Figure 2.10), provide less information about the relatedness between isolates 
than the rarer SNPs. Although it is important for the location of the LSS to have support of 
more common SNPs it can be assumed that LSSs, as a signature for a specific location, provide 
greater information of the most recent origin of the focal isolate. Therefore, the next step was 
to standardise each SNP’s distribution but allowing the rarer SNPs (such as LSSs) greater 
influence on the origin of the focal isolate. For each focal isolate SNP (S = 1 to S = n) the 
number of other isolates that harbour that SNP in a particular geographic location was 
standardised by the total number of other isolates that harbour that SNP in all locations. This 
will be termed this ṅ. Therefore, an LSS would have a value of ṅ = 1 for the location of the LSS; 
a SNP seen in equal numbers of isolates in two locations will have a value of ṅ = 0.5 for each 
location, and so on. An increase in the geographic dispersal of a SNP will correspond with a 
decrease in the value of that SNP at any one geographic location. This standardisation allows 
the comparison of SNPs within the focal isolate (Figure 4.2). 
There is variation in the number of samples for each location in the Bi-allelic Dataset 
(Section 2.3, Figure 2.2b). Therefore, it could be argued that the sampling effort in each 
location should also be taken into account; for example, by dividing each SNP’s incidence at a 
location by the total number of isolates sampled at that location. However, this will artificially 
inflate those locations that were under-sampled. Therefore, this factor is not included in the 
analysis but instead remain aware that the interpretation of the origin of the focal isolate may 
be influenced by this choice. This will likely remain an issue until routine sequencing of MRSA 





Figure 4.2. The number of isolates for each location for a SNP (n(L,S)) is standardised (ṅ) by 
the total number of isolates which harbour the SNP (∑n(L,S)); ṅ = n(L,S)/ ∑n(L,S). An LSS, such 
as S = 4 in (d) gives a standardised value of 1, indicating strong support for that location. The 
standardised values for more common SNPs provide less informative support, such as S = 2 
and S = 5 in (b) and (e). In this hypothetical example, the standardised incidences of the SNPs 
begin to indicate more strongly that the possible origin is L = 2, but there are other locations 
with SNPs in common with the focal isolate. Therefore a way to combine the SNPs into one 
diagnostic value is required. 
  
The standardised incidence of each SNP based on its rarity has been determined 
(Figure 4.2). There is still some conflicting evidence on the origin of this hypothetical isolate, so 
all information must be considered before concluding the possible origin. Therefore, the next 
step will combine the standardised incidence of each SNP to give a total value for each 
location. However, there are some issues that need to be addressed first. Thus far it has been 
assumed that each SNP is an individual piece of information, but in this hypothetical example S 




present). SNPs with identical incidences were defined as SLSs in Section 2.4.3. It is possible that 
combining these SNPs to give a total value for each location might count one piece of 
information twice. If it is decided that each SNP which shows identical distribution is only one 
piece of original information there is a secondary problem. In this hypothetical example S = 6 
has very similar distribution as S = 1 and S = 3. Although S = 6 is present in more isolates, every 
isolate which harbours S = 6 also harbours S = 1 and S = 3. It could be said that S = 1 and S = 3 
are “nested” within S = 6. It now becomes difficult to decide how to treat these nested SNPs, 
especially since there are situations where a SNP is not fully nested within another. Therefore, 
although there may be some issues with counting SNPs twice, the simplest case is to continue 
to assume that each SNP is an independent piece of information. Furthermore, this is in line 
with the assumption that each SNP is indicative of a common ancestry. However, the issue of 
identical and nested SNP incidences is certainly an avenue of investigation waiting to be 
resolved. 
Therefore, the standardised incidences of all SNPs at each location were summed (ṅ) 
to give a total value for each location (p) (Figure 4.3a). These values were standardised to 
facilitate comparison between isolates by dividing each location’s value by the total number of 
SNPs the target isolate harbours. This final output can be presented as either a diagnostic 
proportion or percentage of origin (Figure 4.3b). This is termed the Diagnostic Origin Value 
(DOV). A higher DOV indicates that the particular location is the potential geographic origin of 
the focal isolate. However, it is important to note that unless there is a location with an 
obviously highest DOV, the interpretation of this output could be subjective. However, for a 






Figure 4.3. Each location is given a total value (p) which is the sum of each SNP’s proportion 
at that location (ṅ) (a). In order to compare the results for different isolates each location 
value is standardised by the number of SNPs (s) in the focal isolate (b). This results in a 
Diagnostic Origin Value (DOV) for each location; DOV = p/s. In this hypothetical example, the 
final standardisation (b) gives a DOV maximum value above 0.453 for L = 2, and the next 
highest (0.178 for L = 1) is considerably lower. Therefore, L = 2 is the possible origin location 
for this hypothetical isolate within the confines of the sampling. 
 
 In summary, the DOV for a given geographic location for a target isolate was obtained 
by summing together all the standardised instances of each SNP at that location prior to the 
sampling of the target isolate, and then dividing by the total number of SNPs in the target 
isolate (Equation 4.1). This heuristic method is termed the SNP-based Assignment of Pathogen 
Origin (SnAPO): 
 
 Where n(L,S) is the number of isolates at location L harbouring SNP S, ṅ(S) is the 
number of isolates that harbour the SNP S in all locations, and s is the number of SNPs 
harboured in the target isolate. 
4.2.2 Processing the CI Test Subset with SnAPO 
To test the validity of this heuristic method the posited origin locations determined 
from SnAPO was compared with those determined using the Tree-based Assignment of 
Pathogen Origin (TAPO; as presented in Chapter 3). With TAPO there were 127 isolates that 
could be considered as potential Candidate Introductions (CIs) on the Maximum Likelihood 





of varying size but all had relatively high confidence with regards to bootstrap values. In 
Chapter 3 the 127 hospital Cis were reduced down to only 18, based on strict criteria. However 
in this chapter all 127 isolates in the CI Test Subset were processed using SnAPO and obtained 
a diagnostic value for the hospital origin of each of the isolates. Since these isolates were 
identified by the phylogenetic tree as possible introduction events it might be expected that 
there is some more obvious geographic signal than in isolates which are not CIs. However, the 
CIs show a range of SNP incidence, with some of the 127 CIs exhibiting LSSs for multiple 
locations and some not exhibiting any LSSs. Processing the CI Test Subset isolates with SnAPO 
would test whether the origin location predicted by SnAPO concurs to the location posited by 
TAPO. Those isolates which only harbour very common SNPs might prove to be difficult to 
obtain a clear origination signal. 
4.2.3 Processing the 2010 Test Subset with SnAPO 
Thus far, SnAPO has only been used on isolates which are expected to have an 
origination signal, based on their appearance on the ML phylogenetic tree. The next step was 
to determine if SnAPO is a viable analysis approach for any isolate. SnAPO was tested on the 
90 isolates sampled from 2010. Although a few of these 90 test isolates are in fact CIs, there is 
considerable variation in their phylogenetic profile. Some are isolates found in sub-clades that 
are too varied or too small to determine geographic origin via TAPO, other isolates were 
unable to be assigned to a sub-clade, and finally some of the isolates are predicted to have 
originated from their sampling location. 
The 90 isolates were processed using SnAPO, ensuring the temporal order of sampling 
was taken into account. Three colleagues were enlisted to help determine, individually and 
separately, where they predict the 90 test isolates may have originated from, based on the ML 
phylogenetic tree (Chapter 2, Figure 2.4). The investigators were asked to also indicate 
whether they believe the isolate came from the predicted location with high or low 
confidence. The investigators were allowed to use any preferred method to determine origin 
location and confidence. Once the investigators had completed the task they described the 
process they used. Although they all operated independently and therefore had slighty 
differing methods there was a consistent base methodology which I will summarise and 
paraphrase as follows. If an isolate was grouped into one clade with isolates all from one 
location then that was the origin location; if a target isolate was grouped between two clades 
each containing only isolates from one location then the closest clade location was the origin; 




their best judgement. The confidence of the prediction was also based on the investigators 
best judgement. The predictions of the three investigators were compared to each other and 
to the predictions obtained by SnAPO. Not only was the location that was predicted comapred, 
but also the confidence of the prediction when compared to the numerical DOV.  
It is important to note here, that this is a slight change in the Bi-allelic Dataset. Prior to 
this all 1022 isolates were used, with 5469 non-singleton bi-allelic SNPs. For this particular test 
the 90 isolates sampled in 2010 (the 2010 Test Subset) are compared with all the ones 
sampled previously. The 931 isolates sampled between 2001 and 2009 is termed the 
Comparison Subset. All 5469 SNP positions are retained, even for those SNP positions where 
the SNP is only found in isolates in 2010. Furthermore, after processing each isolate from 2010 
it will then be added to the Comparison Subset. Therefore, the first isolate in 2010 will be 
compared to the 931 isolates sampled before it, while the last isolate in 2010 will be compared 
to the 1021 isolates which have been previously sampled and added to the Comparison 
Dataset. This will mimic the potential future practical application of the method as part of the 
routine screening procedure in a healthcare institution. 
4.2.4 Determining the speed of SnAPO 
 The 2010 Test Subset was used to determine the computational speed of SnAPO with 
increasing database size. The time required for SnAPO to process each of the 90 test isolates 
when using the full Comparison Subset (n = 932) and then the time required to process each 
isolate when using half the Comparison Subset (n = 466) was calculated. This will give an idea 
of what effect doubling the size of the dataset will have on processing time. As previously 
stated after each test isolate is processed it is added to the dataset before moving on to the 
next test isolate. 
4.2.5 Processing the 2011 and 2012 isolates 
The 17 isolates sampled in 2011 and 2012 were used to determine how SnAPO would 
perform when the sampling location was unknown. To this end the metadata indicating 
sampling location was removed and the isolates were processed without any knowledge of 
where each isolate was sampled from. SnAPO was used to determine the possible origin 
location for each of the 2011 and 2012 isolates and then this prediction was compared against 
the retrieved sampling location. After each isolate was processed it was added on to the 
dataset (as described in the previous section). This process will mimic a real world situation 




4.2.6 Processing isolates from Holden et al (2013)  
There are 193 isolates analysed in Holden et al (2013) and, with the permission of the 
author, a subset of these isolates was used to test SnAPO’s performance on isolates that come 
from a different dataset. The isolates were sampled from 14 different countries, between 1991 
and 2009 (Figure 4.4). Of the 193 isolates, 86 were sampled from the UK. However, the 
sampling locations within the UK are, in the main, different from the ones used in the data 
previously presented in this thesis. Only two isolates (X07_1361_K, X07_2789_T) in 2006 and 
2007 were sampled from locations that were also sampled in the Bi-allelic Dataset. 
 
Figure 4.4. The sampling effort 
for the Holden et al (2013) 
study, including MSSA isolates. 
Of the 193 isolates in this 
study, 86 isolates were 
sampled from various locations 
within the UK, while the rest 
were from countries around 
the world. More than half of 
the isolates were sampled in 
2006 and 2007 (n = 38 and n = 




 SnAPO was used to process the isolates, excluding MSSA, sampled in 2006 (n = 35) and 
2007 (n = 62) in a similar way to that described previously in this chapter. The isolates in the 
Holden et al (2013) study were mapped to the same reference genome as the ones in the Bi-
allelic Dataset (see Section 2.2) and so the SNPs would be comparable. However, any SNPs not 
found in the Bi-allelic Dataset were excluded, which left 931 SNP positions that appear in the 
isolates from Holden et al (2013) and the Bi-allelic Dataset. As described previously, the isolate 
was compared to isolates which have been sampled prior to the target isolate. However, the 
isolate was not added to the database once it was processed. All except 2 of the isolates from 
2006 and 2007 were sampled from countries other than the UK, or from locations within the 




for all those isolates which originate from locations which do not appear in the Bi-allelic 
Dataset. 
The isolates sampled from 1991 (n = 10) were also processed with SnAPO. These 
isolates were sampled before any isolate in my database, therefore these isolates were 
compared to the entire Bi-allelic Dataset. This was done to test how SnAPO processes isolates 
that may be incorrectly dated. The isolates sampled in 1991 would likely have inconclusive and 
ambiguous SnAPO output, with no clear origin location. 
Finally, a single location was chosen that was most heavily sampled between 2006 and 
2007 in the Holden et al (2013) study and processed the isolates from this location again, but 
this time each target isolate was added on to the dataset once it was processed with SnAPO. 
The location used was London (UK), which was sampled 14 times in 2007. By adding on each 
isolate an increasing signal for London might be expected to be observed in the subsequent 
isolates. However, the location specified by Holden et al (2013) was not more specific than the 
city the isolate was sampled from and so it is possible that these 14 isolates come from 
different hospitals within London.  
As previously stated a maximum DOV of higher than 40% will be used to be indicative 
of a possible origin location according to SnAPO. However, I reiterate that this is an arbitrary 
value and other characteristics of the SnAPO output should be considered; for example, the 








 I initially present (Section 4.3.1) three isolates that have been processed using SnAPO 
to illustrate and further explain the SnAPO process. Section 4.3.2 will investigate the output of 
SnAPO on the Candidate Introduction events (CIs) identified in Chapter 3, to determine if 
SnAPO can predict the same posited geographic origin as the Tree-based Assignment of 
Pathogen Origin (TAPO) method. I will investigate if SnAPO can predict the same posited 
geographic origin as TAPO for any of the isolates sampled in 2010 (Section 4.3.3). The speed of 
SnAPO is also described (Section 4.2.4). Finally I investigate the isolates sampled in 2011 and 
2012 (Section 4.2.5) and those sampled in Holden et al (2013) (Section 4.2.6). 
4.3.1 Case studies of the SNP-based assignment of pathogen origin process 
The three isolates used as examples were all sampled in 2010 and were all chosen 
from the 127 potential CIs. The examples that were chosen from the 127 CIs are those isolates 
that might be expected to have some signal for a geographic origin, as determined by the 
Maximum Likelihood (ML) phylogenetic tree. Initially, the ML phylogenetic profile of each 
isolate was analysed to determine the possible geographic origin based on a Tree-based 
Assignment of Pathogen Origin (TAPO; see Section 3.2.1). The isolates were processed using 
SnAPO in an attempt to elucidate the possible geographic origin of the isolate at both the 
hospital and the RC geographic resolution. The possible hospital origin is displayed as a bar 
chart, while the RC origin is shown as a geographic heat-map with the appropriate RC 
geographic divisions.  
I first present an isolate where the SnAPO output indicates a very strong connection to 
one particular hospital. The second case study isolate is one where SnAPO indicates the origin 
to be within a single RC but not a single hospital. The last case study isolate presented is 
ambiguous and could be considered to have originated from multiple geographic locations, or 
from a location that was not sampled. 
4.3.1.1 Case Study 1 – Isolate X7564_8.37 
Isolate X7564_8.37 was sampled from Chelsea in 2010. This particular isolate harbours 
62 SNPs; 25 of these SNPs are LSSs for London St. Mary. The ML phylogenetic tree places it in a 
sub-clade of London St. Mary isolates (Figure 4.5a), so it could be posited that London St. Mary 
is the origin of this particular isolate. SnAPO provides an output of DOVs for each sampled 
hospital (Figure 4.5b). In this particular case there is a very clear signal that this isolate has 




displayed as a geographic heat-map of the UK and Republic of Ireland (Figure 4.5c). There is a 
clear signal for the South London and environs RC. Therefore, Isolate X7564_8.37 is a clear 
example of an isolate originating from one particular RC (South East England and South 
London) and one particular hospital (London St. Mary). 
 
Figure 4.5a. Part of the ML phylogenetic tree depicting the sub-clade (red dashed box) 
containing isolate X7564_8.37 (red circle). Branch length is proportional to difference in the 
number of SNPs in the isolates. The numbers above the branches leading to bifurcations are 
the bootstrap values. If these numbers are absent then this split has a bootstrap value less 
than 80. The left colour column indicates the hospital the isolate was sampled from, while 
the right colour column indicates the RC. Branches are also coloured by RC. This sub-clade 






Figure 4.5b. The output for isolate X7564_8.37 shows a clear signal for London St. Mary as 
the origin hospital. The hospitals along the x-axis are laid out in a geographic order, with 
each Referral Cluster’s hospitals adjacent to each other. The y-axis denotes the DOV, as a 







Figure 4.5c. The geographic heat-map of origin for isolate X7564_8.37 denoting specific RCs. 
There is a clear signal that the isolate originated from the South London and environs RC. 
Also provided are the top three potential origin hospitals. An increase in opacity indicates a 
greater DOV for that RC; a key is provided with 10% increments. 
 
4.3.1.2 Case Study 2 – Isolate X7748_6.80 
Isolate X7748_6.80 was sampled from Bangor in 2010. The ML phylogenetic tree 
places the isolate in a sub-clade containing a majority of isolates from West Suffolk (Figure 
4.6a), so it is possible that the origin of this isolate is West Suffolk. This isolate harbours 25 
SNPs; 1 of these SNPs is an LSS for Cork. This LSS appears to contradict the ML tree clustering, 
thereby obscuring an obvious origin for this focal isolate. SnAPO provides output DOVs for 
each sampled hospital (Figure 4.6b). There is a signal that this isolate has originated from West 




not as clear as in Case Study 1, with no one particular hospital the obvious geographic origin. 
However, the highest DOVs are all close together, indicating that it might be originating from 
one particular RC. This can be graphically represented as a geographic heat-map of the UK and 
Republic of Ireland (Figure 4.6c). Therefore, although in this focal isolate it is not perfectly clear 
which hospital was the origin, it can be considered that the East of England is the origin RC. 
Furthermore, within that cluster West Suffolk has the greatest DOV, indicating that this is a 
possible origin hospital. 
 
Figure 4.6a. Part of the ML phylogenetic tree depicting the sub-clade (red dashed box) 
containing isolate X7748_6.80 (red circle). Branch length is proportional to difference in the 
number of SNPs in the isolates. The numbers above the branches leading to bifurcations are 
the bootstrap values. If these numbers are absent then this split has a bootstrap value less 
than 80. The left colour column indicates the hospital the isolate was sampled from (orange 
= Bangor, brown = West Suffolk, blue = Papworth), while the right colour column indicates 
the RC (turquois = Wales, light blue = East England). Branches are also coloured by RC. This 
sub-clade clustering, with the majority of isolates sampled in West Suffolk, could indicate 






Figure 4.6b. The output for isolate X7748_6.80 shows that there is a signal for West Suffolk 
as the origin hospital. However, this signal is not very strong and there is a second signal for 
Papworth, which is in the same RC. The hospitals along the x-axis are laid out in a geographic 
order, with each Referral Cluster’s hospitals adjacent to each other. The y-axis denotes the 






Figure 4.6c. The geographic heat-map of origin for isolate X7748_6.80 denoting specific RCs. 
There is a clear signal that this isolate originated from the East of England RC. Also provided 
are the top three potential origin hospitals. An increase in opacity indicates a greater DOV 
for that RC; a key is provided with 10% increments. 
 
4.3.2.3 Case Study 3 – Isolate X7564_8.85 
Isolate X7564_8.85 was sampled from Wishaw in 2010. The ML tree sub-clade shows 
isolates sampled from many different hospitals, yet it could be posited that this particular 
isolate originated from Glasgow Royal Infirmary (Figure 4.7a). Isolate X7564_8.85 has 34 SNPs, 
of which 7 are LSSs. These 7 LSSs are from various different locations; Truro, Belfast, 
Altnaegelvin, Papworth, Leicester, Sheffield and Glasgow Royal Infirmary. This wide variety of 
LSS locations obscures any obvious origin hospital. SnAPO provides DOVs for each sampled 
hospital (Figure 4.7b). This example isolate presents a confusing signal, with no single obvious 




the ML tree. Furthermore, the larger DOVs are not clustered together, implying that there 
might not be one RC that could be the origin. The RC origin DOVs are graphically represented 
as a geographic heat-map of the UK and Republic of Ireland (Figure 4.7c). Therefore, in this 
example isolate there is no clear signal for any particular hospital, nor any particular RC. It 
must be noted that the two RCs with the greatest DOVs are Scotland and Northern Ireland, 
indicating that the origin of this isolate could be in the north of the UK. However, with the 
current sampling it is not possible to identify the origin any further. Therefore, in this particular 
isolate SnAPO has not been able to elucidate much more information than that garnered using 
a tree based approach. 
 
Figure 4.7a. Part of the ML phylogenetic tree depicting the sub-clade (red dashed box) 
containing isolate X7564_8.85 (red circle). Branch length is proportional to difference in the 
number of SNPs in the isolates. The numbers above the branches leading to bifurcations are 
the bootstrap values. If these numbers are absent then this split has a bootstrap value less 
than 80. The left colour column indicates the hospital the isolate was sampled from, while 
the right colour column indicates the RC the isolate was sampled from. Branches are also 
coloured by RC. With this sub-clade clustering it can be difficult to determine the possible 






Figure 4.7b. The output for isolate X7564_8.85 shows a signal for Glasgow Royal Infirmary as 
the origin hospital. However this signal is not clear and the other large DOVs are in 
geographically disparate locations. The hospitals along the x-axis are laid out in a geographic 
order, with each Referral Cluster’s hospitals adjacent to each other. The y-axis denotes the 






Figure 4.7c. The geographic heat-map of origin for isolate X7564_8.85. There are two RCs 
that could be the origin of this isolate: Scotland and Northern Ireland. However there is 
further confusion with the East of England RC showing some indication of origin. Also 
provided are the top three potential origin hospitals. An increase in opacity indicates a 
greater DOV for that RC; a key is provided with 10% increments. 
 
4.3.2 Processing the candidate introductions with SnAPO 
In Chapter 3 there were 127 possible CIs identified at the hospital geographic 
resolution. Of these 127 CIs, SnAPO predicted the same posited origin hospital as TAPO in 86 
of the isolates (67.7%). The remaining 41 isolates have conflicting predictions. The next step 
was to see if any of these 41 isolates could have had an incorrect origin assignment from 
TAPO. Detailed examination of the relevant ML sub-clade indicated that the TAPO prediction 
was incorrect. There are a variety of reasons, listed as follows and in Appendix C 




The prevailing reason for the incorrect origin assignment from TAPO was due to the 
phylogenetic tree construction which groups those isolates that are most similar, regardless of 
temporal order of sampling. Therefore, if the potential CI was sampled before all, or most, of 
the other isolates in their sub-clade, then this would preclude that isolate from being a CI. For 
example, in Figure 4.8 the red isolate could be considered to be a CI from the blue location, 
due to the phylogenetic clustering. However, if the date at which the isolates were sampled is 
also known, then the red isolate can no longer be a CI, since it was sampled prior to all the blue 
isolates. This temporal discrepancy occurred in 22 of the 41 conflicting CIs. 
 
Figure 4.8. A hypothetical sub-clade clustering of five isolates indicating the sampling 
geographic location (either red or blue) and the year in which the sample was obtained. If 
the geographic sampling location of these isolates was the only trait considered then it 
might be posited that the red isolate is an introduction event from the blue location. 
However, if the date of sampling is then taken into account the red isolate can no longer be 
considered as a CI since it was sampled prior to all the other isolates. 
 
There were 19 cases in the 41 isolates where the discrepancy between the SnAPO and 
TAPO origin could not be attributed to the temporal element. However, there are other 
possible reasons to reject the TAPO-predicted geographic origin. In some instances multiple 
isolates appeared to be separate introductions on the ML tree but were actually one 
introduction with subsequent propagation. In a few cases it was the assignation of the sub-
clade by the investigator which was erroneous and the sub-clade should have been grouped 
differently. This final point is due to the subjective nature of the sub-clade groupings.  
Although SnAPO can be applied to all isolates, the results will vary (Table 4.1). For 
some isolates a high DOV is obtained for a single location, while for others there may be 
multiple locations which could be deemed the origin. A noisy signal will likely remain an issue 
until sampling and sequencing of MRSA isolates in all hospitals and other healthcare locations 









Table 4.1. The 127 potential CIs identified by the ML tree were processed using SnAPO. The 
highest DOV indicates the possible origin location for that isolate. Although each isolate does 
give an output with a highest DOV, some isolates have a clearer signal. This table 
summarises the number of isolates which show each maximum value (i.e. the posited origin 
location of the isolate). 
Highest DOV (%) Number of isolates 
0 – 10 0 
10 – 20 1 
20 – 30 6 
30 – 40 10 
40 – 50 19 
50 – 60 15 
60 – 70 13 
70 – 80 14 
80 – 90 8 
90 – 100 0 
 
Using the TAPO method, determining the origin of a potential CI could take some time 
since it has to be done manually by an investigator with an understanding of phylogenetic 
properties. Yet, in the novel method developed here, an isolate can be processed in a matter 
of seconds and provide easily understandable output of a quantifiable nature. 
Using these 127 CIs I have shown that SnAPO can predict the origin hospital in the 
majority of cases. Furthermore, in the minority where there is contradiction, I have shown that 
the TAPO method could be considered incorrect. Therefore, SnAPO can be used to determine 
the origin of isolates which are suspected to have a strong geographic signal, based on their 
ML tree sub-clade clustering. 
4.3.3 Comparing the predictions of the test isolates from 2010 
The 90 isolates sampled in 2010 were processed using SnAPO and then three 
independent investigators were asked to determine the possible geographic origin on the ML 
tree. The investigators were also asked to indicate the level of confidence they have with their 
decision. The posited geographic origin locations, and the confidence of the decision, of the 90 
test isolates determined by all three investigators (using their preferred version of TAPO) and 
SnAPO were then compared against each other at both the hospital (Appendix C, 





The posited origin of TAPO from all investigators and SnAPO was compared at the 
hospital level of geographic resolution (Figure 4.9). It was found that 45 of the 90 isolates 
(50%) were unanimously predicted to be from the same origin hospital by all investigators and 
SnAPO. There was still variation in the confidence each investigator assigned the predicted 
hospital origin, with 28 of the 45 isolates unanimously assigned high confidence and 6 
unanimously assigned low confidence by all investigators. The remaining 11 isolates showed 
variation in confidence by the three investigators. 27 of the 90 isolates (30%) were predicted 
to have the same origin hospital as SnAPO by at least one investigator. In 20 of the 27 isolates 
at least one of the investigators could not assign an origin hospital. Where an origin was able 
to be posited by all investigators, a low confidence was unanimously assigned to 3 of these 27 
isolates’ origins. In 18 of the 90 test isolates (20%) all investigators predicted a different origin 
hospital than SnAPO, with 6 of these isolates unanimously assigned a contradicting hospital 
origin than SnAPO. Some isolates were unable to be assigned an origin hospital by at least one 
investigator. Those that were assigned an origin hospital were given low confidence estimates. 
Furthermore, 3 of these 18 isolates could not be assigned to any origin hospital by any 
investigator. Although one of these 3 isolates has a very low SnAPO DOV maximum (DOV = 
23.6%), the other two had DOVs over 50% (DOV = 53.8% and DOV = 53.6%). Finally, ignoring if 
the posited origin by the investigators contradicted SnAPO it was found that 36 of the 90 test 










Figure 4.9. The summary of the hospital level comparison between the TAPO method and 
SnAPO, for the 90 isolates sampled in 2010. Half of the isolates were consistently predicted 
to have the same origin hospital by all investigators and SnAPO, with a further 27 isolates 
predicted the same origin hospital as SnAPO by at least one investigator. 18 isolates were 
not assigned the same origin hospital as SnAPO by any of the investigators. However, there 
were 6 isolates which were unanimously assigned an origin hospital by the three 
investigators that contradicted the origin hospital posited by SnAPO. 
 
The posited origin of TAPO from all investigators and SnAPO was then compared at the 
RC level of geographic resolution (Figure 4.10). It was found that 58 of the 90 isolates (64.4%) 
were unanimously predicted to be from the same origin RC by all investigators and SnAPO. 
There was still variation in the confidence each investigator assigned the predicted RC origin, 
with 44 of the 58 isolates unanimously assigned high confidence and 2 unanimously assigned 
low confidence by all investigators. The remaining 12 isolates showed variation in confidence 
by the three investigators. Of the 32 isolates not unanimously predicted an origin, 23 (25.6% of 
the 90 test isolates) were predicted to have the same origin RC as SnAPO by at least one 
investigator. In 15 of the 23 isolates at least one of the investigators could not assign an origin 
RC. Where an origin was able to be posited by all investigators, a low confidence was 
unanimously assigned to 5 of these 23 isolates’ origins. In 9 of the 90 test isolates (10%) all 
investigators predicted a different origin RC than SnAPO, but no isolate was unanimously 
assigned a contradicting RC origin than SnAPO. Some isolates were unable to be assigned an 
origin RC by at least one investigator. Those that were assigned an origin hospital were given 
low confidence estimates. Furthermore, 3 of these 9 isolates could not be assigned to any 
origin RC by any investigator. Although one of these 3 isolates has a very low SnAPO DOV 




These 3 isolates were the same as in the hospital-level investigation. Finally, ignoring if the 
posited origin by the investigators contradicted SnAPO it was found that 29 of the 90 test 
isolates (32.2%) could not be unanimously assigned to an origin hospital by all three 
investigators.  
 
Figure 4.10. The summary of the Referral Cluster (RC) level comparison between the TAPO 
method and SnAPO, for the 90 isolates sampled in 2010. 58 isolates are consistently 
predicted to have the same origin RC by all investigators and SnAPO, with a further 23 
isolates predicted the same origin RC as SnAPO by at least one investigator. 9 isolates were 
not assigned the same origin RC as SnAPO by any of the investigators. However, there was 
no isolate which was unanimously assigned an origin RC by the three investigators that 
contradicted the origin RC posited by SnAPO. 
 
4.3.4 Determining the speed of SnAPO 
The computational speed required for each additional 2010 Test Subset isolate 
processed using SnAPO was determined under two conditions; when using the full Comparison 
Subset and half the Comparison Subset. It was observed that doubling the number of the 
isolates in the dataset does not significantly increase the time required to process each isolate, 
with 90 isolates processed using SnAPO in 38.37 seconds and 42.04 seconds, for a dataset size 
of 466 and 932 isolates respectively (Figure 4.11). The time reported here does not include the 
time required to create the database, nor the time required to transform the data into a 





Figure 4.11. A database with n isolates and m SNP positions was used to process the target 
isolates through SnAPO. 90 isolates, sampled in 2010, were used to test the effect of 
doubling n, while keeping m constant at 5461 SNP positions. With n = 466 SnAPO took 38.87 
seconds while with n = 932 SnAPO took 42.04 seconds to process the 90 test isolates. This 
shows that for this database, doubling the number of isolates in the database does not 
double the time required by SnAPO. The time determined here does not include any time 
required to transform the data into the correct format for SnAPO. Furthermore, each target 
isolate only expresses certain SNPs (s), denoted in this diagram by red lines, and this may 
further help speed up the process since SnAPO will only need to examine the previous 
incidence of those SNPs. 
 
4.3.5 Processing the 2011 and 2012 isolates 
 The 17 isolates from 2011 and 2012 were processed with SnAPO with no knowledge of 
the sampling location. The SnAPO predicted origin location was compared with the actual 
sampling location (Table 4.2). The Diagnostic Origin Values (DOVs) for the prediction origin 
location varied greatly between the target isolates (from 13.1% to 73.0%), with 12 isolates 
showing a maximum DOV less than 40%. Therefore, for these 12 isolates the origin location 
cannot be confidently concluded through SnAPO. The large majority (n = 14) of SnAPO 
predicted origin locations do not match with the sampling location, however this is likely due 








Table 4.2. The isolates taken from 2011 and 2012 were processed by SnAPO with the 
sampling location metadata removed. The predicted SnAPO origin location was then 
compared to the sampling location. A number of the sampling locations in 2011 and 2012 
were not previously included in the database. Although the isolates were processed in the 
















X8113_5.88 02/10/2011 Cambridge 73 RC8 Cambridge RC8 
X8140_1.86 16/02/2012 Cambridge 60.6 RC8 Peterborough RC8 
X7915_6.3 08/02/2011 Papworth 51.9 RC8 Yarmouth RC8 
X8113_5.91 23/02/2012 Cambridge 47.2 RC8 Cambridge RC8 
X7915_6.20 26/12/2011 Papworth 45.1 RC8 Ipswich RC8 
X8728_5.50 12/10/2011 Cardiff 37.7 RC16 Southend RC4 
X7915_6.25 25/01/2012 Cambridge 35 RC8 Peterborough RC8 
X7915_6.19 06/10/2011 Cambridge 33.6 RC8 Watford RC4 
X7915_6.1 26/08/2011 Papworth 33 RC8 Yarmouth RC8 
X7915_6.5 25/02/2011 Cardiff 32.7 RC16 Basildon RC4 
X8113_5.90 18/01/2012 Cambridge 31.5 RC8 Cambridge RC8 
X8113_5.89 11/01/2012 Leicester 31.4 RC9 Cambridge RC8 
X8113_5.87 26/05/2011 London St. Mary 26.9 RC1 Cambridge RC8 
X7915_6.18 14/09/2011 London St. Mary 23.4 RC1 Watford RC4 
X7915_6.6 04/09/2011 Cork 18.8 RC13 Basildon RC4 
X8113_5.92 16/03/2012 Manchester 18.3 RC12 Cambridge RC8 
X7915_6.15 27/03/2011 London St. Mary 13.1 RC1 Watford RC4 
 
Of the 5 isolates which show maximum DOVs higher than 40%, 2 of them (X8113_5.88 
and X7915_6.25) were sampled from Cambridge and predicted to come from Cambridge. The 
location predicted by SnAPO for an isolate from a previously un-sampled hospital would likely 
be ambiguous. However there are 2 cases where this is not the case; isolates X7915_6.3 and 
X7915_6.20 (sampled from Yarmouth and Ipswich respectively) both have high maximum 
DOVs and are predicted to originate from a hospital within the same referral cluster as the 
sampling hospital. However, these isolates represent the first samples of their respective 
hospitals in the dataset and therefore the SnAPO-predicted location would always be different 
from the sampling location. The last isolate with a maximum DOV higher than 40% 
(X8140_1.86) is sampled from Peterborough yet SnAPO predicts it to come from Cambridge 






4.3.6 Processing isolates from Holden et al (2013) 
The 10 isolates sampled in 1991 all show ambiguous SnAPO output, with multiple low 
peaks and none over 40%. This is as expected for the isolates from 1991, since the SNPs they 
express are probably in many different locations in the isolates in the Bi-allelic Dataset. 
There are a total of 56 isolates sampled from non-UK countries in 2006 and 2007. Of 
these 28 isolates have high maximum DOVs for locations other than their sampling location, 
and so might be considered to be introduction events. However, it is probable that these are 
not true introduction events, since they are sampled from locations which have not been 
sampled before. The more likely scenario is that the SnAPO posited origin location is the one 
which contains the highest number of similar isolates.  
There are a total of 41 isolates sampled from within the UK in 2006 and 2007. Of 
these, 16 isolates have high maximum DOVs for locations other than their sampling location 
(Table 4.2), and could be considered to be introduction events. However, the majority of these 
isolates were from locations within the UK that not been sampled previously, and so one could 
not confidently assert that these isolates are representative of true introduction events. Only 
one isolate (X07_1361_K sampled in Dundee in 2007) was from a location that had been 
previously sampled and showed a high maximum DOV for a location that was not its sampling 
location. Therefore, this could be a true introduction event.  
Table 4.3. There are 16 isolates from the Holden et al (2013) study sampled in the UK which 
show high DOVs (more than 40%). However, only one of these isolates (X07_1361_K) was 
sampled in a location that had been previously sampled in the Bi-allelic Dataset. Therefore, 
this is the only isolate which could be considered to be an introduction event, since all the 
other isolates came from previously un-sampled locations. Further sampling in those 
locations, coupled with an expanding database would likely reduce this issue. 
Isolate Year Country Sampled SnAPO Origin Max DOV (%) 
X07_1361_K 2006 UK Dundee Kirkcaldy 53.6 
X07_2384_Y 2007 UK Stornoway Manchester 88.4 
X07_5739_N 2007 UK Glasgow Manchester 80.3 
X6401_6_11 2007 UK London London St. Mary 60.3 
X6401_6_13 2007 UK London Papworth 54.0 
X6401_6_14 2007 UK London West Suffolk 41.4 
X6401_6_16 2007 UK London Papworth 61.0 
X6401_6_17 2007 UK London Papworth 58.8 




X6401_6_19 2007 UK London Papworth 61.0 
X6401_6_6 2007 UK London London St. Mary 61.4 
X6401_6_8 2007 UK London Papworth 56.6 
X6401_6_9 2007 UK London Ashford 58.4 
X6401_7_18 2007 UK Manchester Sheffield 40.7 
X6401_7_20 2007 UK Buckinghamshire Papworth 49.3 
X6401_7_21 2007 UK Lincolnshire Cambridge 40.1 
 
A single location was then chosen, and after each isolate from that location was 
processed with SnAPO it was added to the dataset. The 14 isolates sampled from London in 
2007 were chosen. Of these 14 isolates there are 7 isolates with a maximum DOV higher than 
40% (Table 4.3), with 3 isolates showing their origin to be within London; either London St. 
Mary or the new London location. Furthermore, those isolates sampled later show an 
increasing DOV for the new London location.  
Table 4.3. The 14 isolates from the Holden et al (2013) study sampled in London were re-
analysed with SnAPO, with each isolate being added to the dataset once it was processed. 
Therefore, in this situation there is slightly more confidence that the isolates with high DOVs 
could actually have originated from the location posited by SnAPO. There were 7 isolates 
which showed high DOVs over 40%, and of these there are 4 isolates which show a possible 
origin outside of London, indicating possible transmission events. The remaining 3 isolates 
with high DOVs show origins within London, which could indicate transmission events within 
London or, due to large geographic region encompassed by London, this could be the specific 
sampling location. Furthermore, there is a slight increase towards the later isolates for an 
increasing DOV for the London location. 
Isolate Year Sampled SnAPO Origin Max DOV (%) DOV for London (%) 
X6401_6_15 2007 London Papworth 25.6 0 
X6401_6_13 2007 London Papworth 53.3 1.419994251 
X6401_6_16 2007 London Papworth 56.6 6.147975477 
X6401_6_18 2007 London London St. Mary 49.0 0.184030105 
X6401_6_10 2007 London Papworth 29.4 2.416891968 
X6401_6_7 2007 London London St. Mary 26.8 5.358041074 
X6401_6_6 2007 London London St. Mary 57.5 6.681392931 
X6401_6_17 2007 London Papworth 37.1 34.00228515 
X6401_6_12 2007 London Chelmsford 26.1 0 
X6401_6_14 2007 London West Suffolk 41.4 0 
X6401_6_9 2007 London Ashford 58.4 0.587900542 
X6401_6_8 2007 London London 36.9 36.87311994 
X6401_6_11 2007 London London 37.0 37.0379504 





The majority of the London isolates did not show much change between the first 
version of SnAPO, which did not add the isolate to the dataset, and the second version, which 
did add the isolate to the dataset (Figure 4.12). Some isolates showed a slight decrease in 
maximum DOV in the second version, and there are three isolates (X6401_6_13, X6401_6_17 
and X6401_6_11) which showed a decrease in maximum DOVs from above 40% to below 40% 
between the two versions of the SnAPO process. This is likely due to the inclusion of an extra 
category for London, which may now contain some of the DOV signal.  
 
Figure 4.12. The 14 isolates from Holden et al (2013) sampled from London in 2007, were 
processed twice with SnAPO. In the first version each isolate was not added to the dataset, 
while the second version each isolate was added to the database after it was processed. 
Although the majority of the 14 isolates retained the same maximum DOV, there are a few 
which have a decreased maximum DOV in the second version. This is likely due to the 
presence of an extra category for London. A paired t-test shows that there is a significant 
difference in the DOVs of each version, though this is likely driven by a few isolates with 
large differences (such as, X6401_6_13) 
  
4.3.7 Including SnAPO in an analysis pipeline 
 It was stated previously (Section 4.3.1) that processing an isolate using the traditional 
tree-based approach is a lengthy process, requiring a person with an understanding of 




which in itself could take some time depending on the phylogenetic method employed, the 
investigator could spend considerable time classifying each sub-clade and isolate in the tree, 
especially in trees of the size of the current and future MRSA datasets and collections. If WGS 
becomes routine in healthcare institutions the ever expanding database would soon make this 
approach impractical.  
The novel method presented in this paper, SnAPO, provides a quick way to circumvent 
this issue and, if added to an existing sequencing pipeline, would be cheap to implement. 
Furthermore, the output can be easily displayed to facilitate interpretation, with a minimal of 
technical knowledge required to understand the data. As has been mentioned, the 
characteristic examined in this study was the geographic location, but SnAPO could be applied 
to any genetic characteristic where the appropriate metadata are known; for example, 
particular virulence phenotypes. With the drive towards including greater active surveillance 
and WGS in healthcare institutions it is possible that including SnAPO as part of the analysis 
package would greatly facilitate the interpretation and identification of outbreaks within a 
shorter time scale. The use of SnAPO is currently limited to those isolates which have already 
been identified to a particular clonal complex or sequence type using traditional methods, 
such as MLST or PFGE. Therefore, a possible analysis pipeline could look like that described in 
Figure 4.13. 
 
Figure 4.13. A theoretical analysis pipeline for the identification of an MRSA isolate sampled 
from a healthcare facility or laboratory. The identification of the particular Clonal Complex 
(CC) or Sequence Type (ST) would be done with conventional methods, such as MLST or 
PFGE. Once segregated into different lineages, the isolates can be processed using SnAPO to 





The final output of SnAPO could be represented graphically on one sheet for each 
isolate. The following page (Figure 4.14) shows an example output that might be produced by 
a healthcare institution using this method. The sampling effort in each hospital has been 








Figure 4.14. An example output 
that might be produced by a 
healthcare institution using 
SnAPO with a collated online 
database of MRSA genomes. The 
first panel (a) shows the SnAPO 
output as a DOV percentage. In 
this example (isolate number 
1021 in the Bi-allelic Dataset) 
the isolate appears to have been 
originated from Edinburgh Royal 
Infirmary or Inverness. Any LSSs 
the isolate expresses are 
displayed, and the origin 
location as predicted by TAPO. A 
coarser scale of geographic 
resolution is displayed (b) using 
Referral Clusters (RCs). Finally, 
the sampling effort in each 
hospital is included as a final 
panel (c) in the output. The bars 
in (a) and (c) are coloured by the 
RCs (provided as a graphical 
legend in a) and are ordered by 
their geographic proximity. The 
shading in (b) is split into 10% 





 I have presented a novel method for determining the origin of isolates of MRSA based 
on the SNPs that an isolate harbours. I have termed this method the SNP-based Assignment of 
Pathogen Origin (SnAPO). I have shown that SnAPO is fast and easily interpretable. It is also 
objective, in that for a given focal isolate and a given dataset SnAPO will always return the 
same output, unlike in phylogenetic analyses. However the interpretation of the output for 
isolates with no clear DOV may remain a subjective issue. Furthermore, I have shown that any 
isolate can be processed using SnAPO, not just those that are potential Candidate Introduction 
events. The entire process could easily be automated and would replace the labour intensive 
phylogenetic approach. It is important to note that SnAPO does not try to predict future 
transmission events, but rather provides a rapid summary of where it might have originated 
within the confines of the geographic sampling.  
SnAPO is computationally fast with only a slight increase in time required when the 
dataset size is doubled for this database. For a dataset of this size, SnAPO can process a target 
isolate within a second. However, this may change if a centralised repository of MRSA 
genomes and the implementation of SnAPO in healthcare institutions is developed. Therefore, 
the relationship with time for SnAPO could be considered to be at least O(nm). It could be 
argued that since SnAPO only considers the SNPs expressed (s) in a given target isolate then 
the time relationship could be O(ns), and since s < m this would be faster than O(nm). 
Traditional phylogenetic approaches show a larger increase in computational time 
required when doubling the dataset size. For example, NJ is O(n3) (Studier & Kepler, 1988) and 
the construction of the NJ phylogenetic tree (Section 2.4.1, Figure 2.3) took approximately 15 
minutes, though programs such as RapidNJ may decrease the time order of certain steps to 
O(n2) (Simonsen et al, 2011). Alternatively, ML is NP-hard and therefore would take even 
longer than NJ to compute for large datasets (Chor & Tuller, 2005), and the construction of the 
ML tree (Section 2.4.1, Figure 2.4) took approximately two weeks to complete. Therefore, if 
SnAPO is O(nm) then this is faster than ML and could be comparable to NJ, while if SnAPO is 
O(ns) then this would be faster than both phylogenetic methods. 
The time consideration for SnAPO obtained here does not include the time required to 
process the data into a format compatible with the SnAPO process. This formatting would 
slightly increase the computational time required. Conversely, the time it would be required to 
manually assign an origin location to each isolate once the phylogeny has been created is not 
included which, as discussed, is a time consuming process. Furthermore, increasing the 
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number of SNPs (m) would also increase the time required, regardless if using SnAPO or a 
phylogenetic approach. However, I believe that SnAPO would still be computationally faster, 
even if these additional processes were included into the time required to run SnAPO versus 
traditional phylogenetics. Additionally, it might be possible that the dataset used was not 
sufficiently large enough to determine the true time order of SnAPO and so further work in this 
direction with larger datasets would be informative. Conversely, most of the mathematical and 
computational methods used in epidemiology are often very complex and require trained 
personnel to implement and interpret the results. Therefore, there might be a bottleneck in 
the analysis pipeline caused by the limited number of trained personnel available for 
interpretation of other methods. Implementation of easily understandable methods, such as 
SnAPO, that do not require extensive training would reduce the bottleneck and help combat 
the spread of a pathogen.  
The comparison between three investigators’ separate TAPO interpretations and 
SnAPO of the 2010 isolates indicates that TAPO might be too conflicting in its subjectivity. This 
subjectivity would be due to each investigator’s interpretation of the sub-clade clustering and 
phylogenetic metadata. Furthermore, it is possible that SnAPO can provide higher confidence 
to origin locations than that available to phylogenetic methods. Although not all MRSA isolates 
will be able to have an exact origin assignation using SnAPO, I advocate its use for the majority 
of isolates. Furthermore, SnAPO can process every isolate in near real time and could identify 
transmission events that might be missed on the phylogenetic tree. 
However, the majority of the 17 isolates sampled in 2011 and 2012 have DOVs less 
than 40%. This is likely due to the fact that only Cambridge had been sampled prior to 2011 
and so it is not unreasonable to have ambiguous SnAPO output for newly sampled hospitals. 
An interesting case is isolate X8113_5.92 which was sampled in Cambridge but has a low DOV 
positing Manchester as the origin. Therefore, it is possible that this may be an indirect 
introduction event from Manchester to Cambridge. It might be possible to resolve this issue 
with more comprehensive sampling. 
There are 5 isolates with DOVs higher than 40% in the 2011 and 2012 isolates. Of 
these, 3 could be potential candidate introductions at the hospital geographic resolution, since 
they are posited to come from a different hospital than their sampling location with a DOV 
higher than 40%. This approximately matches what was found when using the 91 isolates in 
the 2010 Test Subset, where 24 of them (26.3%) were possible hospital resolution candidate 
introduction events. However, of these 3 possible candidate introductions, 2 were the first 
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samples from their respective hospitals and therefore the sampling hospitals was not a 
possible outcome. Therefore, SnAPO had to posit a different origin hospital to the sampling 
hospital, and so this is not necessarily indicative of a transmission event. Although possible 
that these are true transmission events, it might be not be prudent to conclude that these are 
actual transmission events. The last isolate with a DOV higher than 40% was sampled in 
Peterborough but was predicted to come from Cambridge. This is the second isolate from 
Peterborough in the dataset, and so one can be slightly more confident that this is a true 
transmission event. However, further sampling at that location will be required. 
Future work could look into improving upon the arbitrary 40% DOV threshold which 
may help identify an isolate from an unallocated location, or alternatively to avoid using 
SnAPO in a given location until a sufficient minimum number of isolates have been sampled 
from that location. Finally, it is worth noting that SnAPO does place all the isolates with DOVs 
higher than 40% into the same RC as where they were sampled from, indicating that it is doing 
a reasonable job with the information available. 
Additionally, I have shown that it is possible to process isolates from a different 
dataset using SnAPO. Some of the isolates in Holden et al (2013) were processed with SnAPO 
and it was found that there were a number of isolates with high maximum DOVs. Some of 
these isolates were from non-UK countries, and therefore one could not confidently say that 
they were introduction events from the SnAPO posited UK hospital to that country. However, 
there are a couple of interesting situations. Firstly, there are 13 isolates from Germany that 
have high DOVs. Of these 13 isolates, 7 of them are predicted to have arisen from Manchester 
with high DOVs and the rest are from Papworth. Therefore, although it is unlikely this is 
representing direct introduction events from either Manchester or Papworth to Germany, it 
could be that these UK locations and the German ones historically shared the same isolates. In 
a similar situation, there are 6 isolates from Singapore with high DOVs for UK locations. All of 
these isolates are predicted to come from London St. Mary, and all of them have very similar 
DOVs (within a percentage). Therefore, this could represent some historic connection between 
the isolates in Singapore and those in London St. Mary. 
Many of the UK locations in Holden et al (2013) were locations that do not appear in 
the Bi-allelic Dataset. Therefore, unless there are multiple samples from one location it is not 
possible to be confident in the output. The majority of isolates in Holden et al (2013) were 
from locations not found elsewhere in the Bi-allelic Dataset. However, a number of the isolates 
which were sampled from previously un-sampled locations and have high DOVs, are posited to 
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have an origin outside of their sampling Referral Cluster. Therefore, this lends further support 
to the possibility that these might be actual introduction events. However, as previously 
stated, since these isolates each represent the first incidence of that location in the dataset it 
would be unwise to conclude that they are representative of introduction events.  
The isolates sampled from London in 2007 which were processed twice with SnAPO, 
once with each target isolate not added to the dataset after processing, while the second time 
with each isolate being added to the dataset and used to compare to the following isolates. 
Although some of the maximum DOVs might be lower, the overall output could be considered 
to be more informative since the addition of each target isolate to the dataset enables more 
confidence to be placed in the outputs. However, it should be noted that the new London 
location is still not very specific and the MRSA isolates could have originated from differing 
locations within London. 
Therefore, further sampling from these locations, coupled with a growing database to 
which these isolates can be added, would provide an informative comparison database and 
increase the clarity of the SnAPO output. I believe that the creation of this online database 
would be an important next step in making SnAPO a viable practical tool. Although much more 
work needs to be done to achieve a practical application of SnAPO, it is promising that viable, if 
not yet completely trusted, output can be obtained from isolates sampled in different 
locations for a different study. 
 A crucial part of SnAPO is the development of an online database of MRSA that each 
individual healthcare institution can upload sequences to as they are processed. Although 
screening for MRSA is becoming more commonplace in hospitals in the UK (Dancer, 2008), 
sequencing of those isolates have still to be implemented in the majority of hospitals. 
However, each additional isolate added to the database would increase the resolution of the 
output, allowing for a “snowball effect” to occur. With this in mind, I stress that this must be 
the next step in order to unlock the full potential of SnAPO. The application of SnAPO coupled 
with a collated online MRSA database, would enable the rapid determination of the 
geographic origin, and hence the spread, of MRSA isolates. The containment and eradication 
of an outbreak of a virulent MRSA strain is an expensive process (Kanerva et al., 2007) and so 
identification of the outbreak early will allow better focusing of limited resources and 
personnel. Although the geographic location has been used in this paper, this method could be 
applied to non-geographic characteristic. For example, if certain SNPs are always in isolates 
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with a particular virulence phenotype then this characteristic could be used to determine the 
course of treatment a particular isolate may be susceptible to. 
Unfortunately, there remain limitations to SnAPO. Currently the sampling effort is not 
extensive enough to allow for complete accuracy, but this could be rectified by more universal 
sampling and sequencing of MRSA. Therefore, the geographic origin of each isolate is limited 
to those locations sampled. Other than the sampling issue, the main problems arise with 
homoplasy, recombination, convergent evolution and compensatory mutations. These 
processes could lead to SNPs arising in disparate isolates that have had no recent connection, 
which could lead to an erroneous conclusion of the geographic origin. I have attempted to 
mollify any effect of this by ensuring that any one SNP cannot skew the result too heavily, but 
it is not inconceivable that multiple SNPs in disparate isolates have arisen independently. If 
such a situation was to arise it would be difficult to determine the origin location. It is likely 
this will present as an isolate with a particularly noisy origin signal. 
 Although homoplasy and recombination may result in a noisy origin signal, with 
conflicting output and no location as the immediate obvious origin, this noisy signal could also 
be due to the isolate originating from outside the country or from locations within the UK and 
Ireland that have not been sampled. A noisy output can be attributable to the isolate only 
containing SNPs which are fairly common in all locations, i.e. old SNPs. Therefore, it is possible 
that an isolate with only old SNPs could be from a country outside of the UK and Ireland. In 
Chapter 5 I will investigate the application of a Bayesian approach, and in Chapter 6 I will 
explore the use of other genetic information such as indels. 
SnAPO is, to the best of my knowledge, the first implementation of a method which 
examines the SNP incidence to automatically determine the geographic origin of an isolate 
without using a phylogenetic tree. There have been other attempts to automate this process, 
with a first generation analysis program developed by  Brossette et al. (2000) called the Data 
Mining Surveillance System (DMSS). This system was not focused on MRSA, but rather was 
attempting to be applicable to any nosocomial infection. However, this system still required 
further interpretation of the analysis, and the authors note that it was only the first step in the 
process to automate surveillance systems. Alternatively, Mellmann et al. (2006) have 
developed a similar process using spa type data; attempting to develop a fast diagnostic of 
MRSA epidemic outbreaks. Although they have reported some success, the advent of cheap 
whole genome sequencing (WGS) has opened many other avenues of investigation. Using an 
extensive number of SNPs, as is now possible, gives much greater flexibility. This was seen in a 
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number of recent studies which used WGS to elucidate genetic information from a group of 
MRSA isolates (e.g. Harris et al., 2010, 2013; Price et al., 2014; Tong et al., 2015). These studies 
all used phylogenetic analysis techniques to determine possible transmission routes and 
geographic origins of the MRSA isolates. Therefore, it would be interesting to see if the 
application of SnAPO to the datasets used in these studies would contradict the phylogenetic 
findings. 
However, the SnAPO method would be used once the isolates have been identified to 
a particular clonal complex or sequence type by traditional methods, such as MLST, PFGE or 
spa typing. Therefore, the incorporation of conventional methods, WGS and SnAPO into one 
analysis process would be the optimum solution. With that in mind, I also recommend that 
further exploration of other potential genetic signatures, such as indels, should be carried out 







The development of a novel method, SnAPO, has been shown to successfully identify 
the possible geographic origin of an MRSA isolate within the confines of the sampling. Using 
SnAPO connected with an ever expanding online database of MRSA isolates from around the 
country, it could be possible to confidently, and rapidly, determine the isolate’s geographic 
origin. However, if the target isolate is the first sample obtained from a location then SnAPO 
would posit an origin location that would be different from the sampling location. In these 
situations, it might be erroneous to conclude that that isolate is indicative of a transmission 
event even if there is a high maximum DOV.   
Furthermore, SnAPO is more objective than a phylogenetic approach, in that the 
output remains the same for a given focal isolate and a given dataset. The limitations of SnAPO 
arise when processing isolates with no clear origination signal; these outputs require more 
subjective interpretation. A threshold DOV value could be instigated, over which one might be 
more prepared to trust SnAPO (e.g. origin predictions with DOV values higher than 40%). I will 
investigate whether these limitations may be overcome by alternative methods, such as 
Bayesian analysis in Chapter 5, or by using alternative genetic characteristics, such as indels in 
Chapter 6. 
The work in this chapter shows that signature genetic signals can be teased out of the 
genome and has laid the foundation for future work in this direction. If the sequencing of all 
MRSA isolates in healthcare institutions becomes commonplace, due to the ever decreasing 
cost of WGS, then the implementation of SnAPO as part of the analysis pipeline would provide 
a simple and easily interpretable graphical output of the isolate’s geographic origin. This 
information would be informative for determining spread of particular MRSA strains and 




A Bayesian approach to SnAPO                                     5 
5.1 Introduction 
In the previous chapter I introduced a novel method (SnAPO) which was able to 
determine where a focal isolate may have originated from, within the confines of the Bi-allelic 
Dataset, for the majority of the test isolates. In this chapter, I move away from the heuristic 
SnAPO method and explore a SNP-based Bayesian classification approach to determine the 
geographic origin of an isolate. The Bayesian inference approach is an established non-
heuristic statistical method of classification. Since SnAPO is a heuristic method, it would be 
prudent to investigate if a Bayesian approach concurs with SnAPO. There has been some 
success previously using Bayesian approaches, either at identifying transmission events or 
clustering similar isolates together. An attempt to determine transmission events using 
genomic data and Bayesian inference was conducted by Didelot et al. (2014). This study was 
successful in determining genetic diversity, but there was still considerable uncertainty when 
identifying transmission events. The authors conclude that Bayesian reconstruction may be a 
useful starting point, but traditional epidemiology would remain the main process of 
identifying transmission events. However, the approach used by Didelot et al. (2014) was 
computationally intensive. Furthermore, with an expanding dataset traditional Bayesian 
clustering methods, such as those implemented by STRUCTURE or BAPS software, might be 
impractical (Jombart et al., 2010). Therefore, a less computationally demanding approach 
would be required for practical implementation in a healthcare institution. In this chapter this 
will be attempted to be achieved by considering each SNP individually. It is possible that using 
an individual SNP approach will allow the identification of the geographic origin of an isolate 
using realistic processing requirements. 
In summary, in this chapter a SNP-based Bayesian inference approach is constructed to 
determine the geographic origin of an isolate. This will move away from the heuristic SnAPO 
method described in Chapter 4 and follow established statistical practices. The identification of 
the SNPs used in this thesis is described in Section 2.2 
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5.2 Dataset and methods 
In this chapter it is assumed, for convenience, that the posited geographic origin for 
each of the 90 2010 Test Subset isolates obtained in Chapter 4 is the correct geographic origin. 
Therefore, in the methods described in this chapter the results obtained here will be compared 
with those obtained in Chapter 4. To simplify the narrative the results obtained in Chapter 4 
will be termed the “Primary SnAPO result“. 
5.2.1 Bayesian classification for determining an isolate’s geographic origin 
The method presented here was developed by Jukka Corander and Richard James, and 
implemented on the Bi-allelic Dataset by James Sciberras. It is a SNP-based Bayesian 
classification approach for determining the geographic origin of an isolate. In this situation 
there are a finite number of hospitals (k = 46), each of which is considered a class into which 
the data can be assigned. Unlike the heuristic SnAPO method described in Chapter 4, in this 
chapter an established Bayesian classification process will be used (Corander et al., 2011).  
We will let h denote hospital and s denote SNP locus. In the Bi-allelic Dataset each 
focal isolate comprises of a vector x of 5469 bi-allelic SNP loci s with xs ϵ {0, 1}, where 0 
corresponds to the nucleotide which is a SNP mutation and 1 corresponds to the non-SNP 
nucleotide. Our goal is to determine the probability that x comes from hospital h. To 
determine this we will require a prior distribution and a likelihood function. The prior 
distribution p(h) would come from the number of isolates in the dataset sampled from each 
hospital and the likelihood function will be obtained from the dataset. The formulation of the 
likelihood function is explained in greater detail further on in this section. We use the dataset 
to generate the likelihoods  that at locus s in hospital h we will find nucleotide Z (0, 1). For 
example, at locus s = 1 in a hypothetical focal isolate we have x1 = 0. From the dataset we find 
that the likelihood that there is a 0 at locus 1 in hospital h = 10 is 0.03, while in h = 11 it is 0.6. 
Therefore, locus 1 is implying that hospital 11 is the more likely origin. However, we need to 
combine all 5469 loci s in focal isolate x. We do this by multiplying the likelihoods from all the 
loci, using the  values for the nucleotide Z that appears at each locus in our focal isolate. 
We do this for each hospital in turn. Once we normalise over all possible classes, which in this 
situation are the 46 hospitals, we will have the posterior probability distribution over h for the 
origin of x.  
We derive  values from the dataset as follows. We first take the expected (μ) 
occurrence of Z at locus s in hospital h as the measure of likelihood. If there are  isolates 
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from hospital h in the dataset, and  of them have nucleotide Z at locus s, a simple non-
Bayesian estimate of probability would be . However, we can improve on this 
estimate by implementing a prior belief in the rarity of the SNPs, using the conjugate prior 
distribution. In this case the appropriate conjugate prior is the Beta distribution. The shape of 
the Beta distribution is governed by two hyperparameters (a, b); the distribution mean is 
. The method for determining the values of a and b in this situation are provided 
later on in this section. The posterior distributions is also a Beta, with parameters  and 
 and mean (i.e. likelihood) 
 
Since , then 
 
We now have a prior, which represents a hypothetical extra  isolates in each 
hospital; a of which are SNPs, b are non-SNPs at each locus s. All loci are assumed to be of 
equal importance, so we combine the evidence from all 5469 bi-allelic SNP loci by calculating 
the products of the various  or , guided by the presence or absence of a SNP at each 
locus in the focal isolate vector x. This is repeated for each hospital in the dataset. This gives a 
likelihood function for the vector x. We now include the prior probability p(h), determined by 
the number of isolates at hospital h divided by the number of isolates over all hospitals, to give 
the Bayesian Origin Value (BOV) for hospital h (Equation 5.3):  
 
We normalise BOVh by the sum of all possible classes. For 46 hospitals this is trivial 
compared to other Bayesian classification applications which might have very large number of 
classes. We now have the posterior distribution over h for the focal isolate x. We will term this 
the Bayesian Diagnostic Origin Value (BDOV). It should be noted that the BDOV for a focal 
isolate usually shows one hospital with a much larger BDOV than any other hospital. 
Therefore, examining the log BDOVs would reveal more detail of the BDOVs for the other 
hospitals. 
Thus far we have not yet defined the hyperparameters a and b. We know that SNPs 






distribution is normally constructed through knowledge obtained from sources other than the 
system in question. However, in this situation we will use the dataset to inform us of the prior 
distribution. Although this is counter-intuitive, it is a valid approach since it can be a useful 
approximation (Jukka Corander personal communication, 2015) and there is precedent (for 
example, see the analysis of cancer death rates in the US in 1980-1989 in Gelman et al., 2014). 
The distribution of SNP rarity of all loci in the database (see Section 2.4.2) has a very small 
mean (0.0065) and mode (0.0021), with the majority of SNPs only present in two isolates. This 
is consistent with the proportion of total SNPs in the whole Bi-allelic Dataset (0.0066). With 
two known values (mean and mode) and two unknown values (a and b) we can derive a = 1 
and b = 228 to obtain a Beta distribution which is consistent with the distribution of the SNP 
rarity (Figure 5.1). This means that with this prior expectation we would find 1 in 229 isolates 
harbouring a SNP at any chosen locus. 
 
Figure 5.1. The rarity of the distribution of 
the SNPs in the dataset can be used to 
inform us of the prior distribution. The 
mean (0.0065) and mode (0.0021) of this 
distribution can be used to obtain the two 
hyperparameters (a and b). In this 
situation this gives us values of 1 and 228 
for a and b, respectively (black dashed 
line). SNP rarity is determined by the 
number of isolates harbouring a SNP over 
all isolates in the dataset.  
 
Finally, as with SnAPO, each time we analyse an isolate we add this isolate to the 
dataset before moving on to the next isolate. Therefore, the addition of each isolate would 
subtly change the  for a SNP locus s at a hospital h. Furthermore, the addition of each 
isolate will change the p(h) for the hospital where it was sampled.  
To test the Bayesian classification approach the Primary SnAPO results of the 90 2010 
Test Subset isolates were compared with the results from the method described here. For each 
test isolate I determined which hospital shows the highest value in both methods. I 
determined the number of test isolates which showed the same posited origin hospital in both 
methods, and the number of test isolates which showed the SnAPO posited origin hospital as 
one of the top three Bayesian posited origins. Furthermore, the output of those that do show 
the same posited origin hospital in both methods was examined to determine the level of 
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agreement by comparing the value obtained through each method. For example, even if both 
methods posit the same origin hospital there may be a large discrepancy between the BDOV 
and the SnAPO DOV. It must be noted that this would be subject to interpretation by the 
investigator, since the SnAPO method is heuristic and therefore it is not yet clear what 
constitutes a “high” DOV. Nevertheless, very low DOVs would still imply a noisy signal. Finally, 
those test isolates which did not show the same posited origin hospital were examined and 




5.3.1 Bayesian classification for determining an isolate’s geographic origin  
 It was found that 72 of the 90 isolates (80.0%) sampled in 2010 showed the same 
posited hospital origin with the Bayesian approach as with SnAPO. The majority of the test 
isolates show a single large BDOV, while SnAPO is much more varied (Table 5.1). Therefore, 
agreement in both methods does not automatically indicate that the origin posited by either is 
the true origin of the isolate. The noisiness of the SnAPO signal must be taken into 
consideration, leading to some subjective interpretation by the investigator on the validity of 
the results of each method. The BDOVs and the SnAPO DOVs for all isolates is supplied in 
Appendix D (Supplementary Table D1). 
Table 5.1. The value for the posited origin for the 90 isolates in the 2010 Test Subset using 
both the SnAPO (DOV) and the Bayesian inference approach (BDOV) was determined. Most 
of the test isolates exhibit high values when using the Bayesian approach, but there is 
variability in the value when using SnAPO. This indicates that agreement of the two methods 
might not be sufficient for a confident conclusion that the posited origin is the true origin. 
Interpretation of each output by the investigator would be necessary. The BDOV and DOV 
values can be represented either as proportions or percentages 
BDOV or DOV of posited origin 
(%) 
SnAPO isolates Bayesian isolates 
0 – 10 0 0 
10 – 20 5 0 
20 – 30 19 0 
30 – 40 10 0 
40 – 50 16 0 
50 – 60 28 2 
60 – 70 6 2 
70 – 80 4 2 
80 – 90 2 2 
90 – 100 0 82 
 
Those cases that did not show the same posited origin in both methods (Table 5.2) 
were examined and found that for the majority of the test isolates the discrepancy arose due 
to the presence of Location Specific SNPs (LSSs) for the posited origin hospital. SnAPO allows 
the LSSs and rare SNPs more influence in determining possible origin, therefore if an isolate 
harbours an LSS this would increase the final DOV for that hospital. However, the Bayesian 
approach has no such weighting, and this appears to be the reason for the different posited 
origins between the two methods in many of the test isolates. Furthermore, it appears that 
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those isolates which have an unclear output in SnAPO often do not show the same posited 
origin in both methods. Finally, the Bayesian posited hospital origin was one of the top three 
posited hospital origins by SnAPO in 87 of the 90 2010 Test Subset isolates (96.7%). This 
indicates that it is rare for both methods to completely disagree in the posited origin. 
Table 5.2. The 18 isolates of the 2010 Test Subset were examined which showed a different 
posited origin when using the Bayesian approach compared to SnAPO. The differences can 










Description of difference 
X7564_8.19 Belfast Antrim Belfast The SnAPO DOV for Belfast is very 
similar to Antrim, indicating it could 
be from either. 
X7748_6.69 Antrim Altnaegelvin Sunderland The output from SnAPO is very 
unclear and not possible to 
confidently assign origin hospital 
based on SnAPO. 
X7748_6.70 Antrim Antrim Sunderland SnAPO output shows very low DOV 
for Sunderland. An LSS for Antrim 
may be causing difference observed. 
X7564_8.22 Belfast Belfast Dublin Dublin appears as the second highest 
DOV in SnAPO, with similar value to 
Belfast. 
X7564_8.31 Cardiff Cambridge Cardiff Cardiff is second highest DOV in 
SnAPO, while the isolate harbours an 
LSS for Cambridge. 
X7564_8.75 Sunderland Newcastle Sunderland SnAPO output is very ambiguous, 
with Sunderland appearing as second 
highest value. 
X7083_1.29 Cambridge Cambridge Papworth Papworth appears as second highest 
in SnAPO output, and the isolate 




UCL London St. 
Mary 
London St. Mary appears as the 
second highest DOV in SnAPO, with a 
value close to that of UCL. The isolate 
also harbours an LSS for UCL. 
X7748_6.66 York Cambridge Sheffield Sheffield appears as second highest 
DOV in SnAPO, with a value close to 
that of Cambridge. The isolate also 
harbours an LSS for Cambridge. 
X7564_8.42 Cork Dublin Cork The DOV for Cork is very similar to 
that of Dublin in the SnAPO output. 
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X7564_8.89 Wishaw Wishaw Manchester DOV for Manchester is second 
highest in SnAPO. Isolate also 
harbours an LSS for Wishaw. 
X7083_1.30 Cambridge Papworth London St. 
Mary 
London St. Mary is second highest 
DOV in SnAPO. Isolate also harbours 




Kirkcaldy Belfast SnAPO output is very unclear and no 
hospital can be confidently identified 
as the origin. Belfast does appear as 




Kirkcaldy Belfast SnAPO output is very unclear and no 
hospital can be confidently identified 
as the origin. Belfast does appear as 
third highest DOV in SnAPO. 
X7915_8.13 Colchester Norfolk Cardiff Isolate harbours only 8 SNPs, one of 
which is an LSS for Norfolk. 
X7915_6.14 Colchester Papworth Cardiff SnAPO output is unclear and no 
hospital can be confidently identified 








Inverness Inverness has second highest DOV in 
SnAPO, close in value to Edinburgh 
Royal Infirmary. Isolate also harbours 
LSS for Edinburgh Royal Infirmary. 
 
 An example output of the type a healthcare institution may create if they were to 
employ both the SnAPO and the Bayesian method is provided (Figure 5.5). A select few 
examples of the test isolate outputs can be found in Appendix F. Implementation of both 
methods would allow greater flexibility in the interpretation of the output, especially in 
situations where the two methods do not concur. Furthermore, for those isolates which do 
concur then the inclusion of the SnAPO output would indicate whether the isolate shows a 






Figure 5.5. An example of the 
possible output that could be 
created by a healthcare institution to 
determine the origin of an MRSA 
isolate. The sampling effort in each 
hospital is shown (a). This is what 
was used to obtain p(h) in Equation 
5.3. Both the SnAPO (b) and the 
Bayesian method (d) are included, 
allowing for informed interpretation 
should the two methods disagree on 
the posited origin. The log version of 
the Bayesian output is also included 
(c), since more variation is visible in 
this graph. Finally, this example was 
chosen to illustrate how SnAPO (b) 
often has multiple hospitals with 
high DOVs, while the Bayesian 
approach usually shows only one 
hospital with a high value. In the top 
left corner of (b) the origin predicted 
by the ML tree, any LSSs harboured 
by the isolate, and the number of 
SNPs the isolate harbours are all 
displayed. In all plots the bars are 
coloured by Referral Cluster, 




5.4 Discussion and Conclusion 
I have explored the use of a Bayesian classification approach to determine the 
geographic origin of an isolate within the confines of the dataset, and that this approach 
concurs with the Primary SnAPO result in the majority of the 2010 Test Subset isolates. In the 
Bayesian classification approach described here it was assumed that each isolate may have 
originated from within the hospitals sampled; this is termed a “supervised approach” 
(Corander et al., 2013). However, it is likely that some isolates may have originated from un-
sampled hospitals or from outside the UK. A semi-supervised approach is possible by 
introducing an empty extra class with no defined prior likelihood function (Corander et al., 
2011). This would allow those isolates which are unlikely to arise from any currently defined 
class to be assigned as originating from this new, extra class. In this situation, this would not 
force an origin from the hospitals in the dataset on those isolates which may have originated 
from un-sampled locations or from out of the UK. This semi-supervised approach could likely 
be the next step in the development of this method. 
Bayesian inference is an established statistical principle which judges, in probabilistic 
terms for each hospital, whether there is data similar to that observed in the focal isolate in 
the dataset (Corander et al., 2011; Gelman et al., 2014a). Therefore, it might appear that using 
a heuristic method such as SnAPO is unnecessary. However, our Bayesian method has its own 
limitations. Firstly, it assumes that all the SNP loci are independent since the output is 
achieved from the product of each SNP locus. As mentioned in Section 2.4.3, many of the SNPs 
are not independent and furthermore, many of the SNPs are nested within each other. SnAPO 
would be more appropriate if one assumes that the SNPs are non-independent, since the 
impact of each SNP on the result is weighted by their rarity in the dataset. It is important to 
mention that not all SNPs are linked, nor are all SNPs nested. Therefore, neither the Bayesian 
approach described in this chapter, nor the SnAPO method are perfectly appropriate. 
Secondly, the Bayesian inference approach treats each SNP locus as equally important. 
Therefore, the information available in the rarer SNPs might be obscured by the large number 
of non-SNP loci. This is reminiscent of the issues, described in Section 2.5.1, that may preclude 
FST from being an appropriate measure of similarity. Finally, our Bayesian classification is more 
computationally demanding than SnAPO. Currently this is not a serious issue, however with an 
ever-expanding dataset this might prove to be problematic for practical implementation. For 
these reasons, and the high level of agreement between the established Bayesian inference 
and the heuristic SnAPO methods, I suggest that the implementation of the heuristic SnAPO 




between these two approaches. Combining these two novel methods would be the next step 






Expanding SnAPO & exploring limitations                  6 
6.1 Introduction 
 In Chapter 4 I showed that a novel method (SnAPO) was able to posit a geographic 
origin for any isolate, although some isolates resulted in clear output signals, while others 
were ambiguous. In Chapter 5 the principles developed for SnAPO were modified for use in a 
Bayesian approach with similar success. In this chapter I explore and expand the use of SnAPO 
to determine if some of these ambiguous cases might be better described using alternate 
genetic information. I also explore some of the possible limitations of SnAPO; namely, the 
potential lack of robustness to changes in the dataset, and the possible decrease in relevant 
information available in older isolates for determining the posited geographic origin for an 
isolate. 
This chapter will consist of three topics. Firstly, I wished to see if it was possible to use 
other genetic information to obtain a predicted geographic origin for an isolate. To do this the 
use of nucleotide insertions or deletions (indels) was explored.  As with SNPs, there is a very 
slight chance of two indel mutations of exactly same size and nucleotide composition occurring 
at exactly the same genomic position, indicating that they might be valid markers for 
identification of relatedness (Väli et al., 2008). Furthermore, there appears to be a pattern of 
covariation between SNPs and indels within and between species (Chen et al., 2009). These 
factors imply that indels could be used in a similar way to how SNPs were used in Chapter 4 to 
identify a possible geographic origin of an isolate.  
Many studies on sequence variation focus on SNPs, recombination and microsatellites 
(Albers et al., 2011), but the development of the use of indels as genetic markers has lagged 
behind (Väli et al., 2008). This lag is likely due to the increased difficulty in identification of 
indels compared to other genetic markers. There is often a high error rate in mapping indels 
and occasionally it is not possible to uniquely map an indel to a genomic position; for example, 
if a repeat unit in a tandem repeating sequence is deleted then it is difficult to determine 
where in the repeat sequence this deletion occurred (Albers et al., 2011). Furthermore, an 




due to sequencing errors (Albers et al., 2011). Regardless of these difficulties there has been a 
recent increase in the use of indels, as they can be viewed as an untapped resource of genetic 
information. For example, a method to differentiate eukaryotic species has been successfully 
developed which relies on the indel variation in rRNA (Pereira et al., 2010) indicating that there 
is sufficient genetic variation in indels to distinguish organisms at the species level. In recent 
years there has been an increase of the use of indels in studies of humans (Mills et al., 2006) 
and model species such as Drosophila melanogaster (Ometto et al., 2005).  
In general, indels are not as common as SNPs in most species, with indels occurring 
approximately twenty times less often than SNPs in bacteria (Chen et al., 2009). However, in 
most organisms they also tend to be widely spread across a genome (Väli et al., 2008), though 
there is variation between coding and non-coding regions with more indels occurring in non-
coding regions (J. Q. Chen et al., 2009). Indels can be identified based on their size with a 
comparable monetary cost to that of SNP identification (Väli et al., 2008). There are two broad 
methods to identify indels (summarised in Albers et al., 2011). The first involves the assembly 
of short reads de novo and the comparison of these reads to a reference sequence. The second 
method maps each short read independently of other reads to the reference sequence. 
Variation is identified as a difference between the reads mapped to that genomic location and 
the reference sequence at that genomic location. 
The second topic discussed in this chapter will focus on the effect that changes to the 
composition of the dataset may have on the posited origin location of an isolate. This topic will 
consist of two parts. In the first part it is determined whether the sampling effort in the 
dataset affects the designated origin location of an isolate. As was mentioned in Chapter 3 the 
Location Specific SNPs (LSSs) and the rare SNPs may only be rare due to the sampling effort in 
the Bi-allelic Dataset. Therefore, it is possible that alterations to the Bi-allelic Dataset may 
create different posited origin hospitals for a target isolate. This dependency on the sampling 
effort may contribute to a lack of robustness to changes in the dataset in the SnAPO method. 
Therefore, this needs to be explored. The robustness of the method is tested by randomly 
removing isolates and observing if this alters the predicted geographic origin of any of the 
2010 Test Subset isolates. The second part of this topic will focus on the possible influence of 
the age of the isolates in the dataset. It is possible that some of the data used in this thesis are 
too old to provide meaningful information in SnAPO. Therefore, there might be some merit to 
removing old isolates to obtain a clearer signal, if they are not providing any positive 




Finally, the last topic examined in this chapter is the possible variation of information 
signal attributable to individual SNPs, and the possible repercussions if one were to change the 
SNPs an isolate expresses. Therefore, simulations were run which replaced increasing numbers 
of SNPs in each target isolate with a randomly selected SNP and investigated the changes, if 
any, in the SnAPO output. This information was used to determine how many SNPs can be 
modified before the origin location is obscured. For this test, the isolates sampled in 2010 
which showed maximum DOVs higher than 40% were used (see Chapter 4). 
 In summary, in this chapter I will explore three topics related to SnAPO and how it 
might possibly be improved and expanded. I will do this by focusing on the finer, and 
potentially more informative, scale of hospital geographic resolution origin. Firstly, I will 
attempt to implement SnAPO on a different genetic variation characteristic; indels. Secondly, I 
will determine if SnAPO is robust to changes in the composition of the dataset, and if the older 
isolates may impact on the clarity of the final SnAPO output. Finally, I will determine how many 







6.2 Dataset and methods 
 As in Chapter 5, in this chapter it is assumed that the posited geographic origin for 
each of the 90 2010 Test Subset isolates obtained in Chapter 4 is correct. Therefore, in this 
chapter the results obtained here will be, once again, compared with those obtained in 
Chapter 4. The results obtained in Chapter 4 are once again called the “Primary SnAPO result“. 
Additionally, the identification of the SNPs used in this thesis is described in Section 2.2. 
 Furthermore, for each of the isolates processed in Chapter 4 the Diagnostic Origin 
Value (DOV) for the posited geographic origin and the minimum number of hospitals required 
to obtain 90% of the whole DOV signal was determined. A low number of hospitals required to 
obtain 90% of the signal is indicative of a clean signal, usually implying there is one hospital 
with a high DOV. A large number of hospitals required to obtain 90% of the DOV signal is 
indicative of a very noisy output. These two metrics (the DOV of the posited geographic origin, 
and the number of hospitals required for 90% of the DOV signal) can give some indication of 
the clarity of an output; a higher DOV with a low number of hospitals is indicative of a cleaner 
signal. It must be noted that the 90% threshold is an arbitrary value. This value was chosen 
since it was observed that many isolates showed a tiny DOV for every hospital in the dataset 
and taking the number of hospitals required to obtain 100% of the DOV signal usually resulted 
in all the hospitals, which was not informative. 
6.2.1 Amending SnAPO for an indel dataset 
 The indels were identified using Dindel (Albers et al., 2011) with reads being realigned 
around indels using the GATK toolbox and the ratio used was 0.65. Although there is SNP data 
for 1022 isolates, there is only indel data for 1009 isolates. There are 88 isolates sampled in 
2010 with both indel and SNP data. Furthermore, there is only 899 unique indel positions. 
However, each indel position can have up to four unique indels. An indel may range from a 
single insertion or deletion, to a large number of nucleotide insertions or deletions. Therefore, 
a new dataset was constructed with 1009 isolates and 899 unique indel positions. This will be 
termed the Indel Dataset. 
The SnAPO method (Chapter 4) was amended for use on the Indel Dataset; i.e. each 
indel in a focal isolate was examined and it was determined where those indels were 
previously found. This information was then used to determine the origin hospital for the 88 
test isolates from 2010 for which there is indel data. This indel result was compared to the 
Primary SnAPO result to determine if the predicted hospital is the same, or if the Primary 




 The Indel Dataset and Bi-allelic Dataset was then combined for those isolates which 
have both indel and SNP information to examine if the addition of the indel data gives a clearer 
prediction of the origin of the isolate. This will be termed the Combined Dataset. The 88 2010 
isolates with both indel and SNP data are once again used as the test cases. The Combined 
Dataset was processed using the SnAPO method and the results were compared to the Primary 
SnAPO result. I investigated if the posited origin hospital is the same, or if the Primary SnAPO 
result is one of the top three Combined Dataset results. 
6.2.2 Testing the robustness of SnAPO to changes in the dataset 
 Due to the nature of SnAPO, which relies on rare SNPs to help bolster the DOV of a 
specific hospital, knowledge of the robustness of the SnAPO method is required. To test this 
100 isolates were randomly removed from the Bi-allelic Dataset between 2001 and 2009. This 
left 832 isolates sampled between 2001 and 2009. This is termed the Robustness Test Subset. 
SnAPO was recalculated for the 90 isolates sampled in 2010 using this Robustness Test Subset. 
The random removal of 100 isolates and recalculation of SnAPO was repeated 100 times.  
The predicted origin hospital was checked to see if it is the same using both datasets 
and if the Primary SnAPO result is one of the top three SnAPO results using the Robustness 
Test Subset. The value of the SnAPO result obtained using the Robustness Test Subset was 
compared with the value of Primary SnAPO result for each test isolate. Furthermore, the 
minimum number of hospitals required to obtain 90% of the DOV signal was determined.  
6.2.3 Determining the impact of older isolates on SnAPO 
 It is assumed that the isolates sampled earlier in the dataset would, on average, 
harbour older SNPs, and these are likely to be in many locations due to the initial rapid 
dissemination of ST22 across the UK. The SNPs which arose after this spread would more likely 
be representative of a specific location and so provide more information when attempting to 
determine the geographic origin of an isolate. This implies that the older isolates may be 
obscuring some of the signal in SnAPO. Therefore, there may be an age threshold after which 
excluding the older isolates would provide the cleanest signal and still give the same posited 
origin hospital in the majority of isolates. The removal of the older isolates, usually containing 
the more common SNPs, gives further weight to the newer, usually rarer, SNPs. In Chapter 4, 
SnAPO was used on the Comparison Subset to predict the origin hospital for the 2010 Test 




starting with those sampled in 2001. Each of these smaller subsets of the Comparison Subset 
will be termed the Attenuated Subsets.  
The posited origin hospitals from the Primary SnAPO result was compared to each of 
the Attenuated Subset results, and it was determined if the Primary SnAPO result is one of the 
top three Attenuated Subset SnAPO results. The value of the result for each Attenuated 
Subsets was comapred with the value of the Primary SnAPO result. Furthermore, the minimum 
number of hospitals required to obtain 90% of the DOV signal was determined. The optimum 
dataset size will be one which requires the least number of hospitals to provide 90% of the 
DOV signal while still predicting a hospital which matches the Primary SnAPO result posited 
origin. 
6.2.4 Degrading the SnAPO signal 
 The effect of modifying the SNPs an isolate expresses on the final posited origin 
location was explored. To do this the 56 isolates sampled in 2010 which have maximum DOVs 
higher than 40% were used. For convenience it was assumed that the location posited by 
SnAPO in Chapter 4 was the correct location. For each isolate simulations were run where an 
increasing number of SNPs in the target isolate were replaced with randomly selected ones, 
from the total 5469 possible bi-allelic SNP positions. For each target isolate initially one SNP 
was replaced, and the new origin location and maximum DOV posited by SnAPO was 
determined. This simulation was repeated 100 times and observed the number of simulations 
where the posited origin location is different from that posited by the original SNPs, and the 
mean maximum DOV. This process was repeated, but instead replaced two SNPs; and so on. 
This process was repeated until all SNPs that the target isolate expresses were replaced, which 
for the isolates used ranges between 8 to 83 SNPs. The SNPs that are randomly selected could 
not be the same as those already expressed by the target isolate. 
 Therefore, for each target isolate, the number of SNPs that can be replaced before the 
posited origin location is different from that posited in Chapter 4 was determined. Also, the 
number of SNPs that can be replaced before the DOV falls below 40% was found. Next, it was 
determined what the proportion of SNPs that can be replaced in each isolates before either 
the posited location is different than that previously determined in Chapter 4, or the maximum 
DOV falls below 40%. This will provide information as to the reliability of each target isolate’s 





6.3.1 Comparing the indel data with the Primary SnAPO result 
 The Indel Dataset predicted the same origin hospital as the Primary SnAPO result in 63 
of the 88 test isolates (71.6%), and the Primary SnAPO result appeared in the top three 
hospitals predicted by the indel data in 85 of the 88 test isolates (96.6%). However, using the 
Indel Dataset usually (n = 80, 90.9%) gave a lower predicted Diagnostic Origin Value (DOV) for 
the possible origin hospital than the Primary SnAPO result (Figure 6.1a). A paired Mann-
Whitney-U test confirmed that the average DOV for the 88 test isolates as significantly lower 
(V = 3830, p < 0.001) when using the indel data than the SNP data (Figure 6.1b). Furthermore, 
the majority of the test isolates (n = 78, 88.6%) required a greater number of hospitals to 
explain 90% of the DOV signal observed when using the indel data compared to the SNP data 
(Figure 6.1c). A paired Mann-Whitney-U test confirmed that the average number of hospitals 
required to explain 90% of the DOV signal was significantly higher (V = 206, p < 0.001) when 
using the indel data than the SNP data (Figure 6.1d). 
The Indel Dataset and the Bi-allelic Dataset was combined to determine if this 
provided a clearer signal for the possible origin of a given isolate. The Combined Dataset 
predicted the same origin hospital as the Primary SnAPO result in 86 of the 88 test isolates 
(97.7%), and the Primary SnAPO result appeared in the top three hospitals predicted by the 
Combined Dataset in all of the test isolates. However, the Combined Dataset usually (n = 83, 
94.3%) gave a lower DOV for the possible origin hospital than the SNP-only data (Figure 6.1a). 
This was confirmed with a paired Mann-Whitney-U test which showed that the average DOV 
for the Combined Dataset was significantly lower (V = 3863, p < 0.001) than using just the SNP-
only data (Figure 6.1b). Furthermore, all the test isolates (n = 88, 100.0%) required a greater 
number of hospitals to explain 90% of the DOV signal observed when using the Combined 
Dataset compared to the SNP-only data (Figure 6.1c). A paired Mann-Whitney-U test 
confirmed that the average number of hospitals required to explain 90% of the DOV signal was 
significantly higher (V = 0, p < 0.001) when using the Combined Dataset than the SNP-only data 
(Figure 6.1d). 
Therefore, it appears that using a SNP-only dataset provides a clearer signal that using 
either an indel-only dataset or a combined SNP and indel dataset, both in terms of the highest 







Figure 6.1. The Indel Dataset was processed 
using a similar method to SnAPO on the 88 
isolates in 2010 which harboured indels. For 
each of the 88 isolates the possible origin 
hospital was determined using the indel 
data, the SNP data, and the combined indel 
and SNP data. For the majority (n = 81) of the 
88 test isolates the Diagnostic Origin Value 
(DOV) for the posited origin hospital is higher 
using the SNP data than both the indel and 
the combined data (a). Using a paired Mann-
Whitney-U test, the median DOV for the 88 
isolates (b) is significantly higher using just 
the SNP data compared to the indel (V = 
3830, p < 0.001) or the combined data (V = 
3863, p < 0.001). For the majority (n = 73) of 
the 88 test isolates the SNP data required 
fewer hospitals to explain 90% of the DOV 
signal compared to either the indel or the 
combined data (c). Using a paired Mann-
Whitney-U test, the median number of 
hospitals required to explain 90% of the DOV 
signal (d) is significantly smaller when using 
only the SNP data compared to the indel (V = 
206, p < 0.001) or the combined data (V = 0, p 
< 0.001). The boxplots in (c) and (d) show the 
median, range, and interquartile range.
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6.3.2 The robustness of SnAPO to changes in the dataset 
 The 832 isolates in the Robustness Test Subset were used to determine the possible 
origin for each of the 90 2010 Test Subset isolates. The random removal of 100 isolates and 
the recalculation of SnAPO was repeated 100 times. The average value for the DOV of the 
posited origin hospital was determined from the 100 replicates for each test isolate (Figure 
6.2a), along with the average number of hospitals required to explain 90% of the DOV signal 
(Figure 6.2b). It was found that the DOV in the Primary SnAPO result fell within the 
interquartile range of the 100 Robustness Test Subset replicates in 68 (75.5%) of the 2010 Test 
Subset isolates. Furthermore, the number of hospitals required to predict 90% of the DOV 
signal in the Primary SnAPO result was within the interquartile range of the 100 replicates in all 
of the test isolates. 
 Furthermore, removing 100 isolates resulted in a difference in the posited origin for 
only a few of the test isolates. Between 83.5% and 98.9% of the test isolates gave the same 
posited hospital origin as the Primary SnAPO result (Figure 6.2c, red points). There were only 4 
replications which had less than 90% of the 90 2010 Test Subset isolates showing the same 
posited origin as the Primary SnAPO result. However, in each of the 100 replicates the posited 
origin hospital identified in the Primary SnAPO result was always in the top three posited 
hospitals using the Robustness Test Subset replicates for each test isolate, bar one (Figure 6.2c, 







Figure 6.2. The 2010 Test Subset 
isolates were processed using SnAPO 
with the Robustness Test Subset 
isolates. This was repeated 100 times. 
(a) shows the DOV for the posited 
origin hospital for each of the 2010 Test 
Subset isolates. The red points show 
the value obtained with the Primary 
SnAPO result, while the grey bars show 
the median of the 100 replicates of the 
Robustness Test Subset. The number of 
hospitals required to explain 90% of the 
DOV is shown in (b). The red points 
show the number required using the Bi-
allelic Dataset, while the grey bars 
show the median of the 100 replicates 
of the Robustness Test Subset. (c) 
shows the percentage of the 90 test 
isolates which show the same posited 
origin hospital as the Primary SnAPO 
result (red points), and the percentage 
of isolates where the top posited origin 
hospital using the Bi-allelic Dataset was 
one of the top three posited hospitals 
(blue points) using the Robustness Test 
Subsets. In (a) and (b) the error bars 




6.3.3 The impact of older isolates on SnAPO 
 As stated in Section 6.2.3, it is possible that older isolates, harbouring older and more 
common SNPs, may be obscuring some of the possible signal in the SnAPO output. This was 
tested by iteratively removing older isolates. The Attenuated Subsets are created by iteratively 
decreasing the size the Comparison Subset. These Attenuated Datasets were used to generate 
a posited origin hospital for each of the 2010 Test Subset isolates. The Comparison Subset was 
decreased based on the sampling date, removing one year at a time (Figure 6.3a). Initially the 
full Comparison Subset (i.e. 2001 to 2009) was used and then each year was removed until a 
dataset was achieved where only the 2009 isolates were used. It was found that decreasing 
the Comparison Subset in size changed the posited origin hospital for a number of the test 
isolates compared to that in the Primary SnAPO result, with a higher discrepancy observed 
with a smaller dataset (Figure 6.3b, red points). The number of the 90 2010 Test Subset 
isolates which gave the same posited origin as the Primary SnAPO result ranged from 89 
isolates (98.9%) when using isolates sampled from 2002 onwards, down to 41 isolates (45.1%) 
when only using isolates sampled from 2009 onwards. The posited origin hospital from the 
Primary SnAPO result remained as one of the top three hospitals with the Attenuated Subsets 
for all 2010 Test Subset isolates until 2004. However, after 2004 some of the test isolates’ top 
three posited origin hospitals did not contain the Primary SnAPO result. The number of the 90 
2010 Test Subset isolates which showed the Primary SnAPO result as one of the top three 
hospitals (Figure 6.3b, blue points), ranged from 89 isolates (98.9%) when using isolates from 
2005 onwards, down to 75 isolates (83.5%) when using only isolates sampled in 2009 onwards. 
Using only isolates from 2009 onwards showed a noticeable difference from the Primary 
SnAPO result in the predicted origin hospital.  
 It was found that there was a slight increase in the average DOV for the test isolates 
with a decreasing dataset size (Figure 6.3c). However, the individual isolates showed high 
fluctuations, indicating that these high DOVs could be due to the reduced sampling. 
Furthermore, the number of hospitals required to explain 90% of the variation showed a 
decrease with a decreasing dataset size (Figure 6.3d). Once again, the individual isolates 
showed high fluctuations over the years, indicating the influence of the sampling within a 
dataset. These two findings appear to indicate that a smaller dataset provides a clearer and 
sharper signal. However, this must be balanced with the decreasing accuracy of the smaller 
dataset, as indicated in Figure 6.3b. Therefore, although a clearer signal is obtained with fewer 






Figure 6.3. The 2010 Test Subset 
isolates were processed with 
progressively smaller Attenuated 
Subsets, iteratively removing the 
older years. In all figures the x-axis 
denotes the start year of the 
Attenuated Subset. (a) shows the 
decreasing dataset size as each year 
is removed. (b) shows the 
percentage of isolates processed 
using the Attenuated Subsets which 
show the same posited origin 
hospital as the Primary SnAPO 
result (red points), and the 
percentage which show the origin 
posited from the Primary SnAPO 
result as one of the top three 
hospitals posited. (c) shows the 
DOV for the posited origin hospital 
for each isolate (grey points) and 
the mean value (black points) for 
the 2010 Test Subset isolates with 
each Attenuated Subset. (d) shows 
the number of hospitals required to 
explain 90% of the DOV for each of 
the 2010 Test Subset isolates (grey 
points) and the mean (black points) 






6.3.4 Degrading the SnAPO signal 
 The 56 isolates from 2010 which had maximum DOVs higher than 40% were used to 
test how robust the posited origin location for a target isolate is to changes in the composition 
of SNPs expressed in the isolate. For each target isolate an increasing number of SNPs were 
randomly replaced and the new posited location and maximum DOV was noted. This was 
repeated 100 times for each number of SNPs removed. 
 As expected, with an increasing number of SNPs replaced there is a decreasing 
proportion of simulations that posit the same location as was posited in Chapter 4 (Figure 
6.4a). Furthermore, there is a decrease in the average maximum DOV when an increasing 
number of SNPs are replaced (Figure 6.4b).  
 
Figure 6.4. For each target isolate, as an increasing number of SNPs are replaced there is a 
decrease in the number of simulations which show the same hospital as that posited by 
SnAPO in Chapter 4 (a). Although there is some variation, the majority of isolates appear to 
show a sharp decline once more than 70% of the SNPs expressed are replaced. There is also a 
steady decrease in the average maximum DOV for each target isolate with increasing 








 It was found that, for the majority of isolates, if an average of 29.1% of SNPs were 
replaced in a target isolate then the output of SnAPO either shows a different posited origin or 
the maximum DOV falls below 40% (Figure 6.5). If either of these situations arise one cannot 
be confident of the origin through SnAPO. However, there was considerable range in this 
output, with some isolates showing a different posited origin hospital or maximum DOV less 
than 40% once only 2.6% of their SNPs are replaced, while other isolates could withstand 
57.1% of the SNPs being replaced. This variation does not appear to correlate with the number 
of SNPs expressed by an isolate.  
Figure 6.5. If an isolate has 
more than 29% (mean = 
29.1%) of its SNPs replaced  
then SnAPO either gives a 
different posited origin from 
that in Chapter 4 or a 
maximum DOV less than 40%. 
However, there is some 
variation in this value (ranging 
from 2.6% to 57.1%). This 
variation does not appear to 
correlate with the number of 











6.4 Discussion and Conclusion 
 I have shown that it is possible to use indels in a similar manner to SnAPO to identify 
the possible geographic origin of an isolate within the confines of the dataset, either with just 
the indel data or when combined with the SNP data. Furthermore, the geographic origin 
posited using the indel data (either on its own or combined with the SNP data) matches the 
one posited from the SNP-only data in the majority of isolates. However, in the majority of 
isolates there is a reduction in the clarity of the output DOVs; i.e. the highest DOV is lower and 
more hospitals are required to explain 90% of the signal seen. These two factors indicate a 
noisier signal. This is likely due to the reduced number of indels compared to SNPs (899 versus 
5469), with a corresponding reduction in number of unique indels per isolate. Furthermore, 
there is no observable increase in signal clarity for those isolates which had an ambiguous 
output in the Primary SnAPO result. Therefore, although indels can be used in a similar fashion 
as SNPs to determine the geographic origin the output is much less clear. It remains to be seen 
if a similar number of unique indels as SNPs would generate the same output. This would be 
the obvious next step in comparing indel with SNP data in the SnAPO method, and the 
successful development of a method using indels to distinguish species (Pereira et al., 2010) 
indicates that this may be a viable avenue of research. 
Within the confines of this dataset and the genome of MRSA isolates within a clonal 
complex, SnAPO appears to be a robust method since a high percentage of the replicates 
processed with the Robustness Test Dataset showed the same posited origin hospital as the 
Primary SnAPO result. Furthermore, in all bar one of the replicates the top three possible 
origin hospitals always contained the hospital which was predicted as the origin in the Primary 
SnAPO result. Furthermore, removing isolates does not appear to affect the signal clarity and 
sharpness, indicated by the high number of isolates which showed a DOV within the 
interquartile range of the replicates, and the number of hospitals required to explain 90% of 
the signal also falls within the interquartile range of all the replicates. Therefore, not only does 
SnAPO appear robust in determining where an isolate may have originated from, the reduction 
in dataset size does not seem to greatly affect the clarity of the signal. It is likely that a great 
reduction in the dataset, or an increase in the number of hospitals with very few samples, 
would cause a shift in the signal clarity. However, if sequencing becomes commonplace in 
healthcare institutions around the UK then this issue would soon be overcome. 
It appears that excluding those isolates sampled six years prior to the focal isolate (i.e. 






on increasing the signal clarity (i.e. higher DOVs and a reduced number of hospitals required to 
predict 90% of the signal) while retaining a high number of the 90 2010 Test Subset isolates 
predicting the same hospital origin as the Primary SnAPO result (n = 80, 89.0%) and the 
predicted origin hospital in the Primary SnAPO result is always one of the top three predicted 
hospitals using the Attenuated Subset sampled from 2004 onwards. Therefore, it does appear 
that the older isolates are causing increased noise in the final output. If the sequencing of 
isolates becomes commonplace throughout the UK and SnAPO is utilised I suggest that it might 
be wise to have a cut-off point in the dataset, before which the isolates are excluded. 
Finally, I have also shown, using simulations where the SNPs an isolate expresses were 
iteratively replaced, that there is some robustness in each isolate for changing the SNPs 
expressed. To test this the 56 isolates from 2010 which had original SnAPO maximum DOVs 
higher than 40% were used. As expected, the proportion of simulations which showed the 
same posited origin as the unaltered SNPs and the average maximum DOV of each simulation 
showed a decrease with an increasing number of SNPs replaced. However, the maximum DOVs 
for simulations showed a steady decrease, while there appears to be more of a threshold 
when it comes to positing the same origin hospital. On average, if an isolate has 29% of its 
SNPs replaced then one can no longer be confident in the origin location posited, although 
there is some variation in this distribution. This variation does not appear to correlate with the 
number of SNPs an isolate expresses, and it is possible this could be due to the uneven 
sampling in the dataset. It would be interesting, if this dataset is expanded, to re-run these 
robustness simulations and determine if the variation in robustness has decreased. 
In summary, I have explored some of the possible flaws of SnAPO and possible 
applications to alternative genetic information. I have shown that it is possible to use indel 
data to generate predicted origin locations, although this is not as clear as using SNP data. I 
have shown that SnAPO is robust to changes in the database, and that individual isolates vary 
in their robustness to changes within the SNPs expressed. I have also shown that it is possible 
that the older SNPs may be obscuring information, and SnAPO might benefit from having a cut-
off point. 







Concluding remarks                                                          7 
The advancements in Whole Genome Sequencing (WGS) have increased the amount of 
genomic information available for analysis, with current benchtop DNA sequencers able to 
provide accurate genomic data for tens of isolates within a few days with a low financial cost 
(Reuter et al., 2013). The cost and speed of WGS is decreasing much faster than predicted by 
Moore’s Law (see Section 1.1.1), while the advances in computing power and cost hold 
consistent with Moore’s Law. Furthermore, the speed of WGS has increased so much that 
culturing the pathogen to acquire sufficient DNA is becoming the limiting step (Köser et al., 
2014). The advancements in WGS may become an issue, since it cannot be assumed that there 
will always be sufficient available computing power to implement established analysis 
techniques on the large databases that would be generated by WGS. For example, it appears 
that one of the most popular ways to determine the origin of an isolate is to construct a 
phylogenetic tree (see Section 1.4). However, phylogenetic analyses become computationally 
prohibitive with larger datasets and are best for retrospective epidemiology. This implies that 
the implementation of phylogenetic analyses is not practical for rapid results. Therefore, 
investigation into less computationally demanding methods of analysing the same data to 
obtain similar conclusions would be an important next step. This thesis describes a proof-of-
principle method for evaluating if alternative analysis techniques are viable. In this thesis 
Methicillin resistant Staphylococcus aureus (MRSA) and genomic variation in the form of single 
nucleotide polymorphisms (SNPs) and indels was used. I move away from the whole genome 
analysis techniques, such as phylogenetic analysis, and instead focus on individual SNPs. This 
could be colloquially termed as a “SNP-up” approach. The principles used to develop this “SNP-
up” approach would likely be applicable, with some modification, to other pathogens. 
MRSA is a major nosocomial infection which has a great impact on healthcare 
resources (de Angelis et al., 2010) and can cause fatalities in patients, especially those which 
are immunocompromised (Boucher & Corey, 2008; Klevens et al., 2007). There is great drive to 
prevent the dissemination of MRSA, especially since a study by Török et al. (2014) concluded 






implies that the tracking of isolates, determining their likely origin, and prevention of infection 
could be the more viable avenues to combat MRSA spread by targeting the use of the limited 
resources and personnel. This is especially important with the increasing evidence that patient 
referrals are one of the means by which MRSA spreads between healthcare institutions 
(Ciccolini et al., 2013; Donker et al., 2010). Additionally, the implementation of WGS in each 
healthcare institution across the UK, coupled with a centralised online database, would enable 
the rapid creation of a very large source of MRSA genomes and, as was noted in Reuter et al 
(2013), would also allow real-time monitoring of the geographic spread of a pathogen. 
In this thesis I have described the development of a novel heuristic SNP-based 
Assignment of Pathogen Origin (SnAPO) method which obviates the requirement of a 
phylogenetic tree by examining the SNPs harboured within an isolate for geographic signal and 
converting this into a Diagnostic Origin Value (DOV) for each of the locations in the dataset 
(see Chapter 4). It was the variation in the rarity of the SNPs (see Section 2.4), with some SNPs 
confined within a geographic location, which indicated that this information could be 
successfully used to obtain a signal for the possible location of origin of an isolate. SnAPO was 
developed on a collated ST22 MRSA genome dataset sampled from hospitals across the UK and 
Ireland between 2001 and 2010.  The dataset is one of the largest of its kind, and was collated 
mainly from the British Society of Antimicrobial Chemotherapy collection, with some genomes 
taken from the East of England collection. SnAPO has been shown to successfully identify the 
geographic origin (within the confines of the dataset) of the majority of test isolates. I have 
shown that SnAPO is more objective than a phylogenetic approach since the output is constant 
for a given focal isolate and a given dataset, and I also provided a simple and easily 
interpretable graphical output of the isolate’s geographic origin. Furthermore, the high 
variability of the posited origin locations assigned to the test isolates by each of the three 
independent investigators exposed the subjectivity of the phylogenetic approach (see Section 
4.3.3). Additionally, the use of a Bayesian method with established statistical procedures 
resulted in a clear signal which concurs with SnAPO in the majority of test isolates. This implies 
that SnAPO, although a heuristic method, might be a viable one. The methods described in this 
thesis are applicable to isolates within a clonal complex (CC), and therefore should be part of 
an analysis pipeline that could include conventional genotyping techniques. In this way it might 
be possible to focus the limited resources available to combat the dissemination of MRSA. 
There is growing evidence that WGS techniques enhance the diagnostic 






healthcare institutions in the UK, due to the ever decreasing cost, then the implementation of 
SnAPO and the Bayesian method with a collated database would be a powerful tool for 
determining the origin of an isolate. The high correlation between the patient referral data and 
the level of SNP similarity between the MRSA sub-populations (see Section 2.5) indicates that 
it is the movement of patients which could cause introduction events of MRSA, as posited by 
Donker et al., (2010; 2012; 2014). I showed that it is possible to identify introduction events 
based on a single signature SNP only ever seen in one location; a Location Specific SNP (LSS). 
However, this process (see Chapter 3) identified very few introduction events, and still 
required the use of a phylogenetic tree.  
There are clear limitations to SnAPO, even when considering evidence from just this 
single dataset, with some isolates providing no clear signal of origin and therefore requiring 
more subjective interpretation by the investigator. One other issue is the likely non-
independence of many of the SNPs used to generate the output. In this thesis I have assumed 
that all SNPs are independent, however as was shown in Section 2.4 this is unlikely to be the 
case. As discussed in Section 5.4 the non-independence of the SNPs would negatively affect 
the results of both SnAPO and the Bayesian method by counting the same piece of information 
multiple times. Further work would be required to clarify this issue. Furthermore, I have 
assumed that SNPs and indels are inherited stably and are valid indicators of shared heritage in 
MRSA. This assumption is applicable to the dataset used in this thesis, since it was only 
comprised of one CC of MRSA. It is possible that this might not be true for all SNPs and indels, 
with recombination and horizontal gene transfer influencing the posited origin location. 
Nevertheless, this was a useful dataset with which to develop SnAPO and the Bayesian 
method. It is important to mention that any hyper-mutator isolates were excluded in this 
thesis. Due to the assumptions made in SnAPO and the Bayesian approach (see Chapters 4 and 
5, respectively), with regards the SNP evolution and inheritance, the origin of hyper-mutators 
would likely be difficult to resolve. Furthermore, the inclusion of hyper-mutators in the dataset 
might have a negative impact on the isolates subsequently sampled. Exploration of the impact 
of hyper-mutators on SnAPO and the Bayesian method would be interesting, though the 
conservative approach would be to exclude them.  
Although the posited origin of an isolate is dependent on the composition of the 
dataset, I have shown that the SnAPO method is fairly robust to changes in the dataset. I also 
showed that the older isolates (> 6 years prior to focal isolate) may be obscuring the possible 






the dataset. There is some evidence that the particular clones which comprise the S. aureus 
lineages in circulation go through cycles of expansion and replacement. It is possible that this 
may be due to the increase in the number of drug resistance measures a clone has that might 
have a trade-off in cell function and resources; for example, in the case of ST239 which, 
although a very widespread clone, might be on the decline (Castillo-Ramírez et al., 2011). 
Furthermore, clones within a healthcare institution would compete for resources, and this 
could be another driving force of the cycles of lineages observed; for example, the 
replacement of the endemic ST239 by the imported ST22 in hospitals in Singapore from the 
early 2000s onwards (Hsu et al., 2015). This competition may lead to increased genetic 
diversity within a clone (Hsu et al., 2015). Although in this thesis I do suggest imposing an age 
threshold on the isolates included in the dataset, it is possible that the cycle of MRSA lineages 
might begin to repeat. If this was to occur it might be informative to once again include the 
older isolates. Though it is possible that the subsequent cycles will see the SNPs associated 
with different locations. Additionally, it is possible that some of the isolates in the dataset used 
in this thesis were obtained from the same patient. Unfortunately, this information is not 
known for this dataset. I suggest that this might be important information to retain since there 
is evidence for within-host diversity, though this does appear to be variable over time 
(Paterson et al., 2015). The within-host diversity will likely be less than that within a single 
hospital. Multiple isolates from a single patient may give a clearer picture of the possible 
geographic origin of that infection. Additionally, it has been found that non-susceptible MRSA 
strains can arise from susceptible populations in vivo when exposed to antibiotics (van Hal et 
al., 2014). Therefore, it is even more important to ensure that multiple isolates are sequenced 
from each patient. 
SnAPO was created for use on SNP data, but I also have shown that a different source 
of genetic variation information (i.e. indels) can be used to determine the geographic origin of 
an isolate. The successful adaptation of SnAPO to other sources of genetic variation indicates 
that it might be possible to apply this novel method to other systems. However, the use of 
indels may not be appropriate since it appears to decrease the clarity of the possible 
geographic origin. It must be noted that it appears that the number of deletions is greater than 
the number of insertions in eukaryotic organisms (reviewed in Gregory, 2004) and in bacteria it 
appears that those with the smallest genomes are derived from those with the larger genomes 






In this thesis I have focused on genetic characteristics that are linked to geographic 
locations. I focused on the hospital and the Referral Cluster (RC) level of geographic resolution. 
However, a study by Tong et al. (2015) showed that there were intra- and inter-ward 
transmission events within a single hospital. These transmission events occurred at a much 
finer scale of geographic resolution than that tackled in this thesis. Therefore, it would be 
interesting to apply the methods described in this thesis to datasets with finer geographic 
resolution data and investigate if they are able to obtain the same results. Furthermore, other 
genetic characteristics of MRSA could provide potential avenues of research, such as genetic 
variation which is connected to virulence factors. Previous work by Laabei et al. (2014) has 
shown that it is possible to predict an isolate’s toxicity based solely on the SNPs and indels 
harboured in it. It should be possible to amend SnAPO for toxicity or virulence characteristics. 
Since toxicity correlates with severity in vivo, this could be a diagnostic tool for rapidly 
determining the possible health implications of a particular isolate.  
Further work must be carried out to determine if the two SNP-based methods for 
determining an isolate’s origin (SnAPO and Bayesian classification) are applicable to other 
systems. The methods developed in this thesis should be applicable to other CCs of MRSA, due 
to the clonal nature within a CC, and I suggest that application to a different CC of 
Staphylococcus aureus could be the first step in the further development of these methods. It 
would be interesting to use these two methods on other datasets, especially ones which have 
been used to show transmission events. For example, evidence from Holden et al. (2013) and 
Hsu et al. (2015) points to the possible introduction of a single isolate from the UK in 2001 as 
the cause of the ST22 Singapore epidemic. Furthermore, Hsu et al. (2015) demonstrated a 
probable introduction from Singapore to London of the TW20 lineage in 2002. It would be 
interesting to investigate if the use of SnAPO would corroborate these posited introduction 
events, when applied to the datasets used in these studies. 
If the application of SnAPO and the Bayesian approach to other S. aureus lineages is 
successful, then application to a different species of Staphylococcus would be the next step. 
For example, it has already been discovered, using WGS, that S. haemolyticus shows 
phylogeographic clustering based on the core genome SNPs (Cavanagh et al., 2014). I believe 
that it would be possible to apply SnAPO and the Bayesian method to other species within the 
Staphylococcus genus with a minimal amount of modification. This would be slightly 
complicated by the variable levels of recombination and HGT observed in different species 






It would be interesting to investigate if SnAPO and the Bayesian method can be 
applied to other pathogens. For example, Reuter et al. (2013) demonstrated the success of 
WGS in identifying outbreak isolates in vancomycin-resistant Enterococcus faecium and 
carbapenem-resistant Enterobacter cloacae. This study also demonstrated the high 
concordance between the results of standard clinical microbiological practices and those 
obtained through WGS. However, in much the same way that high levels of recombination 
creates issues for the accurate reconstruction of a phylogenetic tree (see Section 1.4.1), the 
application of SnAPO and the Bayesian method to those pathogens which exhibit high levels of 
recombination might prove difficult. For example, Bordetella pertussis might be a valid target 
pathogen since it displays a level of recombination only slightly higher than S. aureus, while 
Streptococcus pneumoniae would likely not be a valid pathogen for these methods due to the 
high levels of recombination (Vos & Didelot, 2009). However, this issue need not be 
insurmountable. It could be possible to identify those regions of the genome which appear to 
be due to recombination and amend the influence of the SNPs in those regions appropriately. 
Work by Castillo-Ramírez et al. (2012) has shown that it is possible to identify the variable 
recombination rates between phylogeographic groups of different MRSA ST239 isolates. 
Furthermore, the construction of SnAPO, which requires multiple SNPs indicating a location to 
increase the confidence in that location as the posited origin, might mollify the influence of 
recombination. The application of the two methods developed in this thesis to other non-
bacterial pathogens would use the same principles but likely require further development of 
the method.  
In summary, the work in this thesis describes a proof-of-principle method that moves 
away from the phylogenetic and whole genome analysis techniques and instead uses a small 
number of genetic signals to obtain a similar result. I showed that genetic signals (such as SNPs 
and indels) can be utilised in novel ways to rapidly produce a summary of the possible 
geographic origin of an isolate and has laid the foundation for future work in this direction. The 
further development of SnAPO and the Bayesian method described in this thesis will be greatly 
facilitated by the continued decrease in the cost of WGS. The methods developed in this thesis 
could be added to the suite of analytical epidemiological tools and are a promising indication 
of the viability of developing cheap, rapid diagnostic tools to be implemented in healthcare 
institutions. I believe that implementation of WGS and the continued development of SnAPO 
on the scale proposed could increase the efficiency of the available healthcare resources and 






this “SNP-up” approach could have much wider applications than just MRSA, and so further 
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Appendix                              A 
Supplementary Table A1. The hospitals sampled in this thesis are numbered according to the 
geographic location and Referral Cluster (RC) they are found in. 
No. Hospital Short Name Hospital Full Name City RC 
1 Truro Treliske Hospital Truro 2 
2 North Devon North Devon District Hospital Barnstaple 2 
3 Bristol Southmead Southmead Hospital Bristol 2 
4 Bristol Royal Infirmary Bristol Royal Infirmary Bristol 2 
5 Southampton Southampton General Hospital Southampton 5 
6 London Northwick Northwick Park Hospital London 1 
7 Chelsea Chelsea & Westminster Hospital London 1 
8 London St. Mary St. Mary’s & Imperial Hospital London 1 
9 Ashford William Harvey Hospital Ashford 1 
10 London St. Bart’s St. Bart’s & The Royal Hospital London 4 
11 UCL University College Hospital London 4 
12 Chelmsford Chelmsford Public Health Laboratory Chelmsford 4 
13 Colchester Colchester Hospital University Colchester 4 
14 Norfolk Norfolk & Norwich Hospital Norwich 8 
15 West Suffolk West Suffolk Hospital Bury St. 
Edmunds 
8 
16 Cambridge Addenbrooke’s Hospital Cambridge 8 
17 Papworth Papworth Hospital Cambridge 8 
18 Leicester Leicester Royal Infirmary Leicester 9 
19 Nottingham University Hospital Nottingham 9 
20 Coventry Coventry & Warwickshire Hospital Coventry 6 
21 Birmingham Birmingham City Hospital Birmingham 6 
22 Shrewsbury Royal Shrewsbury Hospital Shrewsbury 6 
23 Chester Countess of Chester Chester 7 
24 Manchester WythenshaI Hospital Manchester 12 
25 Sheffield Northern General Hospital Sheffield 11 
26 York York Hospitals NHS Trust York 3 
27 Sunderland Sunderland Royal Hospital Sunderland 10 
28 Newcastle Freeman Hospital Newcastle 10 
29 Edinburgh Royal 
Infirmary 
Royal Infirmary of Edinburgh Edinburgh 15 






31 Dundee Ninewells Hospital Dundee 15 
32 Inverness Raigmore Hospital Inverness 15 
33 Glasgow South 
General 
Southern General Hospital Glasgow 15 
34 Glasgow Royal 
Infirmary 
Glasgow Royal Infirmary Glasgow 15 
35 Glasgow Victoria Victoria Infirmary Glasgow 15 
36 Wishaw Wishaw General Hospital Wishaw 15 
37 Altnaegelvin Altnaegelvin Area Hospital Londonderry 14 
38 Antrim Antrim Area Hospital Antrim 14 
39 Belfast Belfast City Hospital Belfast 14 
40 Ulster Ulster Hospital Ulster 14 
41 Dublin Beaumont Hospital Dublin 13 
42 Galway University College Hospital Galway 13 
43 Cork Cork University Hospital Cork 13 
44 Bangor Ysbyty Gwynedd Bangor 16 
45 Wrexham Wrexham Maelor Hospital Wrexham 16 





































































































































































































































































































Altnaegelvin 0 126 213 157 657 652 883 933 881 527 973 366 710 634 272 349 354 477 733 562 672 506 983 863 854 441 474 343 560 791 650 888 880 654 576 170 884 597 716 1008 941 383 522 583 700 400
Antrim 126 0 149 32.1 535 540 759 810 759 403 848 405 587 512 357 245 250 370 609 468 546 404 857 741 730 376 364 241 439 676 537 765 758 532 509 44.7 761 489 591 885 816 275 400 458 574 282
Dublin 213 149 0 136 488 457 720 765 704 370 809 302 542 545 315 347 352 456 572 351 530 495 832 686 691 505 443 345 389 598 455 712 704 561 368 141 708 397 562 832 782 366 359 437 575 230
Belfast 157 32.1 136 0 503 509 727 778 727 371 817 412 555 485 376 231 236 353 577 441 515 388 826 709 698 374 345 227 407 645 506 733 726 505 488 14.3 729 458 559 853 784 258 368 427 544 250
Birmingham 657 535 488 503 0 136 233 278 224 134 321 733 54.6 282 797 453 454 426 89.7 282 116 457 351 206 203 608 404 460 99.2 182 133 230 223 274 430 491 226 178 96.8 350 295 428 135 108 190 261
Bristol.RI 652 540 457 509 136 0 314 342 269 198 392 658 167 409 746 519 522 522 208 167 253 557 444 253 289 691 499 526 141 142 4.29 278 269 405 307 499 274 66.2 228 392 377 502 182 217 326 261
Cambridge 883 759 720 727 233 314 0 57.3 84.5 357 89.5 961 178 369 1030 636 636 572 150 481 225 590 130 84.1 29.5 761 553 645 332 223 313 77.8 80.9 349 619 714 78.4 377 170 144 63.7 605 363 302 242 492
Chelmsford 933 810 765 778 278 342 57.3 0 78.8 407 50.5 997 224 426 1072 693 693 630 202 508 281 647 126 90.4 83.4 818 611 701 377 231 341 69.2 76.7 406 640 765 72.5 407 225 86.4 57.6 662 412 355 299 538
Chelsea 881 759 704 727 224 269 84.5 78.8 0 358 129 926 175 422 1007 663 663 613 166 432 258 635 201 18.7 85.3 801 593 671 321 152 268 9.67 3.74 404 562 715 6.69 334 197 128 129 634 359 316 294 482
Chester 527 403 370 371 134 198 357 407 358 0 446 639 184 246 685 328 330 325 207 268 162 361 463 339 327 494 302 335 57 301 193 364 357 250 408 358 360 192 193 483 416 307 22.2 70.2 219 140
Colchester 973 848 809 817 321 392 89.5 50.5 129 446 0 1045 267 442 1118 721 721 651 240 558 311 666 86.5 141 119 838 633 729 420 281 391 119 127 420 691 804 123 457 259 85.4 41.6 689 453 391 318 581
Cork 366 405 302 412 733 658 961 997 926 639 1045 0 787 841 165 641 646 756 823 502 801 794 1084 910 933 781 744 638 641 792 658 935 926 856 419 422 931 592 821 1050 1024 664 623 710 856 504
Coventry 710 587 542 555 54.6 167 178 224 175 184 267 787 0 287 852 492 493 454 41.3 325 111 481 297 156 149 639 432 500 154 165 164 180 173 276 471 542 176 219 64.7 298 240 465 188 143 177 314
Newcastle 634 512 545 485 282 409 369 426 422 246 442 841 287 0 852 311 309 214 269 513 176 225 410 406 348 399 200 320 288 453 405 422 418 23.1 654 471 419 427 233 512 401 275 268 196 128 348
Galway 272 357 315 376 797 746 1030 1072 1007 685 1118 165 852 852 0 602 607 727 884 607 846 761 1145 990 1001 712 720 597 699 887 745 1015 1007 869 552 389 1011 681 876 1134 1092 632 673 752 890 545
Glasgow.Victoria 349 245 347 231 453 519 636 693 663 328 721 641 492 311 602 0 5.32 127 498 526 411 158 707 645 609 183 126 8.79 383 628 515 666 661 334 623 219 663 494 469 777 683 36.7 339 349 410 291
Glasgow.RI 354 250 352 236 454 522 636 693 663 330 721 646 493 309 607 5.32 0 123 498 530 411 154 706 645 609 179 123 11.3 385 630 518 667 661 332 628 224 663 497 469 777 682 34.2 341 350 409 295
Kirkcaldy 477 370 456 353 426 522 572 630 613 325 651 756 454 214 727 127 123 0 449 567 355 41.8 624 596 548 188 22.8 134 382 608 518 615 610 237 684 340 612 513 416 716 610 95.2 342 319 333 342
Leicester 733 609 572 577 89.7 208 150 202 166 207 240 823 41.3 269 884 498 498 449 0 366 95.3 473 262 148 121 637 428 506 185 191 205 169 163 255 512 564 165 260 35.5 282 210 469 214 154 149 343
N.Devon 562 468 351 441 282 167 481 508 432 268 558 502 325 513 607 526 530 567 366 0 388 607 610 418 456 708 546 530 228 291 168 442 434 515 147 435 438 106 379 552 544 519 246 321 459 235
Sheffield 672 546 530 515 116 253 225 281 258 162 311 801 111 176 846 411 411 355 95.3 388 0 378 311 241 198 543 335 420 169 277 249 260 255 165 535 502 257 287 61.1 366 275 380 178 93.4 73.5 302
Dundee 506 404 495 388 457 557 590 647 635 361 666 794 481 225 761 158 154 41.8 473 607 378 0 634 619 567 175 62 164 417 638 553 637 633 247 726 376 634 551 439 734 625 130 379 350 349 384
Norfolk 983 857 832 826 351 444 130 126 201 463 86.5 1084 297 410 1145 707 706 624 262 610 311 634 0 207 154 808 608 716 447 350 442 191 198 388 749 812 194 506 270 168 71.3 673 473 400 297 602
London.Northwick 863 741 686 709 206 253 84.1 90.4 18.7 339 141 910 156 406 990 645 645 596 148 418 241 619 207 0 78.4 784 575 653 302 143 253 25.5 17.7 389 550 696 21.4 319 180 146 136 616 341 298 279 464
Papworth 854 730 691 698 203 289 29.5 83.4 85.3 327 119 933 149 348 1001 609 609 548 121 456 198 567 154 78.4 0 737 529 618 302 207 288 81.4 81.6 328 595 685 80.5 352 142 168 91.7 578 334 273 220 462
Inverness 441 376 505 374 608 691 761 818 801 494 838 781 639 399 712 183 179 188 637 708 543 175 808 784 737 0 209 179 551 788 687 803 798 421 805 366 800 671 604 904 798 191 509 500 520 473
Edinburgh.RI 474 364 443 345 404 499 553 611 593 302 633 744 432 200 720 126 123 22.8 428 546 335 62 608 575 529 209 0 134 359 586 495 595 590 223 664 332 592 490 396 697 592 91.2 320 297 315 322
Glasgow.S.Gen 343 241 345 227 460 526 645 701 671 335 729 638 500 320 597 8.79 11.3 134 506 530 420 164 716 653 618 179 134 0 390 636 522 675 669 342 626 216 671 500 478 785 691 45.1 346 357 418 295
Shrewsbury 560 439 389 407 99.2 141 332 377 321 57 420 641 154 288 699 383 385 382 185 228 169 417 447 302 302 551 359 390 0 249 136 327 320 288 372 395 323 141 181 448 393 363 44.5 93.8 236 162
Southampton 791 676 598 645 182 142 223 231 152 301 281 792 165 453 887 628 630 608 191 291 277 638 350 143 207 788 586 636 249 0 143 162 155 441 413 634 159 205 225 262 279 606 293 289 340 395
Bristol.Southmead 650 537 455 506 133 4.29 313 341 268 193 391 658 164 405 745 515 518 518 205 168 249 553 442 253 288 687 495 522 136 143 0 277 269 401 310 496 273 66.3 224 392 376 498 178 213 322 258
London.St.Barts 888 765 712 733 230 278 77.8 69.2 9.67 364 119 935 180 422 1015 666 667 615 169 442 260 637 191 25.5 81.4 803 595 675 327 162 277 0 8.15 404 572 721 4.11 343 199 121 120 637 365 321 294 489
London.St.Mary 880 758 704 726 223 269 80.9 76.7 3.74 357 127 926 173 418 1007 661 661 610 163 434 255 633 198 17.7 81.6 798 590 669 320 155 269 8.15 0 401 564 714 4.22 335 194 128 126 632 358 314 291 481
Sunderland 654 532 561 505 274 405 349 406 404 250 420 856 276 23.1 869 334 332 237 255 515 165 247 388 389 328 421 223 342 288 441 401 404 401 0 658 490 401 426 219 492 379 298 272 195 110 359
Truro 576 509 368 488 430 307 619 640 562 408 691 419 471 654 552 623 628 684 512 147 535 726 749 550 595 805 664 626 372 413 310 572 564 658 0 486 568 252 526 675 681 624 385 466 606 342
Ulster 170 44.7 141 14.3 491 499 714 765 715 358 804 422 542 471 389 219 224 340 564 435 502 376 812 696 685 366 332 216 395 634 496 721 714 490 486 0 717 450 546 841 771 245 356 414 530 240
UCL 884 761 708 729 226 274 78.4 72.5 6.69 360 123 931 176 419 1011 663 663 612 165 438 257 634 194 21.4 80.5 800 592 671 323 159 273 4.11 4.22 401 568 717 0 339 196 125 123 634 361 317 292 485
Cardiff 597 489 397 458 178 66.2 377 407 334 192 457 592 219 427 681 494 497 513 260 106 287 551 506 319 352 671 490 500 141 205 66.3 343 335 426 252 450 339 0 274 458 441 481 172 232 360 218
Nottingham 716 591 562 559 96.8 228 170 225 197 193 259 821 64.7 233 876 469 469 416 35.5 379 61.1 439 270 180 142 604 396 478 181 225 224 199 194 219 526 546 196 274 0 308 225 439 203 133 115 332
Ashford 1008 885 832 853 350 392 144 86.4 128 483 85.4 1050 298 512 1134 777 777 716 282 552 366 734 168 146 168 904 697 785 448 262 392 121 128 492 675 841 125 458 308 0 123 746 485 436 385 609
W.Suffolk 941 816 782 784 295 377 63.7 57.6 129 416 41.6 1024 240 401 1092 683 682 610 210 544 275 625 71.3 136 91.7 798 592 691 393 279 376 120 126 379 681 771 123 441 225 123 0 650 423 358 278 552
Wishaw 383 275 366 258 428 502 605 662 634 307 689 664 465 275 632 36.7 34.2 95.2 469 519 380 130 673 616 578 191 91.2 45.1 363 606 498 637 632 298 624 245 634 481 439 746 650 0 320 322 376 285
Wrexham 522 400 359 368 135 182 363 412 359 22.2 453 623 188 268 673 339 341 342 214 246 178 379 473 341 334 509 320 346 44.5 293 178 365 358 272 385 356 361 172 203 485 423 320 0 88.3 238 129
Manchester 583 458 437 427 108 217 302 355 316 70.2 391 710 143 196 752 349 350 319 154 321 93.4 350 400 298 273 500 297 357 93.8 289 213 321 314 195 466 414 317 232 133 436 358 322 88.3 0 149 209
York 700 574 575 544 190 326 242 299 294 219 318 856 177 128 890 410 409 333 149 459 73.5 349 297 279 220 520 315 418 236 340 322 294 291 110 606 530 292 360 115 385 278 376 238 149 0 352








Supplementary Table A3. The driving distances, in kilometres, between each pairwise hospital in the thesis. These distances were calculated by using 





























































































































































































































































































Altnaegelvin 0 84.3 239 114 615 749 771 837 830 490 856 469 648 445 275 280 285 378 680 911 602 409 799 818 749 551 366 283 521 837 746 817 797 465 1010 121 798 684 641 920 808 306 490 537 543 392
Antrim 84.3 0 189 30.4 576 710 686 798 756 338 722 453 611 361 331 196 200 293 610 870 531 325 715 746 665 467 282 199 471 808 704 763 758 381 964 36.5 762 621 565 867 726 222 448 469 458 342
Dublin 239 189 0 161 361 495 539 602 591 255 650 272 395 526 218 361 365 458 427 684 371 489 607 577 541 632 447 363 286 602 505 590 561 533 757 169 563 449 405 690 576 386 263 302 444 157
Belfast 114 30.4 161 0 536 652 694 741 760 412 777 424 570 366 323 200 208 300 602 819 525 329 719 748 669 474 289 206 443 740 676 747 718 386 932 10.2 721 606 555 504 715 229 420 459 461 314
Birmingham 615 576 361 536 0 139 167 230 192 121 252 667 34.9 335 611 461 461 528 72.7 284 140 569 255 179 143 731 470 468 77.4 213 133 194 189 324 400 570 191 168 84.8 284 204 441 111 123 214 208
Bristol.RI 749 710 495 652 139 0 268 251 188 239 307 558 165 476 621 596 596 662 195 153 284 704 341 189 229 865 604 602 172 120 6 192 190 464 271 697 192 67.4 225 280 314 576 239 257 362 342
Cambridge 771 686 539 694 167 268 0 81.1 96 281 73.4 806 134 378 770 571 572 594 123 401 205 678 103 85.1 23.2 797 539 578 238 205 264 90.8 93.5 366 557 699 92.6 318 152 165 47.7 551 284 259 263 367
Chelmsford 837 798 602 741 230 251 81.1 0 65.6 343 41.3 889 192 450 828 629 643 666 195 406 277 737 132 80.7 84 869 611 650 300 187 268 68.3 56 439 509 757 53.5 301 224 106 72.8 623 335 345 322 431
Chelsea 830 756 591 760 192 188 96 65.6 0 319 101 850 155 450 804 640 640 708 163 322 268 748 188 19 99.2 891 638 649 262 123 186 6.3 5.5 437 427 768 5.8 238 213 93.3 140 620 310 309 334 420
Chester 490 338 255 412 121 239 281 343 319 0 365 523 155 300 469 386 381 448 167 394 128 495 369 306 257 651 390 388 69.8 350 249 320 309 289 523 428 312 329 154 446 318 361 22.1 58.3 187 101
Colchester 856 722 650 777 252 307 73.4 41.3 101 365 0 903 215 467 857 657 657 725 205 442 290 764 94.8 117 102 907 653 666 323 234 305 105 108 453 547 785 105 357 244 153 47.8 636 370 359 349 482
Cork 469 453 272 424 667 558 806 889 850 523 903 0 680 789 199 623 629 722 712 683 639 753 859 843 794 895 711 627 553 869 541 722 829 801 819 433 742 494 673 958 844 650 516 570 689 425
Coventry 648 611 395 570 34.9 165 134 192 155 155 215 680 0 331 620 497 496 563 40.4 298 145 606 218 142 106 753 495 503 113 198 147 156 154 320 427 606 156 206 89.9 261 172 476 148 156 207 242
Newcastle 445 361 526 366 335 476 378 450 450 300 467 789 331 0 732 244 232 218 303 630 209 270 409 440 358 421 163 243 365 519 474 451 443 24.2 772 372 445 516 258 535 415 207 321 247 139 391
Galway 275 331 218 323 611 621 770 828 804 469 857 199 620 732 0 568 573 667 650 770 585 698 813 797 748 841 653 571 526 834 615 812 806 746 894 337 808 587 638 918 811 588 470 518 643 369
Glasgow.Victoria 280 196 361 200 461 596 571 629 640 386 657 623 497 244 568 0 5.9 94.7 494 741 402 134 599 630 548 277 84.4 7.5 450 685 590 649 637 264 860 208 637 625 442 769 612 27.2 402 353 341 476
Glasgow.RI 285 200 365 208 461 596 572 643 640 381 657 629 496 232 573 5.9 0 81.4 499 741 395 122 599 629 548 267 82.6 10.1 450 684 589 648 643 252 857 213 646 636 452 752 609 25.8 402 353 340 472
Kirkcaldy 378 293 458 300 528 662 594 666 708 448 725 722 563 218 667 94.7 81.4 0 518 807 425 52.6 667 697 616 238 51.9 92 511 752 657 722 669 238 924 307 713 703 473 778 628 83.8 470 421 376 538
Leicester 680 610 427 602 72.7 195 123 195 163 167 205 712 40.4 303 650 494 499 518 0 340 111 606 184 149 96.1 724 466 532 133 234 181 164 160 291 468 617 163 235 50.4 254 163 485 171 160 191 265
N.Devon 911 870 684 819 284 153 401 406 322 394 442 683 298 630 770 741 741 807 340 0 432 849 516 316 382 992 746 749 327 227 159 326 322 612 142 854 326 203 376 404 468 721 391 402 508 448
Sheffield 602 531 371 525 140 284 205 277 268 128 290 639 145 209 585 402 395 425 111 432 0 511 232 254 181 628 370 409 187 345 281 267 265 197 549 531 267 324 64 360 242 383 145 72.1 95 218
Dundee 409 325 489 329 569 704 678 737 748 495 764 753 606 270 698 134 122 52.6 606 849 511 0 707 738 656 205 109 131 558 794 698 763 745 297 964 336 745 733 550 836 720 135 511 461 427 584
Norfolk 799 715 607 719 255 341 103 132 188 369 94.8 859 218 409 813 599 599 667 184 516 232 707 0 183 116 850 596 607 326 318 338 177 182 395 620 727 179 390 193 252 66 579 359 301 273 447
London.Northwick 818 746 577 748 179 189 85.1 80.7 19 306 117 843 142 440 797 630 629 697 149 316 254 738 183 0 89.2 882 628 639 252 120 181 23.5 17.4 427 422 759 20.2 232 200 145 136 610 299 297 323 419
Papworth 749 665 541 669 143 229 23.2 84 99.2 257 102 794 106 358 748 548 548 616 96.1 382 181 656 116 89.2 0 799 546 557 215 207 227 99.5 95.9 343 502 677 96.3 276 129 183 68.1 528 249 251 241 382
Inverness 551 467 632 474 731 865 797 869 891 651 907 895 753 421 841 277 267 238 724 992 628 205 850 882 799 0 264 270 715 956 840 905 862 442 1127 479 876 906 676 981 837 278 654 624 579 742
Edinburgh.RI 366 282 447 289 470 604 539 611 638 390 653 711 495 163 653 84.4 82.6 51.9 466 746 370 109 596 628 546 264 0 93 453 694 598 647 614 183 866 295 618 644 418 694 578 71.7 411 362 324 480
Glasgow.S.Gen 283 199 363 206 468 602 578 650 649 388 666 627 503 243 571 7.5 10.1 92 532 749 409 131 607 639 557 270 93 0 451 692 595 654 650 263 864 210 653 643 457 759 617 32.6 408 360 346 478
Shrewsbury 521 471 286 443 77.4 172 238 300 262 69.8 323 553 113 365 526 450 450 511 133 327 187 558 326 252 215 715 453 451 0 301 178 264 259 353 430 491 261 176 147 369 275 425 49.9 107 238 132
Southampton 837 808 602 740 213 120 205 187 123 350 234 869 198 519 834 685 684 752 234 227 345 794 318 120 207 956 694 692 301 0 134 129 129 507 320 799 130 185 289 199 251 666 336 346 414 431
Bristol.Southmead 746 704 505 676 133 6 264 268 186 249 305 541 147 474 615 590 589 657 181 159 281 698 338 181 227 840 598 595 178 134 0 191 186 458 279 703 192 61.1 225 278 314 569 225 251 356 348
London.St.Barts 817 763 590 747 194 192 90.8 68.3 6.3 320 105 722 156 451 812 649 648 722 164 326 267 763 177 23.5 99.5 905 647 654 264 129 191 0 6.5 437 432 776 3.3 242 212 90.8 131 635 311 310 328 432
London.St.Mary 797 758 561 718 189 190 93.5 56 5.5 309 108 829 154 443 806 637 643 669 160 322 265 745 182 17.4 95.9 862 614 650 259 129 186 6.5 0 431 433 770 4.1 240 209 95.5 131 623 307 305 330 390
Sunderland 465 381 533 386 324 464 366 439 437 289 453 801 320 24.2 746 264 252 238 291 612 197 297 395 427 343 442 183 263 353 507 458 437 431 0 726 391 444 504 238 523 404 227 306 236 123 379
Truro 1010 964 757 932 400 271 557 509 427 523 547 819 427 772 894 860 857 924 468 142 549 964 620 422 502 1127 866 864 430 320 279 432 433 726 0 974 464 319 493 514 592 838 524 519 628 567
Ulster 121 36.5 169 10.2 570 697 699 757 768 428 785 433 606 372 337 208 213 307 617 854 531 336 727 759 677 479 295 210 491 799 703 776 770 391 974 0 766 611 570 882 740 235 443 481 469 334
UCL 798 762 563 721 191 192 92.6 53.5 5.8 312 105 742 156 445 808 637 646 713 163 326 267 745 179 20.2 96.3 876 618 653 261 130 192 3.3 4.1 444 464 766 0 243 211 93.5 128 627 308 307 325 392
Cardiff 684 621 449 606 168 67.4 318 301 238 329 357 494 206 516 587 625 636 703 235 203 324 733 390 232 276 906 644 643 176 185 61.1 242 240 504 319 611 243 0 266 343 364 616 221 297 386 288
Nottingham 641 565 405 555 84.8 225 152 224 213 154 244 673 89.9 258 638 442 452 473 50.4 376 64 550 193 200 129 676 418 457 147 289 225 212 209 238 493 570 211 266 0 307 189 431 157 110 130 252
Ashford 920 867 690 504 284 280 165 106 93.3 446 153 958 261 535 918 769 752 778 254 404 360 836 252 145 183 981 694 759 369 199 278 90.8 95.5 523 514 882 93.5 343 307 0 189 732 430 414 415 499
W.Suffolk 808 726 576 715 204 314 47.7 72.8 140 318 47.8 844 172 415 811 612 609 628 163 468 242 720 66 136 68.1 837 578 617 275 251 314 131 131 404 592 740 128 364 189 189 0 591 312 297 299 405
Wishaw 306 222 386 229 441 576 551 623 620 361 636 650 476 207 588 27.2 25.8 83.8 485 721 383 135 579 610 528 278 71.7 32.6 425 666 569 635 623 227 838 235 627 616 431 732 591 0 383 334 321 452
Wrexham 490 448 263 420 111 239 284 335 310 22.1 370 516 148 321 470 402 402 470 171 391 145 511 359 299 249 654 411 408 49.9 336 225 311 307 306 524 443 308 221 157 430 312 383 0 383 199 100
Manchester 537 469 302 459 123 257 259 345 309 58.3 359 570 156 247 518 353 353 421 160 402 72.1 461 301 297 251 624 362 360 107 346 251 310 305 236 519 481 307 297 110 414 297 334 383 0 132 149
York 543 458 444 461 214 362 263 322 334 187 349 689 207 139 643 341 340 376 191 508 95 427 273 323 241 579 324 346 238 414 356 328 330 123 628 469 325 386 130 415 299 321 199 132 0 272







Supplementary Table A4. 
The Fixation Index (FST) is 
calculated for each 
pairwise MRSA hospital 
sub-populations. FST is a 
measure of population 
structure which compares 
the average number of 
pairwise differences 
between two sub-
populations with the 
average number within 
the same sub-population. 
Values close to 0 indicate 
that the two populations 
are highly genetically 
similar, while values close 
to 1 imply that the two 
sub-populations are 
genetically distinct. It is 
possible to obtain 
negative values, which 
implies that the 
individuals from different 
sub-populations are 














































































































































































































































































































































Truro 0 0.08 0.56 0.34 0.29 0.65 0.28 0.26 0.14 0.82 0.13 0.3 0.13 0.17 0.19 0.15 0.15 0.16 0.3 0.08 0.31 0.14 0.18 0.14 0.31 0.69 0.23 0.15 0.13 0.22 1 0.57 0.39 0.36 0.38 0.18 0.38 0.18 0.31 NA 0.25 0.24 0.27 0.27 0.09 0.44
N.Devon 0.08 0 0.63 0.34 0.24 0.69 0.38 0.35 0.15 0.84 0.22 0.29 0.14 0.12 0.11 0.08 0.08 0.11 0.19 0.04 0.27 0.09 0.15 0.09 0.33 0.66 0.15 0.07 0.08 0.19 1 0.51 0.41 0.37 0.39 0.12 0.38 0.18 0.32 NA 0.26 0.26 0.3 0.22 0 0.34
Bristol.Southmead 0.56 0.63 0 -0.09 0.2 0.6 0.25 0.18 -0.02 0.8 0.04 0.17 0.02 0.04 0.08 0.06 0.06 0.02 0.21 -0.06 0.17 0.01 0.02 -0.01 0.15 0.64 0.16 0.06 0 0.06 1 0.52 0.33 0.23 0.25 0.04 0.26 0.05 0.17 NA 0.09 0.09 0.13 0.18 -0.02 0.41
Bristol.RI 0.34 0.34 -0.09 0 0.1 0.57 0.21 0.11 -0.13 0.79 -0.03 0.08 -0.07 -0.08 -0.04 -0.06 -0.05 -0.09 0.09 -0.18 0.03 -0.1 -0.08 -0.14 0.06 0.6 0.07 -0.04 -0.1 -0.04 1 0.46 0.27 0.15 0.2 -0.06 0.18 -0.06 0.08 NA 0.02 0.01 0.06 0.07 -0.14 0.33
Southampton 0.29 0.24 0.2 0.1 0 0.66 0.34 0.28 0.09 0.83 0.15 0.22 0.12 0.07 0.08 0.07 0.06 0.04 0.25 -0.01 0.23 0.06 0.11 -0 0.26 0.64 0.15 0.04 0.05 0.15 1 0.51 0.38 0.31 0.33 0.09 0.34 0.12 0.27 NA 0.2 0.2 0.23 0.18 -0.02 0.4
London.Northwick 0.65 0.69 0.6 0.57 0.66 0 -0.1 -0.14 -0.06 0.71 -0.22 0.16 -0.13 0.01 0.06 0.03 0.03 0.01 0.12 -0.09 0.13 -0 0.01 -0.04 0.14 0.63 0.15 0.04 -0.01 0.06 1 0.51 0.26 0.22 0.25 0.03 0.25 0.02 0.15 NA 0.08 0.07 0.1 0.16 -0.04 0.4
Chelsea 0.28 0.38 0.25 0.21 0.34 -0.1 0 0.04 0.21 0.68 0 0.38 0.08 0.27 0.28 0.23 0.24 0.24 0.34 0.16 0.38 0.22 0.25 0.19 0.38 0.71 0.32 0.24 0.21 0.31 1 0.62 0.4 0.41 0.4 0.24 0.41 0.22 0.37 NA 0.3 0.28 0.32 0.34 0.2 0.56
London.St.Mary 0.26 0.35 0.18 0.11 0.28 -0.14 0.04 0 0.05 0.72 -0.08 0.23 -0.06 0.09 0.12 0.1 0.1 0.08 0.2 -0.01 0.23 0.08 0.09 0.03 0.23 0.66 0.2 0.1 0.06 0.15 1 0.55 0.31 0.28 0.29 0.12 0.32 0.09 0.22 NA 0.15 0.14 0.19 0.23 0.04 0.46
Ashford 0.14 0.15 -0.02 -0.13 0.09 -0.06 0.21 0.05 0 0.83 0.16 0.21 0.16 0.1 0.15 0.13 0.12 0.13 0.29 0.06 0.26 0.1 0.14 0.07 0.25 0.67 0.22 0.12 0.1 0.2 1 0.56 0.4 0.33 0.34 0.13 0.35 0.14 0.27 NA 0.21 0.2 0.18 0.25 0.07 0.48
London.St.Barts 0.82 0.84 0.8 0.79 0.83 0.71 0.68 0.72 0.83 0 -0.05 0.37 0.13 0.27 0.27 0.22 0.24 0.23 0.35 0.16 0.38 0.23 0.24 0.2 0.37 0.72 0.32 0.24 0.2 0.3 1 0.62 0.34 0.41 0.4 0.25 0.43 0.21 0.36 NA 0.29 0.27 0.31 0.35 0.2 0.55
UCL 0.13 0.22 0.04 -0.03 0.15 -0.22 0 -0.08 0.16 -0.05 0 0.24 -0.01 0.12 0.14 0.11 0.11 0.11 0.24 0.02 0.26 0.11 0.12 0.06 0.24 0.67 0.21 0.11 0.07 0.16 1 0.55 0.33 0.29 0.3 0.12 0.33 0.1 0.23 NA 0.15 0.15 0.2 0.23 0.06 0.47
Chelmsford 0.3 0.29 0.17 0.08 0.22 0.16 0.38 0.23 0.21 0.37 0.24 0 0.03 -0.2 0.05 0.02 0 0 0.13 -0.07 0.15 -0 0.02 -0.04 0.16 0.62 0.11 0.01 -0 0.08 1 0.49 0.34 0.25 0.27 0.01 0.28 0.06 0.19 NA 0.11 0.12 0.14 0.16 -0.11 0.39
Colchester 0.13 0.14 0.02 -0.07 0.12 -0.13 0.08 -0.06 0.16 0.13 -0.01 0.03 0 0.03 0.04 0.01 0 0.04 0.15 -0.05 0.18 0.01 0.07 0.02 0.21 0.64 0.12 0.04 0 0.11 1 0.49 0.35 0.27 0.3 0.07 0.29 0.06 0.21 NA 0.14 0.15 0.19 0.15 -0.04 0.38
Norfolk 0.17 0.12 0.04 -0.08 0.07 0.01 0.27 0.09 0.1 0.27 0.12 -0.2 0.03 0 0 -0.03 -0.05 -0.03 0.1 -0.09 0.11 -0.04 -0 -0.07 0.15 0.61 0.07 -0.04 -0.04 0.04 1 0.46 0.33 0.23 0.27 -0.01 0.25 0.03 0.17 NA 0.1 0.12 0.14 0.12 -0.18 0.35
W.Suffolk 0.19 0.11 0.08 -0.04 0.08 0.06 0.28 0.12 0.15 0.27 0.14 0.05 0.04 0 0 0.01 0.05 0.14 0.31 0.07 0.3 0.1 0.19 0.1 0.33 0.68 0.19 0.13 0.12 0.22 1 0.54 0.44 0.37 0.38 0.15 0.39 0.18 0.33 NA 0.27 0.26 0.29 0.19 0.07 0.47
Cambridge 0.15 0.08 0.06 -0.06 0.07 0.03 0.23 0.1 0.13 0.22 0.11 0.02 0.01 -0.03 0.01 0 0.08 0.2 0.37 0.14 0.36 0.14 0.26 0.18 0.39 0.7 0.24 0.17 0.17 0.28 1 0.57 0.46 0.41 0.43 0.21 0.42 0.23 0.38 NA 0.3 0.31 0.34 0.18 0.13 0.49
Papworth 0.15 0.08 0.06 -0.05 0.06 0.03 0.24 0.1 0.12 0.24 0.11 0 0 -0.05 0.05 0.08 0 0.14 0.32 0.06 0.31 0.09 0.2 0.11 0.34 0.68 0.19 0.11 0.12 0.22 1 0.55 0.43 0.37 0.39 0.16 0.39 0.18 0.33 NA 0.27 0.27 0.29 0.19 0.07 0.47
Leicester 0.16 0.11 0.02 -0.09 0.04 0.01 0.24 0.08 0.13 0.23 0.11 0 0.04 -0.03 0.14 0.2 0.14 0 0.26 -0.04 0.21 0.06 0.1 0.04 0.26 0.65 0.13 0.04 0.04 0.13 1 0.52 0.37 0.27 0.29 0.06 0.3 0.05 0.23 NA 0.18 0.15 0.22 0.19 -0 0.42
Nottingham 0.3 0.19 0.21 0.09 0.25 0.12 0.34 0.2 0.29 0.35 0.24 0.13 0.15 0.1 0.31 0.37 0.32 0.26 0 -0.21 -0.01 -0.2 -0.09 -0.15 0.08 0.56 -0.03 -0.14 -0.16 -0.07 1 0.39 0.28 0.15 0.21 -0.13 0.18 -0.06 0.1 NA 0.02 0.04 0.06 0 -0.3 0.17
Coventry 0.08 0.04 -0.06 -0.18 -0.01 -0.09 0.16 -0.01 0.06 0.16 0.02 -0.07 -0.05 -0.09 0.07 0.14 0.06 -0.04 -0.21 0 0.3 0.14 0.19 0.12 0.33 0.68 0.18 0.13 0.11 0.21 1 0.57 0.4 0.34 0.35 0.14 0.36 0.14 0.29 NA 0.22 0.21 0.26 0.26 0.1 0.5
Birmingham 0.31 0.27 0.17 0.03 0.23 0.13 0.38 0.23 0.26 0.38 0.26 0.15 0.18 0.11 0.3 0.36 0.31 0.21 -0.01 0.3 0 -0.1 -0.06 -0.12 0.1 0.59 0.03 -0.09 -0.09 -0.02 1 0.44 0.3 0.18 0.23 -0.07 0.21 -0.04 0.12 NA 0.06 0.04 0.09 0.08 -0.17 0.31
Shrewsbury 0.14 0.09 0.01 -0.1 0.06 -0 0.22 0.08 0.1 0.23 0.11 -0 0.01 -0.04 0.1 0.14 0.09 0.06 -0.2 0.14 -0.1 0 0.11 0.02 0.26 0.65 0.11 0.04 0.04 0.15 1 0.5 0.37 0.31 0.33 0.08 0.33 0.11 0.26 NA 0.18 0.19 0.24 0.11 -0.05 0.41
Chester 0.18 0.15 0.02 -0.08 0.11 0.01 0.25 0.09 0.14 0.24 0.12 0.02 0.07 -0 0.19 0.26 0.2 0.1 -0.09 0.19 -0.06 0.11 0 0.02 0.22 0.66 0.17 0.08 0.05 0.14 1 0.54 0.36 0.28 0.31 0.09 0.31 0.1 0.24 NA 0.16 0.16 0.21 0.21 -0.04 0.45
Manchester 0.14 0.09 -0.01 -0.14 -0 -0.04 0.19 0.03 0.07 0.2 0.06 -0.04 0.02 -0.07 0.1 0.18 0.11 0.04 -0.15 0.12 -0.12 0.02 0.02 0 0.35 0.68 0.23 0.15 0.15 0.25 1 0.58 0.42 0.38 0.38 0.16 0.39 0.2 0.33 NA 0.26 0.26 0.3 0.27 0.1 0.5
Sheffield 0.31 0.33 0.15 0.06 0.26 0.14 0.38 0.23 0.25 0.37 0.24 0.16 0.21 0.15 0.33 0.39 0.34 0.26 0.08 0.33 0.1 0.26 0.22 0.35 0 0.6 0.09 -0.01 -0.06 -0.01 1 0.48 0.3 0.17 0.23 -0.01 0.2 -0.02 0.11 NA 0.04 0.04 0.06 0.13 -0.1 0.36
York 0.69 0.66 0.64 0.6 0.64 0.63 0.71 0.66 0.67 0.72 0.67 0.62 0.64 0.61 0.68 0.7 0.68 0.65 0.56 0.68 0.59 0.65 0.66 0.68 0.6 0 0.2 0.12 0.13 0.23 1 0.56 0.43 0.38 0.38 0.16 0.38 0.18 0.33 NA 0.26 0.24 0.28 0.25 0.06 0.48
Sunderland 0.23 0.15 0.16 0.07 0.15 0.15 0.32 0.2 0.22 0.32 0.21 0.11 0.12 0.07 0.19 0.24 0.19 0.13 -0.03 0.18 0.03 0.11 0.17 0.23 0.09 0.2 0 0.03 0.13 0.24 1 0.54 0.45 0.41 0.42 0.17 0.41 0.18 0.36 NA 0.32 0.3 0.33 0.26 0.08 0.47
Newcastle 0.15 0.07 0.06 -0.04 0.04 0.04 0.24 0.1 0.12 0.24 0.11 0.01 0.04 -0.04 0.13 0.17 0.11 0.04 -0.14 0.13 -0.09 0.04 0.08 0.15 -0.01 0.12 0.03 0 0.15 0.25 1 0.56 0.44 0.39 0.4 0.18 0.4 0.18 0.35 NA 0.29 0.28 0.33 0.26 0.1 0.49
Edinburgh.RI 0.13 0.08 0 -0.1 0.05 -0.01 0.21 0.06 0.1 0.2 0.07 -0 0 -0.04 0.12 0.17 0.12 0.04 -0.16 0.11 -0.09 0.04 0.05 0.15 -0.06 0.13 0.13 0.15 0 0.18 1 0.45 0.36 0.32 0.29 0.16 0.37 0.14 0.28 NA 0.25 0.23 0.29 0.29 0.08 0.5
Kirkcaldy 0.22 0.19 0.06 -0.04 0.15 0.06 0.31 0.15 0.2 0.3 0.16 0.08 0.11 0.04 0.22 0.28 0.22 0.13 -0.07 0.21 -0.02 0.15 0.14 0.25 -0.01 0.23 0.24 0.25 0.18 0 1 0.48 0.29 0.16 0.2 0.01 0.24 -0.01 0.13 NA 0.1 0.08 0.16 0.15 -0.06 0.4
Dundee 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 NA 1 1 1 1 1 1
Inverness 0.57 0.51 0.52 0.46 0.51 0.51 0.62 0.55 0.56 0.62 0.55 0.49 0.49 0.46 0.54 0.57 0.55 0.52 0.39 0.57 0.44 0.5 0.54 0.58 0.48 0.56 0.54 0.56 0.45 0.48 1 0 0.41 0.33 0.36 0.06 0.36 0.12 0.29 NA 0.22 0.22 0.26 0.17 -0.13 0.38
Glasgow.S.Gen 0.39 0.41 0.33 0.27 0.38 0.26 0.4 0.31 0.4 0.34 0.33 0.34 0.35 0.33 0.44 0.46 0.43 0.37 0.28 0.4 0.3 0.37 0.36 0.42 0.3 0.43 0.45 0.44 0.36 0.29 1 0.41 0 0.34 -0.07 0.32 0.46 0.22 0.36 NA 0.34 0.31 0.38 0.43 0.31 0.63
Glasgow.RI 0.36 0.37 0.23 0.15 0.31 0.22 0.41 0.28 0.33 0.41 0.29 0.25 0.27 0.23 0.37 0.41 0.37 0.27 0.15 0.34 0.18 0.31 0.28 0.38 0.17 0.38 0.41 0.39 0.32 0.16 1 0.33 0.34 0 0.04 0.02 0.23 -0.07 0.09 NA 0.05 0.01 0.16 0.21 0.05 0.45
Glasgow.Victoria 0.38 0.39 0.25 0.2 0.33 0.25 0.4 0.29 0.34 0.4 0.3 0.27 0.3 0.27 0.38 0.43 0.39 0.29 0.21 0.35 0.23 0.33 0.31 0.38 0.23 0.38 0.42 0.4 0.29 0.2 1 0.36 -0.07 0.04 0 0.22 0.37 0.09 0.23 NA 0.23 0.18 0.28 0.36 0.22 0.57
Wishaw 0.18 0.12 0.04 -0.06 0.09 0.03 0.24 0.12 0.13 0.25 0.12 0.01 0.07 -0.01 0.15 0.21 0.16 0.06 -0.13 0.14 -0.07 0.08 0.09 0.16 -0.01 0.16 0.17 0.18 0.16 0.01 1 0.06 0.32 0.02 0.22 0 0.34 0.12 0.27 NA 0.23 0.2 0.26 0.24 0.06 0.47
Altnaegelvin 0.38 0.38 0.26 0.18 0.34 0.25 0.41 0.32 0.35 0.43 0.33 0.28 0.29 0.25 0.39 0.42 0.39 0.3 0.18 0.36 0.21 0.33 0.31 0.39 0.2 0.38 0.41 0.4 0.37 0.24 1 0.36 0.46 0.23 0.37 0.34 0 -0.12 0.03 NA 0.03 -0.04 0.13 0.26 0.09 0.49
Antrim 0.18 0.18 0.05 -0.06 0.12 0.02 0.22 0.09 0.14 0.21 0.1 0.06 0.06 0.03 0.18 0.23 0.18 0.05 -0.06 0.14 -0.04 0.11 0.1 0.2 -0.02 0.18 0.18 0.18 0.14 -0.01 1 0.12 0.22 -0.07 0.09 0.12 -0.12 0 0.17 NA 0.18 0.14 0.26 0.33 0.18 0.54
Belfast 0.31 0.32 0.17 0.08 0.27 0.15 0.37 0.22 0.27 0.36 0.23 0.19 0.21 0.17 0.33 0.38 0.33 0.23 0.1 0.29 0.12 0.26 0.24 0.33 0.11 0.33 0.36 0.35 0.28 0.13 1 0.29 0.36 0.09 0.23 0.27 0.03 0.17 0 NA 0.01 -0.04 0.12 0.23 0.06 0.47
Ulster NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
Dublin 0.25 0.26 0.09 0.02 0.2 0.08 0.3 0.15 0.21 0.29 0.15 0.11 0.14 0.1 0.27 0.3 0.27 0.18 0.02 0.22 0.06 0.18 0.16 0.26 0.04 0.26 0.32 0.29 0.25 0.1 1 0.22 0.34 0.05 0.23 0.23 0.03 0.18 0.01 NA 0 -0 0.1 0.27 0.1 0.5
Galway 0.24 0.26 0.09 0.01 0.2 0.07 0.28 0.14 0.2 0.27 0.15 0.12 0.15 0.12 0.26 0.31 0.27 0.15 0.04 0.21 0.04 0.19 0.16 0.26 0.04 0.24 0.3 0.28 0.23 0.08 1 0.22 0.31 0.01 0.18 0.2 -0.04 0.14 -0.04 NA -0 0 0.18 0.32 0.17 0.53
Cork 0.27 0.3 0.13 0.06 0.23 0.1 0.32 0.19 0.18 0.31 0.2 0.14 0.19 0.14 0.29 0.34 0.29 0.22 0.06 0.26 0.09 0.24 0.21 0.3 0.06 0.28 0.33 0.33 0.29 0.16 1 0.26 0.38 0.16 0.28 0.26 0.13 0.26 0.12 NA 0.1 0.18 0 0.3 0.14 0.52
Bangor 0.27 0.22 0.18 0.07 0.18 0.16 0.34 0.23 0.25 0.35 0.23 0.16 0.15 0.12 0.19 0.18 0.19 0.19 0 0.26 0.08 0.11 0.21 0.27 0.13 0.25 0.26 0.26 0.29 0.15 1 0.17 0.43 0.21 0.36 0.24 0.26 0.33 0.23 NA 0.27 0.32 0.3 0 0.04 0.45
Wrexham 0.09 0 -0.02 -0.14 -0.02 -0.04 0.2 0.04 0.07 0.2 0.06 -0.11 -0.04 -0.18 0.07 0.13 0.07 -0 -0.3 0.1 -0.17 -0.05 -0.04 0.1 -0.1 0.06 0.08 0.1 0.08 -0.06 1 -0.13 0.31 0.05 0.22 0.06 0.09 0.18 0.06 NA 0.1 0.17 0.14 0.04 0 0.42













in one isolate 
with those of 
another isolate. 
Each SNP found 






The number of 
SNPs found in 
both isolates is 
standardised by 
the sum of the 



























































































































































































































































































Truro 0.00 0.04 0.12 0.08 0.02 0.10 0.12 0.10 0.04 0.10 0.09 0.03 0.08 0.03 0.02 0.02 0.02 0.03 0.05 0.04 0.03 0.03 0.04 0.02 0.05 0.00 0.02 0.02 0.03 0.04 0.02 0.02 0.04 0.05 0.04 0.02 0.04 0.04 0.05 0.04 0.05 0.04 0.04 0.02 0.01 0.08
N.Devon 0.04 0.00 0.00 0.03 0.02 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.03 0.02 0.03 0.04 0.03 0.02 0.10 0.02 0.02 0.03 0.03 0.00 0.01 0.01 0.05 0.03 0.03 0.02 0.05 0.05 0.00 0.01 0.00 0.02 0.01 0.01 0.01 0.03 0.00 0.00 0.00 0.04 0.03 0.14
Bristol.Southmead 0.12 0.00 0.00 0.26 0.02 0.09 0.08 0.09 0.07 0.08 0.08 0.04 0.05 0.03 0.02 0.02 0.02 0.04 0.02 0.05 0.05 0.04 0.06 0.03 0.09 0.00 0.00 0.01 0.03 0.06 0.00 0.00 0.06 0.08 0.07 0.03 0.07 0.06 0.08 0.04 0.08 0.07 0.07 0.02 0.00 0.02
Bristol.RI 0.08 0.03 0.26 0.00 0.02 0.09 0.07 0.08 0.06 0.07 0.07 0.04 0.06 0.04 0.02 0.02 0.02 0.04 0.04 0.06 0.06 0.04 0.06 0.04 0.09 0.00 0.01 0.01 0.04 0.06 0.01 0.01 0.06 0.08 0.07 0.03 0.07 0.06 0.08 0.05 0.08 0.07 0.07 0.02 0.01 0.03
Southampton 0.02 0.02 0.02 0.02 0.00 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.03
London.Northwick 0.10 0.00 0.09 0.09 0.02 0.00 0.28 0.25 0.08 0.26 0.19 0.04 0.12 0.03 0.02 0.02 0.02 0.04 0.07 0.05 0.06 0.03 0.06 0.04 0.09 0.00 0.00 0.01 0.03 0.05 0.00 0.00 0.09 0.08 0.07 0.03 0.07 0.06 0.08 0.05 0.08 0.08 0.08 0.02 0.00 0.01
Chelsea 0.12 0.00 0.08 0.07 0.01 0.28 0.00 0.31 0.05 0.41 0.23 0.03 0.17 0.03 0.01 0.02 0.02 0.03 0.08 0.04 0.04 0.02 0.05 0.02 0.07 0.02 0.00 0.01 0.03 0.04 0.00 0.00 0.09 0.06 0.06 0.02 0.05 0.05 0.06 0.04 0.07 0.06 0.06 0.01 0.00 0.01
London.St.Mary 0.10 0.01 0.09 0.08 0.02 0.25 0.31 0.00 0.06 0.27 0.18 0.04 0.13 0.03 0.02 0.02 0.02 0.04 0.09 0.05 0.05 0.03 0.06 0.03 0.08 0.00 0.00 0.01 0.03 0.04 0.00 0.00 0.08 0.07 0.07 0.03 0.06 0.05 0.07 0.05 0.08 0.07 0.07 0.02 0.00 0.01
Ashford 0.04 0.00 0.07 0.06 0.02 0.08 0.05 0.06 0.00 0.05 0.06 0.07 0.04 0.06 0.02 0.02 0.02 0.03 0.03 0.03 0.04 0.03 0.05 0.02 0.08 0.00 0.01 0.01 0.02 0.04 0.00 0.00 0.04 0.05 0.05 0.02 0.05 0.04 0.05 0.04 0.06 0.05 0.08 0.02 0.01 0.01
London.St.Barts 0.10 0.00 0.08 0.07 0.01 0.26 0.41 0.27 0.05 0.00 0.23 0.03 0.13 0.03 0.01 0.02 0.01 0.03 0.07 0.04 0.04 0.02 0.05 0.02 0.06 0.00 0.00 0.01 0.03 0.04 0.00 0.00 0.14 0.06 0.06 0.02 0.05 0.05 0.06 0.04 0.07 0.06 0.06 0.01 0.00 0.01
UCL 0.09 0.01 0.08 0.07 0.02 0.19 0.23 0.18 0.06 0.23 0.00 0.04 0.12 0.03 0.02 0.02 0.02 0.03 0.07 0.05 0.05 0.03 0.05 0.03 0.08 0.00 0.00 0.01 0.04 0.05 0.01 0.01 0.09 0.07 0.07 0.03 0.07 0.06 0.08 0.04 0.08 0.08 0.07 0.02 0.00 0.02
Chelmsford 0.03 0.00 0.04 0.04 0.01 0.04 0.03 0.04 0.07 0.03 0.04 0.00 0.02 0.10 0.01 0.01 0.02 0.02 0.03 0.02 0.03 0.02 0.03 0.02 0.06 0.00 0.00 0.00 0.01 0.02 0.00 0.00 0.03 0.03 0.03 0.01 0.03 0.02 0.04 0.02 0.04 0.03 0.05 0.01 0.01 0.01
Colchester 0.08 0.03 0.05 0.06 0.02 0.12 0.17 0.13 0.04 0.13 0.12 0.02 0.00 0.04 0.04 0.05 0.04 0.03 0.07 0.04 0.04 0.04 0.04 0.02 0.05 0.01 0.02 0.02 0.03 0.04 0.03 0.03 0.04 0.04 0.04 0.02 0.04 0.04 0.05 0.05 0.05 0.04 0.04 0.04 0.02 0.04
Norfolk 0.03 0.02 0.03 0.04 0.02 0.03 0.03 0.03 0.06 0.03 0.03 0.10 0.04 0.00 0.02 0.02 0.03 0.02 0.04 0.03 0.03 0.03 0.03 0.02 0.05 0.00 0.02 0.01 0.02 0.03 0.02 0.02 0.02 0.03 0.03 0.02 0.03 0.02 0.03 0.03 0.03 0.03 0.03 0.02 0.04 0.03
W.Suffolk 0.02 0.03 0.02 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.04 0.02 0.00 0.09 0.07 0.02 0.02 0.03 0.02 0.05 0.02 0.01 0.02 0.00 0.03 0.02 0.02 0.03 0.03 0.03 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.04 0.02 0.02 0.02 0.07 0.01 0.03
Cambridge 0.02 0.04 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.05 0.02 0.09 0.00 0.10 0.03 0.02 0.03 0.02 0.06 0.01 0.01 0.02 0.00 0.04 0.02 0.02 0.03 0.04 0.04 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.05 0.02 0.01 0.02 0.10 0.02 0.04
Papworth 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.04 0.03 0.07 0.10 0.00 0.03 0.02 0.03 0.02 0.05 0.02 0.01 0.02 0.00 0.04 0.03 0.02 0.03 0.03 0.03 0.01 0.03 0.02 0.02 0.03 0.02 0.02 0.05 0.02 0.01 0.02 0.07 0.02 0.04
Leicester 0.03 0.02 0.04 0.04 0.03 0.04 0.03 0.04 0.03 0.03 0.03 0.02 0.03 0.02 0.02 0.03 0.03 0.00 0.02 0.05 0.04 0.04 0.03 0.02 0.04 0.01 0.04 0.04 0.03 0.04 0.02 0.02 0.04 0.06 0.05 0.03 0.05 0.06 0.06 0.04 0.05 0.05 0.04 0.03 0.01 0.03
Nottingham 0.05 0.10 0.02 0.04 0.02 0.07 0.08 0.09 0.03 0.07 0.07 0.03 0.07 0.04 0.02 0.02 0.02 0.02 0.00 0.02 0.02 0.03 0.02 0.01 0.03 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.03 0.07
Coventry 0.04 0.02 0.05 0.06 0.02 0.05 0.04 0.05 0.03 0.04 0.05 0.02 0.04 0.03 0.03 0.03 0.03 0.05 0.02 0.00 0.04 0.04 0.04 0.02 0.05 0.00 0.05 0.03 0.04 0.05 0.02 0.03 0.05 0.07 0.06 0.04 0.07 0.06 0.07 0.04 0.06 0.07 0.05 0.03 0.01 0.03
Birmingham 0.03 0.02 0.05 0.06 0.03 0.06 0.04 0.05 0.04 0.04 0.05 0.03 0.04 0.03 0.02 0.02 0.02 0.04 0.02 0.04 0.00 0.04 0.04 0.03 0.06 0.01 0.03 0.02 0.02 0.04 0.01 0.02 0.03 0.04 0.04 0.03 0.04 0.04 0.05 0.03 0.05 0.04 0.04 0.02 0.01 0.02
Shrewsbury 0.03 0.03 0.04 0.04 0.02 0.03 0.02 0.03 0.03 0.02 0.03 0.02 0.04 0.03 0.05 0.06 0.05 0.04 0.03 0.04 0.04 0.00 0.03 0.02 0.04 0.01 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.03 0.02 0.02 0.03 0.03 0.03 0.04 0.03 0.02 0.03 0.07 0.04 0.04
Chester 0.04 0.03 0.06 0.06 0.02 0.06 0.05 0.06 0.05 0.05 0.05 0.03 0.04 0.03 0.02 0.01 0.02 0.03 0.02 0.04 0.04 0.03 0.00 0.03 0.07 0.00 0.01 0.01 0.02 0.04 0.01 0.01 0.04 0.05 0.05 0.02 0.05 0.04 0.06 0.03 0.06 0.05 0.05 0.02 0.03 0.02
Manchester 0.02 0.00 0.03 0.04 0.03 0.04 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.02 0.01 0.02 0.03 0.02 0.03 0.00 0.03 0.01 0.01 0.01 0.01 0.02 0.00 0.00 0.02 0.03 0.03 0.03 0.02 0.02 0.03 0.02 0.03 0.02 0.02 0.02 0.00 0.01
Sheffield 0.05 0.01 0.09 0.09 0.02 0.09 0.07 0.08 0.08 0.06 0.08 0.06 0.05 0.05 0.02 0.02 0.02 0.04 0.03 0.05 0.06 0.04 0.07 0.03 0.00 0.03 0.01 0.02 0.04 0.05 0.00 0.01 0.06 0.08 0.07 0.03 0.07 0.06 0.08 0.05 0.08 0.07 0.09 0.02 0.00 0.02
York 0.00 0.01 0.00 0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.03 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Sunderland 0.02 0.05 0.00 0.01 0.02 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.02 0.02 0.03 0.04 0.04 0.04 0.02 0.05 0.03 0.04 0.01 0.01 0.01 0.01 0.00 0.09 0.02 0.02 0.05 0.05 0.00 0.01 0.00 0.02 0.01 0.03 0.01 0.03 0.00 0.00 0.00 0.04 0.03 0.05
Newcastle 0.02 0.03 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.02 0.01 0.02 0.02 0.03 0.04 0.02 0.03 0.02 0.03 0.01 0.01 0.02 0.00 0.09 0.00 0.02 0.02 0.03 0.03 0.01 0.02 0.02 0.02 0.03 0.04 0.03 0.03 0.02 0.02 0.01 0.02 0.01 0.03
Edinburgh.RI 0.03 0.03 0.03 0.04 0.01 0.03 0.03 0.03 0.02 0.03 0.04 0.01 0.03 0.02 0.02 0.02 0.02 0.03 0.02 0.04 0.02 0.03 0.02 0.01 0.04 0.00 0.02 0.02 0.00 0.07 0.04 0.15 0.09 0.08 0.11 0.03 0.05 0.07 0.07 0.03 0.06 0.06 0.04 0.02 0.03 0.03
Kirkcaldy 0.04 0.02 0.06 0.06 0.02 0.05 0.04 0.04 0.04 0.04 0.05 0.02 0.04 0.03 0.03 0.03 0.03 0.04 0.03 0.05 0.04 0.03 0.04 0.02 0.05 0.00 0.02 0.02 0.07 0.00 0.06 0.03 0.09 0.11 0.11 0.04 0.08 0.08 0.10 0.04 0.08 0.07 0.06 0.03 0.01 0.03
Dundee 0.02 0.05 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.03 0.02 0.03 0.04 0.03 0.02 0.03 0.02 0.01 0.03 0.01 0.00 0.00 0.00 0.05 0.03 0.04 0.06 0.00 0.06 0.00 0.01 0.00 0.02 0.01 0.01 0.01 0.03 0.00 0.00 0.00 0.04 0.03 0.06
Inverness 0.02 0.05 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.03 0.02 0.03 0.04 0.03 0.02 0.03 0.03 0.02 0.03 0.01 0.00 0.01 0.00 0.05 0.03 0.15 0.03 0.06 0.00 0.00 0.01 0.00 0.03 0.01 0.01 0.01 0.03 0.00 0.00 0.00 0.04 0.07 0.06
Glasgow.S.Gen 0.04 0.00 0.06 0.06 0.01 0.09 0.09 0.08 0.04 0.14 0.09 0.03 0.04 0.02 0.01 0.01 0.01 0.04 0.02 0.05 0.03 0.02 0.04 0.02 0.06 0.00 0.00 0.01 0.09 0.09 0.00 0.00 0.00 0.19 0.40 0.04 0.09 0.11 0.13 0.04 0.10 0.11 0.08 0.01 0.00 0.01
Glasgow.RI 0.05 0.01 0.08 0.08 0.02 0.08 0.06 0.07 0.05 0.06 0.07 0.03 0.04 0.03 0.02 0.02 0.03 0.06 0.02 0.07 0.04 0.03 0.05 0.03 0.08 0.00 0.01 0.02 0.08 0.11 0.01 0.01 0.19 0.00 0.23 0.08 0.12 0.14 0.17 0.05 0.14 0.15 0.10 0.02 0.00 0.02
Glasgow.Victoria 0.04 0.00 0.07 0.07 0.02 0.07 0.06 0.07 0.05 0.06 0.07 0.03 0.04 0.03 0.02 0.01 0.02 0.05 0.02 0.06 0.04 0.02 0.05 0.03 0.07 0.00 0.00 0.02 0.11 0.11 0.00 0.00 0.40 0.23 0.00 0.05 0.12 0.14 0.16 0.05 0.13 0.14 0.09 0.01 0.00 0.01
Wishaw 0.02 0.02 0.03 0.03 0.01 0.03 0.02 0.03 0.02 0.02 0.03 0.01 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.04 0.03 0.02 0.02 0.03 0.03 0.00 0.02 0.02 0.03 0.04 0.02 0.03 0.04 0.08 0.05 0.00 0.05 0.05 0.05 0.03 0.05 0.05 0.04 0.02 0.01 0.02
Altnaegelvin 0.04 0.01 0.07 0.07 0.02 0.07 0.05 0.06 0.05 0.05 0.07 0.03 0.04 0.03 0.02 0.02 0.03 0.05 0.02 0.07 0.04 0.03 0.05 0.02 0.07 0.01 0.01 0.03 0.05 0.08 0.01 0.01 0.09 0.12 0.12 0.05 0.00 0.19 0.21 0.05 0.17 0.19 0.13 0.02 0.00 0.01
Antrim 0.04 0.01 0.06 0.06 0.02 0.06 0.05 0.05 0.04 0.05 0.06 0.02 0.04 0.02 0.02 0.02 0.02 0.06 0.02 0.06 0.04 0.03 0.04 0.02 0.06 0.01 0.03 0.04 0.07 0.08 0.01 0.01 0.11 0.14 0.14 0.05 0.19 0.00 0.19 0.05 0.13 0.14 0.10 0.02 0.01 0.02
Belfast 0.05 0.01 0.08 0.08 0.02 0.08 0.06 0.07 0.05 0.06 0.08 0.04 0.05 0.03 0.02 0.02 0.02 0.06 0.02 0.07 0.05 0.03 0.06 0.03 0.08 0.00 0.01 0.03 0.07 0.10 0.01 0.01 0.13 0.17 0.16 0.05 0.21 0.19 0.00 0.06 0.17 0.18 0.12 0.02 0.00 0.02
Ulster 0.04 0.03 0.04 0.05 0.02 0.05 0.04 0.05 0.04 0.04 0.04 0.02 0.05 0.03 0.04 0.05 0.05 0.04 0.03 0.04 0.03 0.04 0.03 0.02 0.05 0.00 0.03 0.03 0.03 0.04 0.03 0.03 0.04 0.05 0.05 0.03 0.05 0.05 0.06 0.00 0.05 0.05 0.05 0.05 0.01 0.04
Dublin 0.05 0.00 0.08 0.08 0.02 0.08 0.07 0.08 0.06 0.07 0.08 0.04 0.05 0.03 0.02 0.02 0.02 0.05 0.02 0.06 0.05 0.03 0.06 0.03 0.08 0.00 0.00 0.02 0.06 0.08 0.00 0.00 0.10 0.14 0.13 0.05 0.17 0.13 0.17 0.05 0.00 0.19 0.15 0.02 0.00 0.01
Galway 0.04 0.00 0.07 0.07 0.02 0.08 0.06 0.07 0.05 0.06 0.08 0.03 0.04 0.03 0.02 0.01 0.01 0.05 0.02 0.07 0.04 0.02 0.05 0.02 0.07 0.01 0.00 0.02 0.06 0.07 0.00 0.00 0.11 0.15 0.14 0.05 0.19 0.14 0.18 0.05 0.19 0.00 0.15 0.02 0.00 0.01
Cork 0.04 0.00 0.07 0.07 0.02 0.08 0.06 0.07 0.08 0.06 0.07 0.05 0.04 0.03 0.02 0.02 0.02 0.04 0.02 0.05 0.04 0.03 0.05 0.02 0.09 0.00 0.00 0.01 0.04 0.06 0.00 0.00 0.08 0.10 0.09 0.04 0.13 0.10 0.12 0.05 0.15 0.15 0.00 0.02 0.00 0.01
Bangor 0.02 0.04 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.04 0.02 0.07 0.10 0.07 0.03 0.02 0.03 0.02 0.07 0.02 0.02 0.02 0.00 0.04 0.02 0.02 0.03 0.04 0.04 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.05 0.02 0.02 0.02 0.00 0.02 0.04
Wrexham 0.01 0.03 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.02 0.04 0.01 0.02 0.02 0.01 0.03 0.01 0.01 0.04 0.03 0.00 0.00 0.00 0.03 0.01 0.03 0.01 0.03 0.07 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.02 0.00 0.03








Table A6. The 
SNPCONNECTIVITY 
matrix. For each 
pair of hospitals I 
determine which 
of the 5469 SNPs 
appear in both. 
This is now the 
SNP connectivity 
of those two 
hospitals. A higher 
number of SNPs 
appearing in both 
hospitals indicates 




number of the 
SNPs provide 
connectivity 
within a hospital 
by being 
harboured in 







































































































































































































































Truro 327 30 20 68 90 25 35 67 65 23 86 11 41 31 22 102 88 45 57 32 35 51 36 46 42 5 49 42 10 13 3 6 25 13 7 14 33 32 41 6 48 5 25 31 7 61
N.Devon 30 66 0 21 34 1 1 24 3 0 13 0 5 3 5 17 28 8 32 4 5 14 46 4 13 1 13 13 3 3 3 3 1 3 0 4 4 4 6 0 3 0 3 17 3 19
Bristol.Southmead 20 0 42 40 6 5 6 7 19 6 7 5 7 5 7 25 9 5 5 8 6 7 6 5 5 0 0 7 6 10 0 1 6 6 5 6 5 7 8 6 6 5 5 5 0 25
Bristol.RI 68 21 40 227 61 5 6 47 36 7 24 14 12 15 23 62 81 19 27 36 19 23 41 72 28 0 12 20 16 21 4 4 14 19 12 15 24 17 29 10 26 11 18 64 4 41
Southampton 90 34 6 61 410 6 6 73 23 6 62 13 18 15 33 119 135 104 43 77 55 60 61 92 76 25 49 52 11 20 3 9 10 16 11 11 50 29 43 8 24 13 24 72 3 100
London.Northwick 25 1 5 5 6 50 24 31 30 22 42 7 24 5 5 35 25 10 24 6 8 6 6 21 7 1 1 6 5 5 0 1 24 5 5 5 6 6 6 5 24 7 21 5 0 7
Chelsea 35 1 6 6 6 24 72 67 13 31 41 5 32 5 5 37 19 10 27 6 6 10 5 13 6 5 6 7 6 5 0 1 31 7 5 5 5 6 11 6 32 5 13 6 0 12
London.St.Mary 67 24 7 47 73 31 67 316 37 34 120 21 66 16 41 84 84 20 58 54 20 28 42 85 23 3 14 23 16 17 3 4 39 16 13 13 28 17 25 10 51 15 44 34 6 24
Ashford 65 3 19 36 23 30 13 37 352 13 64 38 28 33 47 153 129 28 27 36 25 37 29 52 25 2 47 22 18 25 3 7 22 25 13 23 30 17 31 9 68 9 71 33 6 34
London.St.Barts 23 0 6 7 6 22 31 34 13 53 41 5 23 5 5 42 16 5 22 5 6 7 5 13 5 0 1 6 6 5 0 1 51 5 5 5 5 6 9 6 23 5 13 5 0 6
UCL 86 13 7 24 62 42 41 120 64 41 369 19 72 15 73 135 120 41 43 79 40 86 34 62 47 5 19 40 34 47 3 6 58 34 23 15 55 38 52 22 99 41 79 41 5 55
Chelmsford 11 0 5 14 13 7 5 21 38 5 19 104 5 46 13 56 60 7 14 6 15 13 12 14 10 0 1 6 5 6 0 0 5 5 5 6 13 5 11 5 20 7 18 26 3 8
Colchester 41 5 7 12 18 24 32 66 28 23 72 5 134 13 17 64 38 11 34 24 11 20 16 18 17 3 9 14 10 12 3 5 23 16 6 8 19 9 20 6 56 7 25 19 3 17
Norfolk 31 3 5 15 15 5 5 16 33 5 15 46 13 75 13 54 34 10 17 11 14 13 22 16 11 0 7 10 8 9 3 3 6 11 6 9 14 8 14 5 13 5 12 17 10 12
W.Suffolk 22 5 7 23 33 5 5 41 47 5 73 13 17 13 443 244 208 55 9 87 31 71 37 39 24 4 69 17 9 19 3 5 8 26 11 18 43 14 33 5 45 10 27 73 3 26
Cambridge 102 17 25 62 119 35 37 84 153 42 135 56 64 54 244 1438 601 123 51 126 60 109 62 104 153 39 74 62 21 36 8 8 53 52 22 26 76 37 70 12 108 18 81 93 15 116
Papworth 88 28 9 81 135 25 19 84 129 16 120 60 38 34 208 601 1250 116 56 122 59 105 70 100 104 10 64 72 21 37 3 10 26 51 21 32 115 44 119 18 98 21 81 107 7 91
Leicester 45 8 5 19 104 10 10 20 28 5 41 7 11 10 55 123 116 368 14 71 52 55 53 63 75 6 58 44 15 21 3 7 13 19 14 25 47 34 45 13 40 16 27 41 3 96
Nottingham 57 32 5 27 43 24 27 58 27 22 43 14 34 17 9 51 56 14 89 11 12 21 34 20 25 2 16 18 8 8 3 4 22 9 5 8 10 9 10 5 33 7 17 19 6 27
Coventry 32 4 8 36 77 6 6 54 36 5 79 6 24 11 87 126 122 71 11 496 71 72 61 48 51 7 74 62 19 30 4 7 16 30 19 17 66 41 55 16 49 21 53 36 4 78
Birmingham 35 5 6 19 55 8 6 20 25 6 40 15 11 14 31 60 59 52 12 71 200 56 36 48 31 5 38 38 9 11 4 7 9 9 7 22 36 28 35 6 26 11 15 31 3 41
Shrewsbury 51 14 7 23 60 6 10 28 37 7 86 13 20 13 71 109 105 55 21 72 56 392 98 46 50 6 42 42 17 17 3 11 8 21 6 19 47 29 46 6 45 11 23 86 53 64
Chester 36 46 6 41 61 6 5 42 29 5 34 12 16 22 37 62 70 53 34 61 36 98 393 36 40 2 24 25 17 16 3 9 10 14 13 16 27 15 23 7 40 10 29 32 61 55
Manchester 46 4 5 72 92 21 13 85 52 13 62 14 18 16 39 104 100 63 20 48 48 46 36 408 75 19 47 72 17 21 4 8 20 18 13 22 43 35 40 11 53 11 38 85 8 36
Sheffield 42 13 5 28 76 7 6 23 25 5 47 10 17 11 24 153 104 75 25 51 31 50 40 75 359 32 44 57 32 79 3 7 24 29 31 20 51 48 52 13 35 15 29 44 6 40
York 5 1 0 0 25 1 5 3 2 0 5 0 3 0 4 39 10 6 2 7 5 6 2 19 32 46 13 3 0 5 0 1 1 0 1 0 4 3 6 0 2 2 5 4 0 9
Sunderland 49 13 0 12 49 1 6 14 47 1 19 1 9 7 69 74 64 58 16 74 38 42 24 47 44 13 370 129 11 15 5 8 5 12 4 9 31 27 30 2 21 2 15 29 9 43
Newcastle 42 13 7 20 52 6 7 23 22 6 40 6 14 10 17 62 72 44 18 62 38 42 25 72 57 3 129 355 19 42 3 10 17 27 34 24 61 62 64 35 47 21 40 37 5 33
Edinburgh.RI 10 3 6 16 11 5 6 16 18 6 34 5 10 8 9 21 21 15 8 19 9 17 17 17 32 0 11 19 129 73 5 29 26 30 27 15 15 28 29 12 46 11 15 9 9 20
Kirkcaldy 13 3 10 21 20 5 5 17 25 5 47 6 12 9 19 36 37 21 8 30 11 17 16 21 79 5 15 42 73 293 8 3 25 90 31 24 57 69 70 30 65 21 39 20 3 28
Dundee 3 3 0 4 3 0 0 3 3 0 3 0 3 3 3 8 3 3 3 4 4 3 3 4 3 0 5 3 5 8 26 3 1 5 0 3 3 3 4 0 6 1 4 3 3 4
Inverness 6 3 1 4 9 1 1 4 7 1 6 0 5 3 5 8 10 7 4 7 7 11 9 8 7 1 8 10 29 3 3 72 1 3 0 16 7 6 6 1 6 1 4 7 8 7
Glasgow.S.Gen 25 1 6 14 10 24 31 39 22 51 58 5 23 6 8 53 26 13 22 16 9 8 10 20 24 1 5 17 26 25 1 1 135 45 66 12 12 24 30 12 33 11 29 6 0 11
Glasgow.RI 13 3 6 19 16 5 7 16 25 5 34 5 16 11 26 52 51 19 9 30 9 21 14 18 29 0 12 27 30 90 5 3 45 174 48 25 27 52 62 14 36 11 27 25 3 20
Glasgow.Victoria 7 0 5 12 11 5 5 13 13 5 23 5 6 6 11 22 21 14 5 19 7 6 13 13 31 1 4 34 27 31 0 0 66 48 101 13 16 26 25 13 19 11 17 11 0 12
Wishaw 14 4 6 15 11 5 5 13 23 5 15 6 8 9 18 26 32 25 8 17 22 19 16 22 20 0 9 24 15 24 3 16 12 25 13 123 23 24 25 11 23 11 14 19 3 12
Altnaegelvin 33 4 5 24 50 6 5 28 30 5 55 13 19 14 43 76 115 47 10 66 36 47 27 43 51 4 31 61 15 57 3 7 12 27 16 23 264 60 110 31 62 54 47 40 4 26
Antrim 32 4 7 17 29 6 6 17 17 6 38 5 9 8 14 37 44 34 9 41 28 29 15 35 48 3 27 62 28 69 3 6 24 52 26 24 60 180 134 46 38 21 36 15 4 16
Belfast 41 6 8 29 43 6 11 25 31 9 52 11 20 14 33 70 119 45 10 55 35 46 23 40 52 6 30 64 29 70 4 6 30 62 25 25 110 134 302 45 57 23 47 34 4 30
Ulster 6 0 6 10 8 5 6 10 9 6 22 5 6 5 5 12 18 13 5 16 6 6 7 11 13 0 2 35 12 30 0 1 12 14 13 11 31 46 45 53 32 21 29 7 0 8
Dublin 48 3 6 26 24 24 32 51 68 23 99 20 56 13 45 108 98 40 33 49 26 45 40 53 35 2 21 47 46 65 6 6 33 36 19 23 62 38 57 32 395 37 160 36 4 33
Galway 5 0 5 11 13 7 5 15 9 5 41 7 7 5 10 18 21 16 7 21 11 11 10 11 15 2 2 21 11 21 1 1 11 11 11 11 54 21 23 21 37 101 62 13 0 12
Cork 25 3 5 18 24 21 13 44 71 13 79 18 25 12 27 81 81 27 17 53 15 23 29 38 29 5 15 40 15 39 4 4 29 27 17 14 47 36 47 29 160 62 324 30 3 25
Bangor 31 17 5 64 72 5 6 34 33 5 41 26 19 17 73 93 107 41 19 36 31 86 32 85 44 4 29 37 9 20 3 7 6 25 11 19 40 15 34 7 36 13 30 354 3 55
Wrexham 7 3 0 4 3 0 0 6 6 0 5 3 3 10 3 15 7 3 6 4 3 53 61 8 6 0 9 5 9 3 3 8 0 3 0 3 4 4 4 0 4 0 3 3 62 9








Table A7. The 
majority of SNPs (n 
= 2655) are only 
ever seen in two 
isolates. These rare 
SNPs might be more 
informative in the 
SNP connectivity 
since I are removing 
those more 
common SNPs 
which might be 
present in all sub-
populations, and 
therefore contribute 
“noise” to the 
network. For each 
pair of hospitals I 
determine which of 
these rare SNPs 
appear in both. This 








































































































































































































































Truro 101 0 0 9 3 0 0 1 1 0 3 0 0 0 0 2 3 2 0 0 0 0 0 0 0 0 3 1 0 0 0 0 0 1 0 1 0 0 1 0 2 0 1 0 0 2
N.Devon 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Bristol.Southmead 0 0 13 12 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bristol.RI 9 0 12 78 0 0 0 1 0 0 0 0 0 0 1 14 23 0 0 0 0 0 2 2 0 0 1 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Southampton 3 0 0 0 121 0 0 23 0 0 0 0 1 0 2 3 0 8 0 5 0 0 1 0 3 0 1 0 1 0 0 1 0 1 0 0 0 0 3 0 0 0 0 0 0 7
London.Northwick 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
Chelsea 0 0 0 0 0 0 10 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
London.St.Mary 1 0 0 1 23 0 10 98 0 0 2 0 23 0 0 10 0 0 0 0 0 2 0 21 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 1 0 0 0
Ashford 1 0 0 0 0 0 0 0 91 0 1 0 0 0 3 21 3 1 0 0 0 0 0 1 1 0 32 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0
London.St.Barts 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0
UCL 3 0 0 0 0 0 0 2 1 0 64 0 11 0 1 0 5 0 1 0 6 29 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1
Chelmsford 0 0 0 0 0 0 0 0 0 0 0 21 0 2 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Colchester 0 0 0 0 1 0 0 23 0 0 11 0 56 3 0 11 1 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Norfolk 0 0 0 0 0 0 0 0 0 0 0 2 3 8 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
W.Suffolk 0 0 0 1 2 0 0 0 3 0 1 0 0 0 78 25 17 1 0 0 0 6 1 1 0 0 4 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
Cambridge 2 0 1 14 3 0 0 10 21 1 0 0 11 0 25 571 111 12 0 18 1 1 5 1 18 2 1 1 1 1 0 0 0 1 0 1 5 0 4 0 2 1 2 2 0 17
Papworth 3 0 0 23 0 0 0 0 3 0 5 9 1 0 17 111 383 0 1 9 0 0 2 1 0 1 4 0 0 0 0 1 0 0 0 2 1 0 25 0 2 0 0 3 0 5
Leicester 2 0 0 0 8 4 0 0 1 0 0 0 0 0 1 12 0 126 1 0 0 0 4 0 4 0 11 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 1 0 0 26
Nottingham 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1
Coventry 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 18 9 0 0 135 4 0 1 0 1 1 0 1 0 1 0 0 0 1 1 0 1 2 1 0 0 0 0 1 0 2
Birmingham 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 1 0 0 0 4 71 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0
Shrewsbury 0 0 0 0 0 0 0 2 0 0 29 0 0 0 6 1 0 0 0 0 0 120 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 8
Chester 0 0 0 2 1 0 0 0 0 0 0 0 0 2 1 5 2 4 0 1 0 0 90 0 1 0 1 0 0 0 0 0 0 0 1 0 2 0 2 0 2 0 1 0 0 4
Manchester 0 0 0 2 0 0 0 21 1 0 1 0 0 0 1 1 1 0 0 0 0 0 0 83 1 0 1 12 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 0 3
Sheffield 0 0 0 0 3 0 0 0 1 0 0 0 5 0 0 18 0 4 0 1 0 1 1 1 110 2 0 0 0 37 0 0 0 0 0 2 0 0 0 0 0 0 1 1 1 0
York 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 1 0 0 0 0 2 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
Sunderland 3 0 0 1 1 0 0 0 32 0 0 0 0 0 4 1 4 11 0 0 0 2 1 1 0 0 135 30 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 2
Newcastle 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 12 0 0 30 143 0 0 0 0 0 0 9 0 0 0 0 0 0 0 1 0 0 1
Edinburgh.RI 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 25 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kirkcaldy 0 0 0 1 0 0 0 0 1 0 2 0 0 0 1 1 0 0 0 1 0 0 0 0 37 0 0 0 6 92 0 0 1 20 0 0 17 0 0 0 0 0 0 1 0 1
Dundee 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inverness 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Glasgow.S.Gen 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 24 0 1 0 0 0 0 0 0 0 6 0 0 0
Glasgow.RI 1 0 0 0 1 0 0 1 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 20 0 0 0 44 0 0 0 0 0 0 0 0 0 0 0 0
Glasgow.Victoria 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 9 0 0 0 0 1 0 14 0 0 0 0 0 0 0 0 0 0 1
Wishaw 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 63 1 0 1 0 0 0 0 0 0 0
Altnaegelvin 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 5 1 0 0 1 0 0 2 0 0 0 1 0 0 17 0 0 0 0 0 1 85 0 10 0 0 24 0 0 0 0
Antrim 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47 11 5 0 0 0 0 0 0
Belfast 1 0 0 0 3 0 0 0 0 0 0 0 0 0 0 4 25 1 0 1 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 1 10 11 92 0 0 1 1 1 0 2
Ulster 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 5 0 0 0 0 0 0
Dublin 2 0 0 0 0 0 0 0 1 0 0 1 0 0 0 2 2 1 1 0 0 2 2 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 108 1 18 0 0 0
Galway 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 1 0 1 53 26 0 0 0
Cork 1 0 0 0 0 0 0 1 1 0 1 0 0 0 0 2 0 1 0 0 0 0 1 0 1 0 0 1 0 0 0 0 6 0 0 0 0 0 1 0 18 26 114 3 0 1
Bangor 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 0 0 1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 3 86 0 10
Wrexham 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0







Supplementary Table A8. I extracted the relevant Patient Referral data from Donker et al (2012, 2014) of the 27 English hospitals which appear in this 















































































































































































Bristol.RI 249994 562 5 7 837 6 33 90 27 9 33 4 22 3 24 11 3 47 19 12 28 23198 25 29 26 16 85
N.Devon 533 85401 4 6 153 2 14 31 8 1 21 3 8 3 14 0 8 23 3 14 14 221 30 19 8 14 25
York 14 5 134785 8 28 11 29 10 88 9 14 30 16 17 8 12 9 21 142 6 7 9 23 35 6 12 19
Colchester 7 9 6 136310 16 244 599 11 9 1 7 2 156 3 1234 5 2350 229 8 9 37 4 18 13 4 5 110
Truro 737 141 17 19 310174 10 40 88 62 16 44 4 20 19 55 17 26 154 14 33 27 301 73 87 29 39 90
W.Suffolk 5 8 5 233 14 97233 4506 7 16 4 10 4 622 5 48 2 100 46 4 7 22 7 16 23 3 6 32
Cambridge 41 7 19 731 45 5256 325666 84 58 19 33 9 1650 7 150 12 477 187 37 16 67 19 106 103 19 25 192
Southampton 95 32 11 10 80 10 85 259616 16 8 22 7 22 5 52 16 18 73 16 48 37 39 32 28 9 20 75
Sheffield 11 12 116 8 62 11 54 49 608013 42 49 21 66 107 20 64 4 43 143 8 13 37 213 456 72 54 32
Chester 4 6 8 6 18 4 22 7 47 167193 11 2 6 74 3 624 5 13 7 6 9 10 19 15 7 115 12
Coventry 39 16 6 9 65 13 27 27 45 19 214924 12 29 15 28 16 5 75 32 8 35 18 1011 108 310 55 48
Sunderland 5 1 22 6 3 3 8 12 23 4 4 207303 6 8 4 8 4 12 6138 1 8 1 11 16 10 4 14
Norfolk 18 9 20 178 25 720 1519 22 51 5 39 6 408353 4 119 8 104 141 17 21 45 16 80 76 9 8 93
Manchester 7 4 16 4 29 2 3 7 83 106 10 8 5 115453 6 76 3 24 39 2 11 7 29 21 5 36 23
London.St.Barts 45 11 3 1479 62 36 151 54 28 7 17 3 77 5 168389 10 1627 1189 21 39 200 21 51 26 29 6 542
Chelmsford 12 2 5 3 14 3 10 18 64 674 19 8 3 84 17 204787 4 22 26 3 5 6 17 23 17 36 13
Chelsea 9 10 5 2405 27 82 454 18 10 4 5 5 97 1 1361 5 144302 405 12 12 67 12 16 11 4 6 96
UCL 57 27 23 275 197 46 201 105 50 14 84 9 120 27 1341 20 480 153247 47 589 1402 58 136 73 24 29 2301
Newcastle 24 6 146 13 18 5 44 15 122 20 34 7369 17 27 22 34 5 38 310548 10 7 19 34 83 21 13 36
Ashford 21 17 4 9 40 14 19 43 14 8 9 4 17 3 43 6 11 482 6 88938 88 11 7 17 5 3 764
London.Northwick 29 10 4 33 25 17 58 35 19 3 33 7 27 15 214 9 55 1120 5 91 146872 26 69 23 24 11 7571
Bristol.Southmead 20556 250 8 8 383 6 20 53 13 7 19 10 14 8 25 8 9 54 21 8 25 376519 33 25 23 20 42
Leicester 28 24 28 16 71 21 108 40 192 19 1108 13 86 29 62 15 21 102 37 9 88 23 464062 2508 148 44 62
Nottingham 34 9 36 16 86 25 93 28 393 21 130 15 72 32 26 16 10 67 83 19 25 24 2623 379656 69 36 41
Birmingham 38 7 8 5 28 7 14 19 60 8 264 5 9 8 31 16 5 23 16 3 24 26 137 73 235250 142 39
Shrewsbury 21 10 14 10 47 3 21 21 56 106 56 1 12 35 8 38 5 30 13 9 13 14 40 36 144 208120 30





Appendix                              B 
Supplementary Table B1. There are 18 Candidate Introductions (CIs) at the hospital 
geographic resolution which also harbour a LSS for the TAPO posited origin location. 12 of 
the CIs are between Referral Clusters (RCs), while the rest are within RCs. 
Strain Code Year Sampling Location TAPO Referral Cluster 
8728 5.17 2001 Cork Coventry Between 
7554 6.12 2001 Newcastle Sunderland Within 
7922 1.38 2001 Papworth Ashford Between 
7414 7.72 2002 West Suffolk Cambridge Within 
8728 5.23 2003 Kirkcaldy Altnaegelvin Between 
7712 8.69 2004 Bristol Royal Infirmary Manchester Between 
7414 8.74 2004 Shrewsbury Cardiff Between 
7521 5.13 2005 Altnaegelvin Papworth Between 
7521 5.58 2006 Kirkcaldy Glasgow Royal Infirmary Within 
7521 6.76 2007 Southampton Truro Between 
7065 8.76 2007 Cambridge Bristol Royal Infirmary Between 
7469 7.7 2008 Ashford Cork Between 
7469 7.9 2008 Ashford Truro Between 
7480 8.19 2008 UCL Cork Between 
7469 7.15 2008 Bangor Manchester Between 
7748 6.65 2009 West Suffolk Papworth Within 
7083 1.16 2009 Cambridge Papworth Within 






Supplementary Table B2. There are 16 Candidate Introductions (CIs) at the Referral Cluster 
(RC) geographic resolution which also harbour a LSS for the TAPO posited origin location. 10 
of the CIs are to RCs that are non-adjacent. The rest are between adjacent RCs or RCs which 
share a sea border. 
Strain Code Year Sampling Location TAPO Referral Cluster 
8728 5.17 2001 RC 13 RC 6 Non-adjacent 
7922 1.38 2001 RC 8 RC 1 Non-adjacent 
7712 8.38 2003 RC 4 RC 8 Adjacent 
8728 5.23 2003 RC 15 RC 14 Adjacent via sea 
7712 8.69 2004 RC 2 RC 12 Non-adjacent 
7414 8.74 2004 RC 6 RC 16 Adjacent 
7521 5.13 2005 RC 14 RC 8 Non-adjacent 
7521 6.76 2007 RC 5 RC 2 Adjacent 
7065 8.70 2007 RC 8 RC 15 Non-adjacent 
7065 8.76 2007 RC 8 RC 2 Non-adjacent 
7469 7.9 2008 RC 1 RC 2 Non-adjacent 
7480 8.19 2008 RC 4 RC 13 Non-adjacent 
7469 7.15 2008 RC 16 RC 12 Non-adjacent 
7480 8.61 2009 RC 16 RC 2 Adjacent 
7564 8.78 2004 RC 10 RC 14 Adjacent via sea 





Appendix                               C 
Supplementary Table C1. The summary of all 127 Candidate Introductions with the 
predictions for both TAPO and SnAPO. For the 41 isolates where there is contradiction 
between the two methods I provide an explanation why there is a discrepancy. In all 41 
cases the discrepancy could be attributed to the TAPO method, with 22 potential CIs 
sampled before the other isolates in the sub-clade, while the 19 possible CIs could be 

































29/01/01 Norfolk Truro Southampton Sampled before 
















26/07/01 Papworth Sheffield Sheffield NA 
X7922_
1.38 






10/01/02 Dublin Cork Cork NA 
X7554_
6.93 
04/02/02 Cambridge Cork Chelmsford Sampled before 
















17/03/02 Shrewsbury Chester Chester NA 
X7414_
7.56 
20/03/02 Glasgow Royal 
Infirmary 












28/05/02 Papworth Bangor UCL Sampled before 




07/06/02 Newcastle Sunderland Sunderland NA 
X7712_
8.38 
02/01/03 UCL Papworth Papworth NA 
X7414_
8.32 
15/01/03 Cambridge Papworth Papworth NA 
X7712_
8.12 
07/02/03 Shrewsbury Bangor Papworth Sampled before 




23/02/03 Papworth West Suffolk West Suffolk NA 
X7712_
8.32 















15/08/03 Kirkcaldy Altnaegelvin Altnaegelvin NA 
X7712_
8.73 
06/01/04 Cambridge Papworth Papworth NA 
X7414_
8.62 
09/01/04 Leicester Chester Chester NA 
X7712_
8.69 
17/01/04 Bristol Royal 
Infirmary 
Manchester Manchester NA 
X7414_
8.80 
18/01/04 Shrewsbury Birmingham Birmingham NA 
X7414_
8.87 
20/01/04 Sunderland Newcastle Newcastle NA 
X7521_
5.6 
22/01/04 UCL Truro London St. 
Mary 
Sampled before 




25/01/04 Coventry Shrewsbury Shrewsbury NA 
X7712_
8.42 
25/01/04 Altnaegelvin Belfast Altnaegelvin Could be 
considered part 






03/02/04 Altnaegelvin Belfast Altnaegelvin Could be 
considered part 






10/02/04 Shrewsbury Cardiff Cardiff NA 
X7922_
1.86 








20/02/04 London St. 
Mary 
Coventry Coventry NA 
X7480_
7.29 
06/01/05 Shrewsbury Chester Chester NA 
X7521_
5.30 






13/01/05 Cambridge Papworth Papworth NA 
X7480_
7.39 
14/01/05 Sunderland Newcastle Newcastle NA 
X7480_
7.13 
18/01/05 Newcastle Sunderland Newcastle Could be 
considered 
smaller subclade 




24/01/05 Altnaegelvin Papworth Papworth NA 
X7480_
7.24 
11/02/05 Manchester Southampton Southampton NA 
X7480_
7.10 
23/02/05 Newcastle Sunderland Newcastle Could be 
considered 
smaller subclade 




20/04/05 Papworth Cambridge Papworth Mistakenly 
assigned to 
subclade, should 




11/08/05 Papworth West Suffolk West Suffolk NA 
X8140_
1.26 
26/08/05 Papworth West Suffolk West Suffolk NA 
X8140_
1.34 
30/12/05 Papworth Cambridge Papworth Only 2 isolates 
sampled before in 
subclade and 












15/01/06 Dublin Kirkcaldy Kirkcaldy NA 
X7521_
6.9 
16/01/06 UCL Truro London St. 
Mary 
Sampled before 
all Truro isolates 
in subclade. 




5.58 Infirmary Infirmary 
X7521_
5.79 








23/01/06 Dublin Cork Cork NA 
X7480_
7.54 
06/03/06 Altnaegelvin Dublin Dublin NA 
X7065_
8.2 
20/07/06 Cambridge Papworth Papworth NA 
X7065_
8.12 
19/09/06 Cambridge West Suffolk West Suffolk NA 
X7065_
8.15 
26/09/06 Cambridge West Suffolk West Suffolk NA 
X8140_
1.51 
19/10/06 Papworth Cambridge Cambridge NA 
X8140_
1.52 








01/01/07 Coventry Chester Coventry Could be 
considered part 




18/01/07 Dublin Cork Papworth Sampled before 




22/01/07 Belfast Dublin Dublin NA 
X7469_
7.2 
31/01/07 West Suffolk Cambridge Cambridge NA 
X7521_
6.72 
31/01/07 Shrewsbury Bangor Bangor NA 
X7521_
6.76 
18/02/07 Southampton Truro Truro NA 
X7065_
8.42 
19/02/07 Cambridge Papworth Papworth NA 
X7065_
8.43 























14/08/07 Papworth Southampton Southampton NA 
X7922_
1.5 








14/09/07 Papworth Cambridge Cambridge NA 
X7065_
8.76 













07/01/08 Cardiff Southampton Southampton NA 
X7469_
7.84 
23/01/08 Southampton Papworth Papworth NA 
X7469_
7.19 
05/02/08 Dublin Cork Cork NA 
X7469_
7.20 








16/02/08 Ashford Cork Cork NA 
X7469_
7.9 
22/02/08 Ashford Truro Truro NA 
X7480_
8.19 
26/02/08 UCL Cork Cork NA 
X7469_
7.37 


















18/03/08 Sheffield Manchester Manchester NA 
X7469_
7.26 
25/03/08 Dublin Cork Cork NA 
X7469_
7.15 
08/04/08 Bangor Manchester Manchester NA 
X7065_
8.87 
08/05/08 Cambridge Papworth Papworth NA 
X7065_
8.91 
20/07/08 Cambridge Papworth Papworth NA 
X7469_
7.76 
02/08/08 Manchester Newcastle Newcastle NA 
X7748_
6.64 
01/01/09 West Suffolk Sunderland Sunderland NA 
X7480_
8.38 








10/01/09 West Suffolk Papworth Papworth NA 
X7748_
6.35 
14/01/09 Manchester Ashford Ashford NA 
X7480_
8.23 
26/01/09 Antrim Belfast Belfast NA 
X7480_
8.24 







31/01/09 Cambridge Papworth Papworth NA 
X7480_
8.61 







19/03/09 Antrim Belfast Belfast NA 
X7083_
1.13 
24/03/09 Cambridge Papworth Papworth NA 
X7480_
8.68 
27/03/09 Cork Dublin Dublin NA 
X7480_
8.41 











04/05/09 Cambridge Papworth Papworth NA 
X7480_
8.82 






26/05/09 Chester Sheffield Sheffield NA 
X7083_
1.22 
02/08/09 Cambridge Papworth Papworth NA 
X7083_
1.24 



































26/01/10 Galway Cork Cork NA 
X7564_
8.85 







27/01/10 Cambridge Papworth Papworth NA 
X7083_
1.29 











09/02/10 Leicester Southampton Southampton NA 
X7564_
8.65 
17/02/10 Shrewsbury Bangor Bangor NA 
X7564_
8.37 














12/05/10 Cambridge Papworth Papworth NA 
X7083_
1.35 
26/06/10 Cambridge Papworth Papworth NA 
X7748_
6.80 
29/06/10 Bangor West Suffolk West Suffolk NA 
X7915_
6.10 
10/07/10 Colchester Cambridge Cambridge NA 
X7083_
1.38 



































Supplementary Table C2. The summary of all 90 isolates sampled in 2010 with the predicted origin hospital from three independent investigators using 
the TAPO compared to the posited origin from the SnAPO method. Each investigator was also asked to indicate how confident they were with their 
posited hospital origins. Furthermore, I have included the SnAPO Diagnostic Origin Value (DOV) for the posited origin location. 
Strain Code Sampling Date Sampling Location SnAPO SnAPO DOV TAPO 1 TAPO 1 Confidence TAPO 2 TAPO 2 Confidence TAPO 3 TAPO 3 Confidence
X7564_8.19 01/01/2010 Belfast Antrim 0.29 Belfast High Antrim Low Antrim Low
X7564_8.91 01/01/2010 Wrexham Chester 0.536 NA NA NA NA NA NA
X7564_8.25 03/01/2010 Cardiff Cardiff 0.803 Cardiff High Cardiff High Cardiff High
X7564_8.92 03/01/2010 Bristol Southmead Bristol Royal Infirmary 0.512 Bristol Royal Infirmary Low Bristol Royal Infirmary Low Bristol Royal Infirmary Low
X7564_8.69 04/01/2010 Southampton Southampton 0.661 Southampton High Southampton High Southampton Low
X7564_8.20 05/01/2010 Belfast Belfast 0.241 Belfast High Belfast Low Belfast High
X7564_8.26 05/01/2010 Cardiff Leicester 0.596 Leicester Low NA NA NA NA
X7564_8.44 06/01/2010 Coventry Coventry 0.499 NA NA Coventry Low NA NA
X7564_8.93 06/01/2010 Bristol Southmead Bristol Royal Infirmary 0.338 Bristol Royal Infirmary Low Bristol Royal Infirmary High Bristol Royal Infirmary Low
X7564_8.50 07/01/2010 Newcastle Newcastle 0.644 Newcastle Low NA NA Newcastle Low
X7564_8.66 07/01/2010 Glasgow Southern General Glasgow Southern General 0.406 Glasgow Southern General Low Glasgow Southern General Low NA NA
X7564_8.35 09/01/2010 Chelsea London St. Mary 0.307 NA NA NA NA London St. Mary Low
X7564_8.21 12/01/2010 Belfast Glasgow Royal Infirmary 0.406 Antrim Low Antrim Low Glasgow Royal Infirmary Low
X7564_8.27 12/01/2010 Cardiff Cardiff 0.416 Cardiff High Cardiff High Cardiff High
X7564_8.61 13/01/2010 London Northwick Cambridge 0.125 London Northwick Low London Northwick High London Northwick High
X7748_6.69 13/01/2010 Antrim Altnaegelvin 0.172 Altnaegelvin Low Altnaegelvin Low Altnaegelvin Low
X7748_6.70 13/01/2010 Antrim Antrim 0.381 Altnaegelvin Low Altnaegelvin Low Altnaegelvin Low
X7564_8.28 14/01/2010 Cardiff Cardiff 0.437 Cardiff High Shrewsbury Low Cardiff High
X7564_8.52 14/01/2010 Leicester Leicester 0.522 Leicester Low Leicester Low Leicester Low
X7564_8.29 15/01/2010 Cardiff Cardiff 0.611 Cardiff High Cardiff High Cardiff High
X7564_8.30 17/01/2010 Cardiff Cardiff 0.594 Cardiff High Cardiff High Cardiff High
X7564_8.74 18/01/2010 Sunderland Sunderland 0.585 Sunderland High Sunderland High Sunderland Low
X7564_8.84 20/01/2010 Wishaw Inverness 0.532 Inverness Low Inverness Low Newcastle Low
X7564_8.22 21/01/2010 Belfast Belfast 0.361 Belfast Low NA NA Dublin Low
X7564_8.31 23/01/2010 Cardiff Cambridge 0.399 Truro High Cambridge Low Truro High
X7564_8.83 24/01/2010 West Suffolk Papworth 0.51 NA NA Papworth Low Papworth Low
X7564_8.15 26/01/2010 Dublin Dublin 0.509 Dublin High Dublin High Dublin High
X7564_8.80 26/01/2010 Galway Cork 0.34 Cork Low Dublin Low Dublin High
X7564_8.85 26/01/2010 Wishaw Glasgow Royal Infirmary 0.207 Glasgow High Glasgow Royal Infirmary High Glasgow Royal Infirmary Low
X7083_1.28 27/01/2010 Cambridge Papworth 0.485 NA NA Papworth Low NA NA
X7564_8.53 28/01/2010 Leicester Leicester 0.504 Leicester High Leicester High Leicester High
X7748_6.77 29/01/2010 Bangor Bangor 0.547 Bangor High Bangor High Bangor High
X7564_8.75 05/02/2010 Sunderland Newcastle 0.267 Newcastle Low Newcastle Low Newcastle Low
X7083_1.29 07/02/2010 Cambridge Cambridge 0.575 NA NA Papworth Low NA NA
X7564_8.79 07/02/2010 Ulster Belfast 0.292 Belfast Low Antrim Low Belfast Low
X7564_8.76 08/02/2010 Sunderland Sunderland 0.597 Sunderland High Sunderland High Sunderland High
X7564_8.54 09/02/2010 Leicester Southampton 0.626 Southampton High Southampton High Southampton Low
X7564_8.68 09/02/2010 Glasgow Southern General UCL 0.35 UCL High UCL High UCL High
X7564_8.70 09/02/2010 Southampton Southampton 0.776 Southampton High Southampton High Southampton Low
X7748_6.66 09/02/2010 York Cambridge 0.263 NA NA Southampton Low Southampton Low
X7748_6.67 11/02/2010 York Sheffield 0.236 NA NA NA NA NA NA
X7564_8.86 13/02/2010 Wishaw Manchester 0.273 NA NA Birmingham Low NA NA
X7748_6.72 16/02/2010 UCL London St. Mary 0.223 Dublin Low NA NA Dublin Low
X7564_8.65 17/02/2010 Shrewsbury Bangor 0.475 Bangor High Bangor High Bangor High







X7564_8.37 20/02/2010 Chelsea London St. Mary 0.575 London St. Mary High London St. Mary High London St. Mary High
X7748_6.73 20/02/2010 UCL London St. Mary 0.302 London St. Mary Low London St. Mary Low NA NA
X7564_8.17 21/02/2010 Dublin Dublin 0.265 Dublin Low Dublin Low Dublin Low
X7564_8.18 26/02/2010 Dublin Dublin 0.549 Dublin High Dublin High Dublin High
X7748_6.75 01/03/2010 UCL London St. Mary 0.244 Colchester Low NA NA London St. Mary Low
X7564_8.77 02/03/2010 Truro Truro 0.54 Truro High Truro High Truro High
X7564_8.71 06/03/2010 London St. Barts UCL 0.263 UCL High UCL High UCL High
X7564_8.24 20/03/2010 Cambridge Papworth 0.241 Papworth Low Papworth Low Papworth Low
X7564_8.64 27/03/2010 Inverness Inverness 0.826 Inverness High Inverness High Inverness High
X7564_8.16 04/04/2010 Dublin Dublin 0.507 Dublin High Dublin High Dublin High
X7564_8.38 06/04/2010 Cork Dublin 0.55 Dublin High Dublin High Dublin High
X7564_8.88 06/04/2010 Wishaw Glasgow Royal Infirmary 0.207 Glasgow High Glasgow Royal Infirmary High Glasgow Royal Infirmary Low
X7564_8.43 08/04/2010 Cork Cork 0.495 Cork High Cork High Cork High
X7564_8.42 11/04/2010 Cork Dublin 0.4 Dublin High Dublin High Dublin High
X7564_8.40 13/04/2010 Cork Cork 0.552 Cork High Cork High Cork High
X7915_6.9 14/04/2010 Colchester London St. Mary 0.74 London St. Mary Low NA NA NA NA
X7564_8.89 16/04/2010 Wishaw Wishaw 0.511 NA NA Birmingham Low NA NA
X7564_8.32 17/04/2010 Chester Chester 0.575 NA NA Chester Low Chester Low
X7564_8.90 21/04/2010 Wrexham Shrewsbury 0.237 NA NA NA NA Shrewsbury Low
X7564_8.33 29/04/2010 Chester Chester 0.538 NA NA NA NA NA NA
X7083_1.30 12/05/2010 Cambridge Papworth 0.42 Papworth High Papworth Low Papworth Low
X7564_8.34 18/05/2010 Chester Chester 0.273 Chester High Chester High NA NA
X7083_1.31 20/05/2010 Cambridge Papworth 0.487 Papworth High Papworth High Papworth High
X8728_5.51 24/05/2010 Colchester UCL 0.267 Dublin Low NA NA Dublin Low
X7083_1.32 07/06/2010 Cambridge Cambridge 0.473 Cambridge High Cambridge High Cambridge High
X7083_1.34 25/06/2010 Cambridge UCL 0.26 UCL High UCL High UCL High
X7083_1.35 26/06/2010 Cambridge Papworth 0.567 Cambridge Low Cambridge Low Cambridge High
X7748_6.80 29/06/2010 Bangor West Suffolk 0.315 Papworth Low Papworth Low Papworth Low
X7083_1.36 30/06/2010 Cambridge Cambridge 0.741 Cambridge High Cambridge High Cambridge High
X7564_8.56 30/06/2010 North Devon Chester 0.542 NA NA Chester Low Chester Low
X7915_6.10 10/07/2010 Colchester Cambridge 0.442 Papworth Low Papworth Low Papworth Low
X7083_1.38 18/08/2010 Cambridge Papworth 0.633 Papworth High Papworth High Papworth High
X7564_8.58 28/08/2010 North Devon Cardiff 0.415 Cardiff High Cardiff High Cardiff High
X8728_5.39 12/09/2010 Edinburgh Royal Infirmary Kirkcaldy 0.135 NA NA Glasgow Victoria Low NA NA
X7083_1.39 14/09/2010 Cambridge Cambridge 0.46 Cambridge Low Cambridge Low Cambridge High
X7564_8.47 17/09/2010 Edinburgh Royal Infirmary Inverness 0.7 Inverness High Inverness High Inverness High
X8728_5.38 19/09/2010 Edinburgh Royal Infirmary Kirkcaldy 0.177 NA NA Kirkcaldy Low Glasgow Royal Infirmary Low
X7564_8.73 02/10/2010 London St. Barts UCL 0.251 UCL High UCL High UCL High
X7915_6.13 08/10/2010 Colchester Norfolk 0.501 NA NA Norfolk Low Norfolk Low
X7564_8.55 10/10/2010 Manchester Manchester 0.576 Manchester High Manchester Low NA NA
X7564_8.81 10/10/2010 Galway Altnaegelvin 0.587 Altnaegelvin Low NA NA Altnaegelvin Low
X7564_8.87 10/10/2010 Wishaw Wishaw 0.781 Inverness Low Inverness Low Newcastle Low
X7915_6.14 30/10/2010 Colchester Papworth 0.158 NA NA NA NA Belfast Low
X7564_8.48 16/12/2010 Edinburgh Royal Infirmary Edinburgh Royal Infirmary 0.477 Inverness High Inverness High Inverness High








Supplementary Table C3. The summary of all 90 isolates sampled in 2010 with the predicted origin Referral Cluster (RC) from three independent 
investigators using the TAPO compared to the posited origin from the SnAPO method. Each investigator was also asked to indicate how confident they 
were with their posited RC origins. Furthermore, I have included the SnAPO Diagnostic Origin Value (DOV) for the posited origin location. 
Strain Code Sampling Date Sampling Location SnAPO SnAPO DOV TAPO 1 TAPO 1 Confidence TAPO 2 TAPO 2 Confidence TAPO 3 TAPO 3 Confidence
X7564_8.19 01/01/2010 RC14 RC14 0.568 RC14 High RC14 High RC14 High
X7564_8.91 01/01/2010 RC16 RC7 0.536 NA NA NA NA NA NA
X7564_8.25 03/01/2010 RC16 RC16 0.816 RC16 High RC16 High RC16 High
X7564_8.92 03/01/2010 RC2 RC2 0.679 RC2 High RC2 High RC2 High
X7564_8.69 04/01/2010 RC5 RC5 0.661 RC5 High RC5 High RC5 Low
X7564_8.20 05/01/2010 RC14 RC14 0.334 RC14 High RC14 High RC14 High
X7564_8.26 05/01/2010 RC16 RC9 0.596 RC9 Low NA NA NA NA
X7564_8.44 06/01/2010 RC6 RC6 0.506 NA NA RC6 Low NA NA
X7564_8.93 06/01/2010 RC2 RC2 0.544 RC2 High RC2 High RC2 Low
X7564_8.50 07/01/2010 RC10 RC10 0.672 RC10 Low NA NA RC10 Low
X7564_8.66 07/01/2010 RC15 RC15 0.774 RC15 High RC15 High RC15 High
X7564_8.35 09/01/2010 RC1 RC1 0.348 NA NA NA NA RC1 Low
X7564_8.21 12/01/2010 RC14 RC15 0.531 RC14 Low RC14 Low RC15 Low
X7564_8.27 12/01/2010 RC16 RC16 0.44 RC16 High RC16 High RC16 High
X7564_8.61 13/01/2010 RC1 RC1 0.317 RC1 High RC1 High RC1 High
X7748_6.69 13/01/2010 RC14 RC14 0.242 RC14 High RC14 High RC14 High
X7748_6.70 13/01/2010 RC14 RC14 0.508 RC14 High RC15 High RC14 High
X7564_8.28 14/01/2010 RC16 RC16 0.448 RC16 High RC6 Low RC16 High
X7564_8.52 14/01/2010 RC9 RC9 0.522 RC9 Low RC9 Low RC9 Low
X7564_8.29 15/01/2010 RC16 RC16 0.622 RC16 High RC16 High RC16 High
X7564_8.30 17/01/2010 RC16 RC16 0.608 RC16 High RC16 High RC16 High
X7564_8.74 18/01/2010 RC10 RC10 0.593 RC10 High RC10 High RC10 Low
X7564_8.84 20/01/2010 RC15 RC15 0.547 RC15 Low RC15 Low RC10 Low
X7564_8.22 21/01/2010 RC14 RC14 0.485 RC14 Low NA NA RC13 Low
X7564_8.31 23/01/2010 RC16 RC8 0.424 RC2 High RC8 Low RC2 High
X7564_8.83 24/01/2010 RC8 RC8 0.556 RC8 Low RC8 High RC8 High
X7564_8.15 26/01/2010 RC13 RC13 0.577 RC13 High RC13 High RC13 High
X7564_8.80 26/01/2010 RC13 RC13 0.494 RC13 High RC13 High RC13 High
X7564_8.85 26/01/2010 RC15 RC15 0.264 RC15 High RC15 High RC15 Low
X7083_1.28 27/01/2010 RC8 RC8 0.587 RC8 Low RC8 Low NA NA
X7564_8.53 28/01/2010 RC9 RC9 0.505 RC9 High RC9 High RC9 High
X7748_6.77 29/01/2010 RC16 RC16 0.552 RC16 High RC16 High RC16 High
X7564_8.75 05/02/2010 RC10 RC10 0.454 RC10 High RC10 High RC10 High
X7083_1.29 07/02/2010 RC8 RC8 0.811 RC8 Low RC8 Low NA NA
X7564_8.79 07/02/2010 RC14 RC14 0.63 RC14 High RC14 High RC14 High
X7564_8.76 08/02/2010 RC10 RC10 0.704 RC10 High RC10 High RC10 High
X7564_8.54 09/02/2010 RC9 RC5 0.626 RC5 High RC5 High RC5 Low
X7564_8.68 09/02/2010 RC15 RC4 0.361 RC4 High RC4 High RC4 High
X7564_8.70 09/02/2010 RC5 RC5 0.776 RC5 High RC5 High RC5 Low
X7748_6.66 09/02/2010 RC3 RC8 0.308 NA NA RC5 Low RC5 Low
X7748_6.67 11/02/2010 RC3 RC8 0.259 NA NA NA NA NA NA
X7564_8.86 13/02/2010 RC15 RC12 0.273 NA NA RC6 Low NA NA
X7748_6.72 16/02/2010 RC4 RC1 0.277 RC13 Low NA NA RC13 Low
X7564_8.65 17/02/2010 RC6 RC16 0.499 RC16 High RC16 High RC16 High







X7564_8.37 20/02/2010 RC1 RC1 0.603 RC1 High RC1 High RC1 High
X7748_6.73 20/02/2010 RC4 RC1 0.362 RC1 Low RC1 Low RC1 High
X7564_8.17 21/02/2010 RC13 RC13 0.384 RC13 Low RC13 Low RC13 Low
X7564_8.18 26/02/2010 RC13 RC13 0.601 RC13 High RC13 High RC13 High
X7748_6.75 01/03/2010 RC4 RC1 0.33 RC4 Low NA NA RC1 Low
X7564_8.77 02/03/2010 RC2 RC2 0.54 RC2 High RC2 High RC2 High
X7564_8.71 06/03/2010 RC4 RC4 0.271 RC4 High RC4 High RC4 High
X7564_8.24 20/03/2010 RC8 RC8 0.505 RC8 High RC8 High RC8 High
X7564_8.64 27/03/2010 RC15 RC15 0.828 RC15 High RC15 High RC15 High
X7564_8.16 04/04/2010 RC13 RC13 0.566 RC13 High RC13 High RC13 High
X7564_8.38 06/04/2010 RC13 RC13 0.787 RC13 High RC13 High RC13 High
X7564_8.88 06/04/2010 RC15 RC15 0.311 RC15 High RC15 High RC15 Low
X7564_8.43 08/04/2010 RC13 RC13 0.679 RC13 High RC13 High RC13 High
X7564_8.42 11/04/2010 RC13 RC13 0.769 RC13 High RC13 High RC13 High
X7564_8.40 13/04/2010 RC13 RC13 0.688 RC13 High RC13 High RC13 High
X7915_6.9 14/04/2010 RC4 RC1 0.749 RC1 Low NA NA NA NA
X7564_8.89 16/04/2010 RC15 RC15 0.513 NA NA RC6 Low NA NA
X7564_8.32 17/04/2010 RC7 RC7 0.575 RC2 Low RC7 Low RC7 Low
X7564_8.90 21/04/2010 RC16 RC6 0.245 NA NA NA NA RC6 Low
X7564_8.33 29/04/2010 RC7 RC7 0.538 NA NA NA NA NA NA
X7083_1.30 12/05/2010 RC8 RC8 0.509 RC8 High RC8 Low RC8 Low
X7564_8.34 18/05/2010 RC7 RC7 0.273 RC7 High RC7 High NA NA
X7083_1.31 20/05/2010 RC8 RC8 0.737 RC8 High RC8 High RC8 High
X8728_5.51 24/05/2010 RC4 RC4 0.293 RC13 Low NA NA RC13 Low
X7083_1.32 07/06/2010 RC8 RC8 0.842 RC8 High RC8 High RC8 High
X7083_1.34 25/06/2010 RC8 RC4 0.346 RC4 High RC4 High RC4 High
X7083_1.35 26/06/2010 RC8 RC8 0.921 RC8 High RC8 High RC8 High
X7748_6.80 29/06/2010 RC16 RC8 0.526 RC8 High RC8 High RC8 Low
X7083_1.36 30/06/2010 RC8 RC8 0.937 RC8 High RC8 High RC8 High
X7564_8.56 30/06/2010 RC2 RC7 0.542 RC2 Low RC7 Low RC7 Low
X7915_6.10 10/07/2010 RC4 RC8 0.642 RC8 High RC8 High RC8 High
X7083_1.38 18/08/2010 RC8 RC8 0.912 RC8 High RC8 High RC8 High
X7564_8.58 28/08/2010 RC2 RC16 0.498 RC16 High RC16 High RC16 High
X8728_5.39 12/09/2010 RC15 RC15 0.387 RC15 High RC15 High RC15 High
X7083_1.39 14/09/2010 RC8 RC8 0.758 RC8 High RC8 High RC8 High
X7564_8.47 17/09/2010 RC15 RC15 0.703 RC15 High RC15 High RC15 High
X8728_5.38 19/09/2010 RC15 RC15 0.348 RC15 High RC15 High RC15 Low
X7564_8.73 02/10/2010 RC4 RC4 0.333 RC4 High RC4 High RC4 High
X7915_6.13 08/10/2010 RC4 RC8 0.68 NA NA RC8 Low RC8 Low
X7564_8.55 10/10/2010 RC12 RC12 0.576 RC12 High RC12 High NA NA
X7564_8.81 10/10/2010 RC13 RC14 0.665 RC14 Low NA NA RC14 Low
X7564_8.87 10/10/2010 RC15 RC15 0.876 RC15 Low RC16 Low RC10 Low
X7915_6.14 30/10/2010 RC4 RC8 0.298 NA NA NA NA RC14 Low
X7564_8.48 16/12/2010 RC15 RC15 0.836 RC15 High RC15 High RC15 High




Appendix                             D 
 
Supplementary Table D1. The origin locations posited by SnAPO and Bayesian inference, 
with the values of those posited origins. The SnAPO values show greater variation than the 
Bayesian values. If the origin posited by both methods concurs then the values posited by 
both should be considered, since agreement does not automatically mean that it is the true 
origin. 







X7564_8.19 Belfast Antrim Belfast 29.01 100.00 
X7564_8.91 Wrexham Chester Chester 53.62 100.00 








X7564_8.69 Southampton Southampton Southampton 66.10 100.00 
X7564_8.20 Belfast Belfast Belfast 24.10 100.00 
X7564_8.26 Cardiff Leicester Leicester 59.59 100.00 
















X7564_8.35 Chelsea London St. 
Mary 
London St. Mary 30.70 100.00 
X7564_8.78 Newcastle Belfast Belfast 24.42 99.92 





X7564_8.27 Cardiff Cardiff Cardiff 41.59 100.00 
X7564_8.61 London 
Northwick 
Cambridge London St. Mary 12.50 98.63 
X7748_6.69 Antrim Altnaegelvin Sunderland 17.20 99.56 
X7748_6.70 Antrim Antrim Sunderland 38.09 99.56 
X7564_8.28 Cardiff Cardiff Cardiff 43.70 100.00 
X7564_8.52 Leicester Leicester Leicester 52.16 100.00 




X7564_8.30 Cardiff Cardiff Cardiff 59.39 100.00 
X7564_8.74 Sunderland Sunderland Sunderland 58.54 100.00 
X7564_8.84 Wishaw Inverness Inverness 53.20 68.82 
X7564_8.22 Belfast Belfast Dublin 36.12 95.52 
X7564_8.31 Cardiff Cambridge Cardiff 39.93 98.33 
X7564_8.83 West Suffolk Papworth Papworth 50.96 99.99 
X7564_8.15 Dublin Dublin Dublin 50.89 100.00 
X7564_8.80 Galway Cork Cork 34.04 100.00 





X7083_1.28 Cambridge Papworth Papworth 48.55 100.00 
X7564_8.53 Leicester Leicester Leicester 50.44 100.00 
X7748_6.77 Bangor Bangor Bangor 54.66 100.00 
X7564_8.75 Sunderland Newcastle Sunderland 26.68 99.74 
X7083_1.29 Cambridge Cambridge Papworth 57.49 99.71 
X7564_8.79 Ulster Belfast Belfast 29.21 100.00 
X7564_8.76 Sunderland Sunderland Sunderland 59.66 100.00 
X7564_8.54 Leicester Southampton Southampton 62.58 100.00 
X7564_8.68 Glasgow 
South General 
UCL London St. Mary 34.98 96.71 
X7564_8.70 Southampton Southampton Southampton 77.59 100.00 
X7748_6.66 York Cambridge Sheffield 26.35 98.63 
X7748_6.67 York Sheffield Sheffield 23.61 99.92 
X7564_8.86 Wishaw Manchester Manchester 27.28 99.82 
X7748_6.72 UCL London St. 
Mary 
London St. Mary 22.28 98.94 
X7564_8.65 Shrewsbury Bangor Bangor 47.46 100.00 
X7564_8.82 Galway Cork Cork 53.93 100.00 
X7564_8.37 Chelsea London St. 
Mary 
London St. Mary 57.54 100.00 
X7748_6.73 UCL London St. 
Mary 
London St. Mary 30.23 100.00 
X7564_8.17 Dublin Dublin Dublin 26.45 99.98 
X7564_8.18 Dublin Dublin Dublin 54.92 100.00 
X7748_6.75 UCL London St. 
Mary 
London St. Mary 24.36 100.00 
X7564_8.77 Truro Truro Truro 54.01 72.62 
X7564_8.71 London St. 
Bart’s 
UCL UCL 26.25 95.57 
X7564_8.24 Cambridge Papworth Papworth 24.08 66.26 
X7564_8.64 Inverness Inverness Inverness 82.61 100.00 
X7564_8.16 Dublin Dublin Dublin 50.70 100.00 









X7564_8.43 Cork Cork Cork 49.52 100.00 
X7564_8.42 Cork Dublin Cork 39.97 99.96 
X7564_8.40 Cork Cork Cork 55.22 100.00 
X7915_6.9 Colchester London St. 
Mary 
London St. Mary 74.03 100.00 
X7564_8.89 Wishaw Wishaw Manchester 51.09 97.65 
X7564_8.32 Chester Chester Chester 57.51 100.00 
X7564_8.90 Wrexham Shrewsbury Shrewsbury 23.67 58.78 
X7564_8.33 Chester Chester Chester 53.78 99.43 
X7083_1.30 Cambridge Papworth London St. Mary 42.00 99.72 
X7564_8.34 Chester Chester Chester 27.33 100.00 
X7083_1.31 Cambridge Papworth Papworth 48.73 100.00 
X8728_5.51 Colchester UCL UCL 26.68 83.68 
X7083_1.32 Cambridge Cambridge Cambridge 47.29 100.00 
X7083_1.34 Cambridge UCL UCL 25.96 86.25 
X7083_1.35 Cambridge Papworth Papworth 56.67 100.00 
X7748_6.80 Bangor West Suffolk West Suffolk 31.47 100.00 
X7083_1.36 Cambridge Cambridge Cambridge 74.13 100.00 
X7564_8.56 North Devon Chester Chester 54.16 100.00 
X7915_6.10 Colchester Cambridge Cambridge 44.19 100.00 
X7083_1.38 Cambridge Papworth Papworth 63.31 100.00 




Kirkcaldy Belfast 13.45 99.96 








Kirkcaldy Belfast 17.72 99.97 
X7564_8.73 London St. 
Bart’s 
UCL UCL 25.06 94.76 
X7915_6.13 Colchester Norfolk Cardiff 50.08 79.02 
X7564_8.55 Manchester Manchester Manchester 57.59 100.00 
X7564_8.81 Galway Altnaegelvin Altnaegelvin 58.66 100.00 
X7564_8.87 Wishaw Wishaw Wishaw 78.07 100.00 

















Appendix                                E 
 Here I provide a select number of examples from the 90 test isolates which were 
processed using SnAPO, as described in Chapter 4. I chose these examples to exhibit the 
variety of output possible using SnAPO. Each of the examples have the following layout. The 
first panel (a) shows the SnAPO output as a DOV percentage. I also display any LSSs the isolate 
expresses, and the origin location as predicted by TAPO. (b) displays a coarser scale of 
geographic resolution using RCs. Finally, the sampling effort for each hospital is shown in (c). 
The bars in (a) and (c) are coloured by the RCs (provided as a graphical legend in a) and are 
ordered by their geographic proximity. The shading in (b) is split into 10% bins, with the in the 
top right corner. A brief description of the following examples are provided here: 
 Isolate 933 shows two possible origin hospitals in neighbouring RCs. 
 Isolate 936 shows one very high peak for a single hospital and RC. This type of output 
is similar to the majority of the test isolates. 
 Isolate 943 shows an ambiguous output, with no one hospital or RC as the obvious 
origin location. 
 Isolate 947 shows a very unclear output, with no location as an obvious origin at either 
the hospital or RC geographic resolution. 
 Isolate 970 shows two possible origin hospitals in neighbouring RCS, though this 
output is slightly ambiguous due to lower DOVs. 
 Isolate 972 shows three possible origin hospitals in three disparate RCs. This output is 
therefore ambiguous as to the true origin of this isolate. 
 Isolate 983 shows two possible origin locations in neighbouring RCs of different 
countries; England and Wales. 
 Isolate 985 shows an ambiguous hospital origin, but a clearer RC origin. 
 Isolate 991 shows two very similar origin hospitals, but a very clear RC origin. 

































































Appendix                                F 
 Here I provide a select number of examples from the 90 test isolates which were 
processed using the Bayesian classification approach, as described in Chapter 5. I chose these 
examples to exhibit the variety of output possible, and they are the same examples as those 
shown in Appendix E. Each of the following examples has the same layout, given here. The 
sampling effort of each hospital is shown in (a). Both the SnAPO (b) and the Bayesian method 
outputs (d) are included. I also include the log version of the Bayesian output (c). I also display 
any LSSs the isolate expresses, the number of SNPs the isolate harbours, and the origin 
location as predicted by TAPO in (b). In all plots the bars are coloured by Referral Cluster, 
provided as a graphical legend in (a). Brief descriptions of the following images are provided 
here: 
 Isolate 933 shows the typical high peak in the Bayesian output, which concurs with one 
of the two high peaks in the SnAPO output. 
 Isolate 936 shows the typical high peak in the Bayesian output which concurs with the 
SnAPO output. The log Bayesian output also appears uniform. 
 Isolate 943 shows an ambiguous SnAPO output, though the Bayesian output concurs 
with the highest SnAPO peak. 
 Isolate 947 shows a very unclear SnAPO output, and therefore the high peak seen in 
the Bayesian output could be suspect. 
 Isolate 970 shows a discrepancy between the predicted SnAPO and Bayesian origin. 
 Isolate 972 shows an ambiguous SnAPO output, with a mismatch between the SnAPO 
predicted origin and the Bayesian one. 
 Isolate 983 shows concurrence between the two methods, however there are two 
possible origin locations with high values. 
 Isolate 985 shows an ambiguous SnAPO output, though the Bayesian output concurs 
with the high peaks of the SnAPO output. 
 Isolate 991 shows two possible SnAPO origins, with the Bayesian output concurring 
with the slightly lower of the two. 
 Isolate 1020 shows an unclear SnAPO output, with an ambiguous Bayesian output. 
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